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133 2.1
'The three little sentences that will get you through life. 
Number one, ‘Coverfor me’.
Number two, ‘Oh, good idea, boss’.
Number three, ‘It was like that when I got here’.”
Homer J. Simpson
Summary
The rab family of small, ras-like GTPases regulate membrane trafficking events in the 
secretory and endocytic pathways. They appear to be involved in all stages of 
vesicular transport, from vesicle budding and cargo selection to motility, docking and 
membrane fusion. Through a cycle of GTP binding and hydrolysis, rab-effector 
proteins are recruited to membrane sub-domains in a temporally and spatially specific 
manner. Several rab proteins localise to the Golgi apparatus, the organelle consisting 
of stacked, flattened, membrane-bound cisternae through which newly-synthesised 
proteins are transited and modified, and where proteins and lipids are sorted and 
packaged for transport to other subcellular destinations. The structure of the Golgi is 
maintained by a matrix of proteins, many of which have now been shown to be rab- 
effector proteins. This thesis focuses on Golgi-localised rab proteins and their 
effector proteins. The cw-Golgi-localised rab protein, rabl, is shown to interact with 
the Golgi matrix/golgins GM130 and p i 15 while rab2 binds GM130 as well as a 
novel tethering factor named golgin-45. siRNA-mediated depletion of these rabs and 
golgins revealed them to be important for the maintenance of Golgi structure and 
suggested that p i 15 is primarily recruited to Golgi membranes by its interaction with 
rabl rather than its association with GM130. A search for additional rabl effectors 
revealed potential interactions between rabl and the phosphoinositide- 
binding/metabolising proteins centaurin(32 and MTMR6. A search for novel effectors 
of the 7raMJ-Golgi-localised rab protein, rab6, was also made, revealing specific 
interactions with the dynactin subunit p i50^ '"^ "^  and the dynactin/dynein accessory 
proteins BicDl and BicD2. These interactions are proposed to mediate the 
recruitment of dynactin/dynein to membranous cargo and control minus-end directed, 
microtubule-dependent vesicle motility. An additional rab6 effector, GOPC, was also 
identified, which may be responsible for cargo recognition and sorting. Finally, the 
cis-Golgi rab-effector and matrix protein, GM130, is shown to have a hitherto 
unsuspected role in the activation of a family of Golgi-localised Ste20 kinases. The 
implications of all these interactions for Golgi structure and function is discussed.
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Chapter 1: Introduction
1
1
1.1 The Secretory Pathway
The secretory pathway in eukaryotic cells is the pathway by which new proteins and 
lipids synthesized at the endoplasmic reticulum are delivered to different sub- ■*. -,
compartments within the cell or secreted from the cell. The vectorial transport of this 
material through the endomembrane system is a subject, which has fascinated cell 
biologists for decades (Mellman and Warren 2000).
The pathway begins with the translocation of newly synthesized proteins into the 
endoplasmic reticulum (ER). In animal cells, this usually occurs co-translationally, as 
signal-peptides in the protein sequence direct the attachment of the ribosome to the 
ER membrane and the translocation of the protein through a pore (the translocon) into 
the internal lumen of the ER. For soluble secretory proteins, the signal sequence is at
:the amino terminus of the protein and is cleaved following the translocation of the 
protein into the ER lumen (Rapoport et al. 1996). Type I integral membrane proteins 
also have a cleavable N-terminal signal peptide as well as a stop-transfer signal later 
in the protein sequence, which prevents further translocation of the polypeptide 
through the translocon and becomes the transmembrane domain of the protein (Goder 
and Spiess 2001). Type II and type III membrane proteins have internal signal 
sequences that direct the insertion of the nascent polypeptide into the translocon 
(either the C- or N- termini of the protein respectively) but also act as transmembrane 
anchors so that integral membrane proteins of the correct topology are formed. 
Multispanning transmembrane proteins are formed by a combination of start- and 
stop-transfer sequences (Goder and Spiess 2001). For all integral membrane proteins, 
the transmembrane domains partition into the ER membrane during their passage 
through the translocon.
_
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Following translocation, proteins are acted upon by numerous ER proteins responsible 
for ensuring their correct folding and processing. The ER quality control system 
utilises a specific glue osyltransferase and lectins to ensure that only correctly folded 
proteins are able to exit the ER (Ellgaard and Helenius 2003). The 
glucosyltransferase recognises misfolded proteins and adds glucose residues to the 
ends of N-linked sugar chains on the protein (Trombetta and Helenius 2000). This 
modified glycan is then recognised by the lectins calnexin and calreticulin and thereby 
retained in the ER. A glucosidase then acts to release the protein and allow it to be re­
sampled by the glucosyltransferase. The cyclical action of these enzymes retain the 
protein in the ER until it has folded correctly (Ellgaard and Helenius 2001).
Once the protein is correctly folded, it must be transported from the ER to the Golgi 
apparatus and then onwards to other compartments of the secretory pathway. The 
pioneering work of Jamieson and Palade used electron microscopy autoradiography to 
first demonstrate this linear transport pathway in pancreatic acinar cells and to show 
the existence of vesicular carriers responsible for transferring material between the 
different organelles (Palade 1975). The mechanisms of vesicle transport will be 
discussed below but, put simply, vesicles form at a donor membrane, budding off to 
contain transportable cargo, before fusing with an acceptor membrane and delivering 
their contents. Thus, cargo is transported in vesicles from the ER to the Golgi 
apparatus, the key organelle of the secretory pathway.
1.2 The Golgi Apparatus
The Golgi was first identified over 100 years ago by the Italian histologist Camillo 
Golgi using a particular silver nitrate staining technique which revealed a distinctive 
reticular network in Purkinje cells (Golgi 1898). It wasn’t until the advent of electron 
microscopy (EM), however, that real insights into the structure and function of the 
Golgi began to be made. Dalton and Felix were the first to observe the Golgi as a 
stack of flattened, membrane-bound, cisternae (Dalton and Felix 1954). EM 
autoradiography was used to show a role for the Golgi in sulphation and glycosylation 
(Godman and Lane 1964; Neutra and Leblond 1966) while, as mentioned above, 
Palade and co-workers were able to show the passage of secretory material through 
the Golgi stack (Palade 1975).
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A complementary technique was that of cellular sub-fractionation, through which the 
glycosylation enzyme galactosyltransferase was found to be enriched in Golgi 
fractions and therefore identified as a resident Golgi marker protein (Fleischer et al. 
1969; Morre et al. 1969). All of this pointed to a role for the Golgi apparatus in 
protein transport and modification. This concept was expanded on as the structure of 
the Golgi was further defined and found to consist of distinct sub-compartments 
containing different glycosyltransferase and other enzyme activities such as 
NADPase.
The Golgi cisternal stack has a defined polarity with a cis face exchanging material 
with the ER and a trans  face communicating with the plasma membrane and 
endosomes. In between the cis- and trans- cisternae are the medial-cistcimc. Albeit 
with some degree of overlap, the different cisternae contain a different complement of 
enzymes such that, as a secretory protein passes through the Golgi in a cis to trans 
fashion, it is acted upon sequentially by these enzymes to produce the correct 
glycosylation patterns and other modifications (Kornfeld and Kornfeld 1985).
In addition to the cisternae, two other structurally and functionally distinct Golgi sub­
compartments have been recognised. The trans-Golgi network (TGN) is located at 
the trans-fâc& of the Golgi stack but has a much more complex tubulo-vesicular 
structure than the fra«5-cisternae. The compartment again has a distinct subset of 
resident proteins and is involved in the sorting and packaging of cargo for delivery to 
the plasma membrane, lysosomes, or endosomes (Griffiths and Simons 1986).
At the cis face of the Golgi is another complex network of tubules and vesicles, 
variously defined as either the cis-Golgi network (CGN), the ER-Golgi intermediate 
compartment (ERGIC) or simply as vesicular-tubular clusters (VTCs). This network 
is thought to be formed by the fusion of ER-derived vesicles en route to the cis-Golgi 
(Schweizer et al. 1988). Whether these clusters fuse directly with a pre-existing cis- 
Golgi cisternae or whether they in fact develop themselves into the cis-Golgi is a 
matter of some debate, which reflects two differing views of the nature of the Golgi 
apparatus and the way in which biosynthetic material passes through it.
The first model to explain Golgi function was the cisternal maturation/progression 
model (Grasse 1957). This proposed that cisternae were formed at the cis-face of the 
Golgi before moving progressively through the Golgi stack, maturing as they did so 
into medial-cist&msLQ followed by fmns-cisternae. At the fra«s-face, the cisternae
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would become fragmented as cargo was selected and packaged into vesicles for 
delivery to their final destinations.
As the existence of vesicular transport became accepted, an alternative model was 
proposed in which the Golgi cisternae were thought to be stable structures with 
transport between cisternae being mediated by vesicles (Farquhar and Palade 1981). 
Supporting this hypothesis was a series of in vitro assays by Rothman and colleagues 
which were able to recreate transport between two different populations of Golgi- 
derived membranes (Fries and Rothman 1980). Although there is good evidence to 
support the idea of anterograde transport through the Golgi by vesicles, many 
problems remain, not least the question of how large macromolecules such as 
procollagen fibrils, which are larger than the vesicles seen to be associated with the 
Golgi, are transported through the Golgi stack.
The cisternal maturation model may account for this by proposing that secretory 
material passes through the Golgi as cisternae mature, but that maturation occurs due 
to the consecutive recycling of enzymes from later Golgi compartments via transport 
vesicles (Pelham 1998).
To date, neither the cisternal maturation nor the stationary cisternae models have been 
proved conclusively. The reality may be that a combination of both processes occurs 
with some secretory material moving in anterograde transport vesicles while Golgi 
enzymes are recycled in retrograde vesicular carriers. Although it is not trivial to 
identify the contents of vesicles passing through the Golgi apparatus, secretory 
proteins as well as resident enzymes have been found in Golgi vesicles (Orel et al.
1997). Golgi enzymes in particular are clearly found in a type of Golgi vesicle known 
as COPI vesicles (see section 1.4). This reflects the general importance of retrieval 
and recycling in the secretory pathway.
1.3 Retention and Retrieval in the Secretory Pathway
Despite the high flux of material through the secretory pathway, the different 
compartments of the pathway are able to maintain separate identities with differing 
complements of resident proteins. This is probably due to a combination of the 
selective retention of resident proteins, the preferential incorporation of secretory 
cargo into anterograde vesicles and the retrieval of proteins which have ‘escaped’ to 
later compartments of the pathway.
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The best understood retrieval mechanisms are those involved in the recycling of 
proteins back to the ER from the Golgi apparatus. Once ER-derived vesicles have 
fused together to form the CGN, a sorting process begins to ensure that resident ER 
proteins are returned. For type I ER membrane proteins, this involves an interaction 
between a ‘retrieval m otif in their cytosolic domains and the y subunit of the COPI 
protein coat of nascent retrograde vesicles (Harter et al. 1996; see section 1.4). This 
retrieval motif is also known as the dilysine motif due to its sequence of KKXX where 
X is any amino acid (Jackson et al. 1993).
Other types of integral membrane proteins may contain other retrieval motifs such as 
the N-terminal RKR motif found in the ATP-sensitive channel (Zerangue et al. 
1999). Lumenal ER proteins contain a retrieval motif at the C-terminus, this time of 
the sequence KDEL (Munro and Pelham 1987). A membrane-spanning KDEL 
receptor, which recognises this motif, is responsible for recycling these proteins back 
to the ER (Lewis and Pelham 1992).
The mechanisms by which resident Golgi proteins remain localised to specific Golgi 
sub-compartments are less clear. Among the models proposed to explain this 
phenomenon are the self-association of Tike’ enzymes to form large oligomeric 
structures, and the preferential partitioning of different proteins into membranes of 
different composition and thickness (Bretscher and Munro 1993; Nilsson and Warren 
1994).
No matter how it is achieved, however, the different organelles of the secretory 
pathway maintain separate identities and transport between these compartments in 
either an anterograde or retrograde direction, occurs via the formation of transport 
vesicles and their specific fusion with their target membrane.
1.4 Mechanisms of Vesicle Budding
The first step in vesicle formation is the recruitment of proteins from the cytosol to the 
membrane surface to form a coat. Cargo must be selected into the nascent vesicle as 
the donor membrane invaginates. The vesicle must then detach from the membrane 
by scission of the bud neck. Finally, the vesicle must shed its protein coat before it is 
ready to fuse with its target membrane.
There are several different sets of coat proteins, defining different classes of vesicle 
within the secretory pathway. The best studied are the COPII vesicles mediating ER
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to Golgi transport, COPI vesicles involved in Golgi to ER and intra-Golgi transport, 
and clathrin vesicles which transport material between the trans-Golgi and the 
endosomes (and also from the plasma membrane to the endosomes in the endocytic 
pathway). There are many similarities between these different types of vesicle but 
there are important differences also.
COPII (Coat Protein II) vesicles form at transitional ER sites -  regions of the ER 
devoid of ribosomes and specialised for the export of material destined for the Golgi. 
The accumulation of COPII components at the transitional ER can be visualised in 
live cells using green fluorescent protein (GPP) tagged proteins (Hammond and Glick 
2000; Stephens et al. 2000). The proteins themselves were originally identified in the 
budding yeast Saccharomyces cerevisiae using a combination of yeast genetics and an 
in vitro assay for ER to Golgi transport (Novick et al. 1980; Baker et al. 1988). Most 
of the mammalian homologues of the proteins involved have now been identified.
The initiator of COPII coat formation is the small GTPase Sarlp. The GDP-bound 
form of Sarlp is predominantly cytosolic but is recruited to the ER membrane by its 
guanine exchange factor (GEF) Secl2p (Barlowe and Schekman 1993). Once 
activated at the membrane, Sarlp-GTP is able to recruit additional components of the 
COPII coat, beginning with the Sec23p-Sec24p complex (Barlowe et al. 1994). The 
function of this complex appears to be both cargo selection (Sec23p can bind to a 
diphenylalanine motif in the cytosolic domains of the p24 family of transmembrane 
proteins required for the efficient ER to Golgi transport of some cargo molecules 
(Dominguez et al. 1998)) and the recruitment of SNARE proteins essential for the 
fusion of the COPII vesicle with its target membrane (Peng et al. 1999; Miller et al. 
2003; Mossessova et al. 2003; and see section 1.5.4). Selectivity seems to arise from 
multiple cargo binding sites (Miller et al. 2003; Mossessova et al. 2003). The 
Secl3p“Sec31p complex is also recruited to the ER membrane resulting in membrane 
deformation and vesicle budding (Barlowe et al. 1994). Once the vesicle has 
completely formed, Sec23p acts as a GTPase activating protein (GAP) for Sarlp 
(Yoshihisa et al. 1993). The release of Sarlp-GDP into the cytosol triggers the 
uncoating of the COPII vesicle prior to its fusion with the CGN.
The formation of COPI vesicles is based on similar principles but involves a different 
set of components. The precise role of these carriers remains controversial but it 
seems that they function mainly in retrograde transport within the Golgi and from the
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Golgi to the ER. They may also play a role in anterograde transport through the Golgi 
(Orci et al, 1997).
As with COPII vesicles, COPI coat formation begins with the recruitment of a small 
GTPase to the donor membrane. In the case of COPI, this GTPase is ARFl (ADP- 
ribosylation factor 1) which is activated at the appropriate membrane by ARFl GEF 
(Serafini et al. 1991; Franco et al. 1998). Once associated with the membrane, ARFl 
is able to recruit the COPI complex, a heptameric complex normally consisting of the 
proteins a , p, |3% y, ô, e, and C-COP (Waters et al. 1991). Different isoforms of these 
subunits can substitute for them in the COPI coat but the purpose of this in vivo is 
unclear. As discussed in section 1.3, the COPI complex (specifically the y subunit) is 
responsible for cargo recognition by an interaction with dilysine motifs. p24 proteins 
are also recognised by the COPI complex during cargo recognition (Dominguez et al.
1998). In addition, recruitment of the COPI complex causes membrane deformation 
and vesicle budding. Interestingly, the kinetics of COPI coat recruitment appears to 
be regulated by the presence of suitable cargo. The GTPase activity of ARFl is 
stimulated by ARFGAP and the COPI complex. However, this stimulation is reduced 
in the presence of a synthetic peptide corresponding to the sorting signal of a p24 
protein (Goldberg 2000). This suggests a model in which the presence of suitable 
cargo for COPI transport inhibits ARFl GTPase activity thereby allowing more time 
for coat assembly, vesicle budding, and scission before ARFl does hydrolyse GTP, 
dissociates from the membrane and triggers uncoating.
ARFl is also involved in the initiation of clathrin coat formation. In the case of TGN 
to endosome transport, ARFl recruits the clathrin adaptor protein AP-1 (Stamnes and 
Rothman 1993). Different adaptor proteins act at other sites of clathrin coat formation 
and the mechanism of their recruitment is not so clear although it is nucleotide 
dependent.
The adaptor proteins are responsible for binding to many of the proteins involved in 
clathrin coat formation and function, including clathrin itself, as well as to cargo 
proteins via various sorting signals found in the cytosolic tails of many membrane 
proteins. The recruitment to the membrane of clathrin, with its distinctive triskelion 
structure, followed by its polymerisation into a basket-like network of hexagons and 
polygons, results in the deformation of the membrane and vesicle budding. Unlike 
COPI and COPII vesicles, scission requires an additional accessory factor -  the
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GTPase dynamin. Dynamin forms a ring at the neck of the bud which somehow 
results in vesicle fission. Clathrin coat formation appears to be much more regulated 
than COPI or COPII vesicle budding, as reflected in the existence of a variety of 
regulatoi7 factors such as amphyphysin, epsin, and synaptojanin (Kirchhausen 2000). 
Many of these proteins are lipid-modifying enzymes that alter the lipid composition or 
distribution of the forming vesicle, enabling additional proteins to be recruited and 
also affecting membrane curvature. A further difference between clathrin vesicles 
and COPI/COPII vesicles is the mechanism of uncoating. While COPI and COPII 
vesicles uncoat following the release of the small GTPases ARFl and Sarlp 
respectively, clathrin uncoating requires the additional activity of the heat-shock 
proteins Hsc70 and auxilin (Kirchhausen 2000).
Nevertheless, although important differences exist between the different types of 
vesicle coats, the basic principles of coat recruitment, cargo selection, membrane 
deformation, scission and uncoating remain the same. Similarly, the fundamental 
mechanisms by which vesicles dock and fuse with their target membranes are also 
conserved across all vesicle transport steps.
1.5 Mechanisms of Vesicle Targeting
A wide variety of proteins are involved in ensuring that a vesicle docks and fuses 
specifically with its target membrane. These proteins fall into different families, 
individual members of which act at individual vesicle transport steps in the secretory 
and endocytic pathways, reflecting the conserved nature of vesicle targeting. This 
conservation also allowed a number of different experimental approaches towards 
studying vesicle targeting to converge and reveal a general model for docking and 
fusion. The different families of proteins will be discussed below but first we will 
consider the various approaches used to reveal their function.
1.5.1 In vitro reconstitution
The first approach to successfully identify factors essential for membrane transport 
was the reconstitution in vitro of intra-Golgi transport by James Rothman and co­
workers. The approach made use of a membrane protein from the vesicular stomatitis 
virus, called VSV-G, which passes through the secretory pathway of infected cells. 
Early Golgi or ER-derived vesicles from a viral-infected cell line unable to process
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VSV-G oligosaccharides properly were isolated, and then mixed with Golgi 
membranes from wild type cells in the presence of ATP and cytosol. Under these 
conditions, VSV-G protein oligosaccharides were processed properly, indicating that 
fusion had occurred between the vesicles and Golgi membranes (Fries and Rothman 
1980). Using this assay, it was possible to identify a protein essential for membrane 
fusion, which was sensitive to the alkylating agent N-ethyl-maleimide (NEM) (Block 
et al. 1988; Wilson et al. 1989). This NEM-sensitive factor (NSF) was found to be a 
AAA-type ATPase. Co-factors for NSF called SNAPs (Soluble NSF Attachment 
Proteins) were also identified in this way (Clary et al. 1990). NSF and the SNAPs 
were later found to be essential for the function of the SNARE (SNAP Receptor) 
proteins (Sollner et al. 1993), a family of proteins already implicated in vesicle fusion 
by biochemical studies of synaptic vesicles.
1.5.2 Synaptic vesicle characterisation
Studies on purified synaptic vesicles had identified a membrane protein called 
VAMP/synaptobrevin which was able to form a complex with a related protein 
located at the pre-synaptic membrane -  syntaxin (Trimble et al. 1988; Bennett et al. 
1992). When these two proteins were found to form a complex with one another and 
with NSF and SNAP, the proteins were reclassified as SNAP Receptors (SNAREs), 
with VAMP and related proteins being designated vesicle- or v-SNAREs and syntaxin 
and its relatives being known as target membrane- or t-SNAREs (Sollner et al. 1993). 
Support for a role for the SNAREs in membrane fusion came from the observation 
that they could be cleaved by certain neurotoxins such as botulinum toxin which 
inhibit synaptic vesicle exocytosis (Montecucco and Schiavo 1995), The 
identification of proteins related to VAMP and syntaxin in other organelles of the 
secretory and endocytic pathways suggested they were involved in a general 
mechanism of membrane fusion (Sollner et al. 1993). The SNARE proteins were also 
found to be present in yeast and, through a genetic approach, it had already been 
shown that NSF and SNAPs were important for secretion.
1.5.3 Yeast genetic screens
Another approach key to uncovering the basic mechanisms of membrane targeting 
and fusion was the application of genetic screens in S. cerevisiae. This approach was
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begun by Randy Schekman and Peter Novick and resulted in the isolation of many 
conditional mutants deficient in secretion (Novick et al. 1980), Two of the genes 
thereby identified were SEC 18 and SEC17 which encode the yeast homologues of 
NSF and a-SNAP respectively. When these proteins were identified in Rothmans in 
vitro transport assay, it became clear that the mechanisms of membrane targeting were 
conserved and the different experimental approaches began to converge. Thus, when 
the yeast genetic screen revealed the importance of Sec4p for secretion (Salminen and 
Novick 1987), it soon became clear that this protein represented the founding member 
of a family of small ras-related GTPases, the rabs, different members of which existed 
on different organelles of the secretory and endocytic pathways in both yeast and 
mammalian cells (Chavrier et al. 1990).
Rab proteins are one of a number of protein families involved in vesicle transport. 
These different families act together to ensure correct and efficient vesicle targeting, 
with individual family members acting at specific steps in the secretory and endocytic 
pathways. We will now consider these protein families in turn and discuss their 
general roles in vesicle docking and fusion.
1.5.4 SNARE proteins
As discussed above, SNARE proteins were implicated in membrane fusion by a 
number of different observations. The original ‘SNARE hypothesis’ proposed the 
formation of a four-helical bundle between SNAREs on the vesicle membrane and 
SNAREs on the target membrane (Sollner et al. 1993; Rothman 1994). This complex 
would drive membrane fusion as well as providing the necessary specificity to ensure 
only the correct membranes fused.
Most SNARE proteins are short type II membrane proteins with a characteristic 
cytoplasmic a-helical region. An atypical class of SNAREs however is exemplified 
by SNAP-25 (a protein unrelated to the SNAP proteins discussed in section 1.5.1), 
which is required for fusion of synaptic vesicles with the pre-synaptic membrane. 
SNAP-25 is a peripheral membrane protein that associates with the plasma membrane 
by a palmitoyl group. It has two separate a-helices, both of which are involved in 
SNARE complex formation. Thus, the core SNARE complex formed between a 
synaptic vesicle and the plasma membrane consists of one helix contributed by the v- 
SNARE VAMP on the vesicle, and three helices from the t-SNAREs on the target
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membrane -  one from syntaxin and two from SNAP-25 (Fasshauer et al. 1998; Sutton 
et al. 1998). Other SNARE complexes consist of helices contributed by four separate 
SNARE proteins but the pattern of one helix from the vesicle membrane and three 
from the target membrane remains the same (Parlati et al. 2000).
The SNARE complex is a highly stable, SDS-resistant complex and it has been 
proposed that the energy of its formation is able to drive membrane fusion (Lin and 
Scheller 1997). While some have proposed that additional molecules are required to 
catalyse fusion, in vitro reconstitution experiments measuring liposome fusion suggest 
that the SNAREs alone can suffice to drive fusion (Weber et al. 1998; Nickel et al.
1999).
The specificity of SNARE associations has also been called into question. 
Immunoprécipitation of SNARE complexes from yeast cell extracts had suggested 
that SNARE proteins were more promiscuous in their interactions than originally 
thought (von Mollard et al. 1997). Liposome reconstitution experiments have again 
appeared to answer this criticism. SNARE-mediated liposome fusion in vitro only 
occurs with a limited number of SNARE combinations, all of which correspond to a 
genetically or biochemically inferred in vivo interaction (McNew et al. 2000).
Some questions over SNARE function remain. Once membrane fusion has occurred, 
the members of the SNARE complex end up on the same membrane. The complex 
must first be disassembled -  a process catalysed by NSF and its co-factor a-SNAP. It 
is here that the energy input required for membrane fusion is made in the form of ATP 
hydrolysed by NSF. This disassembly of cis complexes by NSF and a-SNAP may 
represent the NSF-dependent ‘priming’ step required immediately prior to membrane 
fusion (Mayer and Wickner 1997). Once the cis complexes have been disassembled, 
the v-SNAREs must be sorted and recycled to their original compartments. Since the 
majority of SNAREs are integral membrane proteins, this recycling cannot occur 
simply via the cytosol and must occur through vesicular transport instead. This is a 
potential problem because, if SNARE proteins were continuously active, a v-SNARE 
recycling in a vesicle might direct that vesicle to simply fuse back with the membrane 
it was supposed to be recycling from. This implies that SNARE activity must be 
regulated in some way and/or that, in vivo, SNARE proteins alone are not responsible 
for determining the directionality and specificity of membrane fusion.
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1.5.5 SM proteins
A potential family of SNARE regulators is the Secl/Muncl8 (SM) family. There are
7 members of this family in the human genome (Bock et al, 2001), which appear to
tightly bind to various SNARE proteins and regulate SNARE function in some way
(Toonen and Verhage 2003). Whether this regulation is positive or negative is
unclear-. Overexpression of many family members inhibits vesicle fusion (Thurmond
et al. 1998) but, on the other hand, loss-of-function mutants also inhibit fusion
suggesting that the activity of these proteins is essential in some way. To make
matters more confusing, different results are obtained with different members of the
family (Toonen and Verhage 2003). This may reflect a specific adaptation of
individual family members to fulfil different roles at different transport steps. In
support of this is the fact that, even though the structure of the SM family proteins is
conserved, their mode of binding to SNAREs is not (Gallwitz and Jahn 2003; Toonen
and Verhage 2003). Some SM proteins bind to monomeric SNAREs while others
.specifically recognise SNARE complexes. SM proteins also show interactions with 
other proteins involved in vesicular transport and may provide a link between these 
proteins and SNARE-mediated membrane fusion (Toonen and Verhage 2003),
1.5.6 Rab proteins
The Rab proteins are a family of small ras-related GTPases, directing particular 
vesicle transport steps in the secretory and endocytic pathways (Novick and Zerial 
1997). The precise ways in which they direct traffic are not entirely clear and may 
differ from Rab to Rab but it is certain that they play an important role in promoting 
the specificity and efficiency of vesicle docking and fusion. The first family members 
to be identified were both in yeast: Sec4p, required for exocytosis, and Yptlp, 
required for ER to Golgi transport (Gallwitz et al. 1983; Salminen and Novick 1987; 
Segev et al. 1988).
As with all small GTPases, the Rabs cycle between the GTP (active) and GDP 
(inactive) bound states. In addition, the Rabs undergo a change in their localisation in 
response to their nucleotide state; a prenyl group at the C-terminus allows Rabs to 
become membrane associated in the GTP-bound form. The C-terminal 
‘hypervariable’ region of the Rabs determines which organelle the active Rab is 
recruited to (Chavrier et al. 1991).
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The GTP cycle is influenced by a number of other proteins. Membrane-bound 
Guanine nucleotide Exchange Factors (GEFs) catalyse the exchange of GTP for GDP, 
thereby activating the Rab and stabilising its membrane association. GTPase 
Activating Proteins (GAPs) stimulate the GTPase activity of Rabs, promoting their 
conversion to the inactive, GDP-bound state. GDP-GTP Dissociation Inhibitors 
(GDIs) are able to extract inactive Rabs from membranes by binding to the prenyl 
group and masking it in the cytosol. This interaction is only disrupted by the 
appropriate GEF (possibly in conjunction with a GDI Displacement Factor, (Dirac- 
Svejstrup et al. 1997)) and the Rab GTP cycle begins again. The YIPl family of 
proteins may also be involved in rab targeting through interactions with the prenyl 
groups at the rabs C-terminus (Calero et al. 2003),
The purpose of this cycle is to regulate the membrane recruitment of Rab proteins 
and, in turn, the membrane recruitment/membrane organisation of various Rab 
effector proteins. The Rab may act as a timer, the longer it is ‘on’, the more its 
effectors become organised and the more efficiently is specific membrane docking 
and fusion promoted (Rybin et al. 1996). Certainly, for homotypic membrane fusion 
such as Rab5 mediated endosome fusion, this makes sense with Rab5 acting as a 
master controller, determining the overall rate at which membrane fusion proceeds. 
For heterotypic membrane fusion however, this timer function makes less sense as it 
would be wasteful for a transport vesicle to form and then not be able to fuse with its 
target membrane due to inactivation of the Rab. Active Rabs are therefore recruited 
to vesicles, either during cargo selection or following budding. The Rab protein 
would then recruit its effectors and remain active until after docking or fusion (Goud 
et at. 1988). Alternatively, some Rab proteins appear to localise to target membranes 
and recruit effector proteins there (Siniossoglou et al. 2000; Wang et al. 2000), In 
this case, regulation of Rab activity would regulate the ability of incoming vesicles to 
dock and fuse with the target membrane. Rab activity on both the vesicle and target 
membranes may therefore produce a two-way signal mediating a specific interaction 
between the two membranes.
The functions of the Rab effector proteins are many and varied and will be discussed 
elsewhere in this thesis. In general, however, they facilitate the specific and efficient 
fusion of membranes by acting at many stages of vesicle transport from vesicle 
formation to motility to attachment to the target membrane. The Rabs themselves
13
Chapter 1: Introduction
organise these multiprotein complexes. This is not just important in vesicular 
transport but also in maintaining ordinary organelle identity and function. The 
presence of Rabs on specific organelles (and specific sub-domains of these organelles) 
may allow a specific network of protein-protein (and protein-lipid) interactions to be 
built up which define that compartment. Unlike SNARE proteins which, as discussed 
in section 1.5.4, must recycle via transport vesicles, Rab proteins recycle via the 
cytosol and can therefore be restricted to a single membrane compartment and give 
that compartment its specific identity. The fact that more than 60 Rab proteins have 
been identified in mammalian cells (Bock et al. 2001), supports the idea that Rab 
proteins are capable of providing such specificity.
1.5.7 Tethering proteins
The third family of proteins involved in vesicle targeting is much more diverse in 
structure and function than either the SNARE or Rab proteins.
The idea of a group of proteins mediating the initial tethering together of membranes 
and providing an extra layer of specificity for membrane recognition events arose 
from several lines of evidence. Not only were there doubts as to the specificity of 
SNAREs pairing, but there were also doubts over the spatial specificity of SNAREs. 
For example, it was observed that exocytosis in budding yeast is restricted to the bud 
tip even though the t-SNAREs involved in exocytosis, Ssolp and Sso2p, are localised 
all over the plasma membrane (Brennwald et aL 1994). This implied that other 
factors were involved in specific membrane recognition. The existence of such 
factors was also suggested by experiments in which giant-squid axons injected with 
tetanus toxin, thus cleaving and inhibiting SNARE proteins and membrane fusion, 
were actually found to accumulate synaptic vesicles docked at the pre-synaptic 
membrane (Hunt et al. 1994). Also, SNARE-mediated liposome fusion proceeds at a 
much slower rate than in vivo vesicle fusion suggesting that additional factors are 
required for maximum efficiency (Fasshauer et al. 2002). Finally, the existence of 
‘tethering factors’ was also indicated for docking and fusion events at membranes 
other than the plasma membrane by freeze fracture electron micrographs of the Golgi 
apparatus. These showed the existence of fibrous elements linking vesicles to Golgi 
membranes, leading to the idea of ‘vesicles on strings’ (Orci et al. 1998).
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The identity of these additional factors has been found in a variety of proteins, many 
of which were discovered as autoantigens in patients suffering from autoimmune 
diseases. Although diverse in structure, they can be broadly classified into two groups 
-  those which form large, relatively stable multimeric complexes, and those which are 
long coiled-coil proteins (Whyte and Munro 2002; Gillingham and Munro 2003).
The multimeric complexes involved in membrane tethering may be sub-divided on the 
basis of certain structural similarities. A subgroup of ‘quatrefoil’ tethering complexes 
which assemble in multiples of four subunits, some of which have a conserved N- 
terminal domain, has recently been proposed (Whyte and Munro 2002). The 
remaining multimeric tethering complexes seem to bear no similarity either to the 
quatrefoil complexes or to each other.
The quatrefoil complexes are the exocyst, an octameric complex required for the 
delivery of Golgi-derived vesicles to the plasma membrane (TerBush et al. 1996), the 
VFT/GARP (Vps52/53/54 or Golgi Associated Retrograde Protein) a tetrameric 
complex implicated in retrograde transport from endosomes to the TGN (Conibear 
and Stevens 2000), and the octameric COG (Conserved Oligomeric Golgi) complex 
involved in recycling through the Golgi (Whyte and Munro 2001). Many of the 
subunits of these complexes have a short conserved coiled-coil domain near the N- 
terminus but the function of this domain has yet to be resolved.
The non-quatrefoil complexes are TRAPP (Transport Protein Particle) involved in ER 
to Golgi transport which can act as a GEF for the yeast Rab Yptlp (Sacher et al. 
2001), the Class C Vps complex involved with docking and fusion to the yeast 
vacuole and mammalian endosomes (also a GEF for the Rab Ypt7p) (Rieder and Emr 
1997), and the Dsllp complex which may tether retrograde COPI vesicles to the ER 
membrane (Andag et al. 2001; Reilly et al. 2001).
The evidence for all of these complexes involvement in membrane tethering is varied 
and ranges from genetic studies in yeast to in vitro transport assays which suggest a 
function in vesicle targeting upstream of the SNAREs. The precise functions of all 
these complexes remain unclear, as does the significance of their multimerisation 
compared to the second group of tethering factors -  the long, coiled-coil proteins. 
Many proteins fall into this second class, although they appear to have little similarity 
to one another apart from the presence of long regions of coiled-coil. Commonly, 
these coiled-coil domains are in the centre of the protein with separate domains at the
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N- and C- termini. The coiled-coil domain consists of heptad repeats of amino acids 
where residues 1 and 4 in the sequence are hydrophobic. This results in a helix that 
coils together with other helices to form an extended, rod-like structure (Burkhard et 
al. 2001). For tethering factors, this coiled-coil is normally a homodimer. Breaks in 
the coiled-coil sequence may produce hinges, allowing flexibility in the protein which 
may be important functionally, for example by bringing two tethered membranes 
closer together for downstream fusion to occur.
So far, proteins of this type have only been identified at the Golgi and on endosomes. 
The Golgi tethering proteins (also known as Golgins) will be discussed later in section 
1.6. The endosomal tethering proteins are best exemplified by EEAl (Early 
Endosomal Antigen 1 ;(Christoforidis et al. 1999)). A central coiled-coil domain is 
flanked at the N- and C- termini by domains responsible for localising EEAl to the 
eaiiy endosome. A FYVE domain at the C-terminus binds to phosphatidylinositol (3) 
phosphate (PtdIns(3)P) while both the N- and C-termini contain domains able to bind 
to the endosome-localised Rab protein Rab5. Both Rab5 binding and PtdIns(3)P 
binding appear to be necessary for correct EEAl localisation (Simonsen et al. 1998). 
The presence of such binding sites at both ends of the protein may suggest a simple 
mechanism for EEAl function in membrane recognition. The protein is certainly 
important for such events since anti-EEAl antibodies greatly inhibit endosome fusion 
in an in vitro assay and EEAl-depleted cytosol can only support the assay if 
recombinant EEAl is re-added (Simonsen et al. 1998). The precise role of EEAl 
may be more complicated however, since it binds directly to the SNARE proteins 
syntaxin 6 and syntaxin 13, and exists on endosomes in large oligomeric complexes 
also containing NSF and the Rab5 effectors Rabaptin-5 and Rabex-5 (McBride et al. 
1999; Simonsen et al. 1999).
It is therefore apparent that a variety of proteins, including SNAREs, Rabs, and 
tethering factors, act together to ensure the specific and efficient targeting of vesicles 
to their target membranes as well as giving identity to membrane sub-compartments. 
This is true throughout the secretory and endocytic pathways, including the Golgi 
apparatus.
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1.6 The Golgi Matrix
It is estimated that, in the exocrine pancreas, more secretory material enters the Golgi 
apparatus from the ER every 5 minutes, than there is protein in the Golgi (Barr and 
Warren 1996). How does the Golgi apparatus maintain its identity and structural 
integrity in the face of such a high flux of material?
One suggestion is that the Golgi apparatus is not, in fact, an independent, stable 
organelle, rather that it arises de novo from the ER. Indeed, under experimental 
conditions in which ER to Golgi transport is blocked (for example, by treatment with 
the fungal metabolite brefeldin A or with dominant-negative forms of Sarlp) many 
Golgi resident proteins relocalise to the ER (Ward et al, 2001).
However, even under these conditions, some Golgi-like structures remain distinct 
from the ER (Seemann et al. 2000). These remnants contain proteins believed to be 
important for the structure of the Golgi. Under certain conditions, Golgi membranes 
could be extracted with detergent leaving a proteinaceous skeleton that retained the 
organisation of Golgi cisternae (Slusarewicz et al. 1994). The existence of such a 
Golgi matrix was also supported by electron microscopy studies of the Golgi 
apparatus showing proteinaceous links between the cisternae (Cluett and Brown 
1992).
Important components of this matrix are a family of proteins identified using a 
functional assay for the post-mitotic reassembly of Golgi stacks which can be 
inhibited by the alkylation agent NEM. This family, known as the GRASPs (for 
Golgi Reassembly Stacking Proteins) consists of two proteins of molecular weight 55 
and 65 KDa (Barr et al. 1997; Shorter et al, 1999). GRASP65 is localised to the cis- 
Golgi while GRASP55 is predominantly at the medial Golgi. Both proteins are 
peripheral membrane proteins on the cytosolic face of Golgi cisternae, and are 
associated with the membrane by N-terminal myristoylation (although how the 
proteins are taigeted specifically to Golgi membranes remains unclear). Both proteins 
are phosphorylated during mitosis which may be significant for the mitotic 
disassembly of the Golgi apparatus. In addition, several Golgi-localised coiled-coil 
autoantigens (or Golgins) were found to be part of the Golgi matrix, suggesting an 
importance not only in vesicle tethering, but also in maintaining Golgi structure.
17
Chapter 1: Introduction
The golgins were originally defined as a family of distantly-related coiled-coil 
proteins localised to the Golgi and found as antigens in autoimmune patients (Chan 
and Fritzier 1998). Additional Golgi coiled-coil proteins have since been discovered 
and classified as golgins even though they are not known to be autoantigens. 
Although little is known about the precise functions of many of these proteins, a 
number of them have had their roles better defined.
1.6.1 Cis-Golgi golgins
Perhaps the best-characterised golgins to date are those at the cis-Go\gi. p ll5  was 
originally identified using Rothman’s transport assay as being required for transport 
through the Golgi (Waters et al. 1992). It is a peripheral membrane protein mainly 
localised to the CGN and the cis-Go\gi (Waters et al. 1992; Nelson et al. 1998) and is 
shown by rotary shadowing to be a homodimer with a N-terminal globular head 
domain and a C-terminal coiled-coil domain, and a length of 45nm (Sapperstein et al. 
1995). A short acidic patch is located at the extreme C-terminus of the protein. The 
budding yeast homologue of p ll5 , Usolp, is similar in structure but is much larger in 
size (approximately 150nm; Yamakawa et al. 1996).
Studies on Usolp provided insight into its function as a tethering factor. Along with 
Yptlp (yeast Rabl), it is required for the docking of ER-derived COPII vesicles with 
Golgi membranes in an in vitro assay (Barlowe 1997; Cao et al. 1998). This would 
seem to occur upstream of SNARE function, since yeast carrying temperature- 
sensitive mutations in ER-to-Golgi SNARE proteins are still able to dock ER-derived 
vesicles with the cw-Golgi, and overexpression of the wild type SNAREs can 
compensate for mutations in USOl and YPTl (Sapperstein et al. 1996).
Recent studies on mammalian pi 15 have suggested a direct interaction with SNAREs, 
thereby linking tethering to fusion. Not only could pi 15 bind to certain early Golgi 
SNARE proteins but an in vitro assay showed that it could actually stimulate SNARE 
complex assembly (Shorter et al. 2002). Additionally, it has been shown that p i 15 is 
important for COPI, as well as COPII, vesicle docking, and that it is involved in the 
stacking of Golgi cisternae following mitosis (Sonnichsen et al. 1998; Shorter and 
Warren 1999). To accomplish these functions, pi 15 interacts with two additional 
golgins at the cw-Golgi: GM130 and giantin,
GM130 was originally identified (as golgin-95) using antisera from an autoimmune 
disease patient and, subsequently, by raising antisera against solubilised Golgi matrix
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(Fritzier et al. 1993; Nakamura et al. 1995). Localised to the cw-Golgi, GM130 is 
predicted to contain extensive regions of coiled-coil forming a homodimer, and has a 
basic domain of 75 amino acids at its N-terminus, which binds to the C-terminal 
acidic patch of pi 15 (Nakamura et al. 1997). This interaction is disrupted at the onset 
of mitosis by the phosphorylation of GM130 on serine25 by Cdkl (Lowe et al. 1998). 
This is thought to be crucial for the mitotic breakdown of the Golgi apparatus due to 
the continued budding of transport vesicles while pll5-GM 130 mediated vesicle 
tethering is inhibited. GM130 is targeted to cw-Golgi membranes by its tight binding 
to GRASP65, an interaction which requires the extreme C-terminus of GM130 (Barr 
et al. 1998).
Giantin, on the other hand, is an integral membrane protein of 400KDa, with a C- 
terminal transmembrane domain and a very large cytoplasmic domain containing 
extensive regions predicted to form coiled-coil (Linstedt and Hauri 1993). It is 
localised to the edges of the Golgi stack and on COPI vesicles and also binds pi 15 via 
its N-terminus (Sonnichsen et al. 1998). Two other integral membrane golgins, 
golgin-84 and CASP, have recently been identified with transmembrane domains 
closely related to that of giantin but with little sequence homology outside of this 
region (Bascom et al. 1999; Gillingham et al. 2002). The functional significance of 
some golgins having transmembrane domains while others (such as p i 15 and GM130) 
are peripheral membrane proteins associated either weakly or strongly with the 
membrane, is unclear. However, the yeast homologue of CASP, Coy Ip, shows a 
genetic interaction with the SNARE protein Goslp, an interaction which is lost if the 
conserved transmembrane domain is mutated (Gillingham et al. 2002). This implies 
that CASP and, by extension, golgin-84 and giantin, could be involved in transmitting 
membrane tethering events to SNARE-mediated fusion events.
How do pi 15, GM130, and giantin act together to mediate docking events at the cis- 
Golgi? The presence of giantin in COPI vesicles and GM130 on Golgi membranes, 
and the ability of both proteins to bind pi 15, suggests a model in which COPI vesicles 
are linked to their target membranes by a giantin-p 115-GM130 ternary complex 
(Sonnichsen et al. 1998) - although this wouldn’t apply to ER-targeted COPI vesicles. 
Such a model is supported by an in vitro assay in which the docking of COPI vesicles 
with Golgi membranes is inhibited if the vesicles are pre-incubated with anti-giantin 
antibody but is unaffected if the Golgi membranes are pre-incubated with anti-giantin.
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Anti-GM130 antibodies, on the other hand, only inhibit the assay if they are pre- 
incubated with Golgi membranes but have no effect when pre-incubated with COPI 
vesicles. The same assay shows a dependence on pi 15 since addition of increasing 
amounts of the protein increases the rate of vesicle docking (Sonnichsen et al. 1998). 
The idea of a giantin-p 115-GM 130 ternary complex is contradicted however by 
evidence that GM130 and giantin compete for the same binding site on p i 15 (Linstedt 
et al. 2000). Also, studies on trafficking between the ER and the Golgi suggest that 
the three proteins act at kinetically distinct stages since anti-pll5 antibodies inhibit 
transport at the CGN stage while anti-GM130 and anti-giantin inhibition occurs at the 
Golgi - with giantin inhibition occurring later than GM130 inhibition (Alvarez et al. 
2001).
Since p i 15, GM130, and giantin are implicated in such a variety of different 
processes (including both retrograde and anterograde transport steps as well as 
cisternal stacking), it is possible that they act in different ways during different events. 
The effects of antibody inhibition may vary depending on precisely which process is 
being measured in a particular assay. In any case, the interactions of these golgins, 
both with each other and with other proteins, is clearly important for membrane 
tethering events at the cis-Go\gi.
1.6.2 Late Golgi golgins
Far less is known about tethering events at later Golgi compartments. With the 
exception of GRASP55, no medial-Golgi components of the Golgi matrix have been 
characterised (Shorter et al. 1999). Several coiled-coil proteins localising to the 
trans-Golgi and TGN have been identified although their precise roles remain unclear. 
These trans-Golgi proteins include golgin-245 and golgin-97 (both identified as 
antigens in autoimmune patients), and the yeast protein Imhlp (Kooy et al. 1992; 
Fritzier et al. 1995; Griffith et al. 1997; Tsukada et al. 1999). A key feature of these 
proteins is the presence of a 50 amino acid sequence known as the GRIP domain (for 
golgin-97, Ran-binding protein 2a, Imhl, and p230/golgin-245) (Barr 1999; Kjer- 
Nielsen et al. 1999; Munro and Nichols 1999). The GRIP domain alone is sufficient 
for targeting to the trans-Golgi for which an invariant tyrosine residue is essential 
(McConville et al. 2002). The domain was originally suggested to have rab6 binding 
properties although, more recently, it has been implicated in binding to ARLl, a
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Golgi-localised member of the ARF-like GTPase family (Van Valkenburgh et al. 
2001). Little is known about the function of ARLs, but the interaction of ARLl with 
GRIP domain proteins is dependent upon the conserved tyrosine residue essential for 
the Golgi targeting of these proteins (Van Valkenburgh et al. 2001).
IMHl shows a genetic interaction with YPT6, the yeast homologue of rab6. 
Overexpression of Imhlp suppresses the temperature sensitive growth of yeast strains 
lacking Ypt6p and deletion of both IMHl and YPT6 leads to a severe growth defect 
(Tsukada et al. 1999). As yet, however, no physical interaction has been found 
between Imhlp and Ypt6p. Nevertheless, it is clear that there is some sort of 
interaction between golgins and rab family members, as indicated by the IMH1/YPT6 
and USOl/YPTl data discussed above. Rab proteins also show an interaction with 
multimeric membrane tethering complexes since RICI (the GEF for YPT6) shows 
synthetic lethality with DORl, a component of the yeast COG complex (Whyte and 
Munro 2001). We shall now consider, therefore, those rab family members that are 
known to localise to the Golgi apparatus.
1.6.3 Golgi-localised rab proteins
Many of the 60-plus rab proteins in the human genome are reported to localise to the 
Golgi apparatus. They are believed to regulate a variety of transport steps to, through, 
and from the Golgi in both anterograde and retrograde directions.
One of the best-characterised Golgi-localised rabs is rabl and its budding yeast 
homologue Yptlp. Rabl (of which there are 2 isoforms, a and b) is ubiquitously 
expressed in mammalian cells and is localised to the CGN and the cis- most cisternae 
of the Golgi stack (Plutner et al. 1991). Overexpression of a dominant-negative form 
of rabl, locked in its GDP-bound form was able to inhibit ER to Golgi transport and 
also early intra-Golgi transport (Tisdale et al. 1992; Nuoffer et al. 1994). Yptlp is 
also important for the same transport steps in yeast, as evidenced by its requirement 
for the in vitro COPII vesicle docking assay described in section 1.6.1 and its genetic 
interactions with a variety of other proteins involved in ER to Golgi transport -  
deletion of Yptlp is suppressed by overexpression of the SNARE proteins Sed5p, 
Betlp, Boslp, and a mutant form of the SM protein Sly Ip (Dascher et al. 1991; Lian 
et al. 1994). Although Yptlp is localised to both vesicles and target Golgi 
membranes, its activity seems to be required at the target membrane, since a Yptlp
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mutant which blocks ER to Golgi traffic in vivo, only affects an in vitro assay when 
present on acceptor membranes instead of wild type protein. Vesicles bearing the 
mutant Yptlp are still competent for docking and fusion (Cao and Barlowe 2000). 
Yptlp has been implicated in both the recruitment of Usolp to membranes and in the 
activation of t-SNAREs prior to membrane fusion (Lupashin and Waters 1997; Cao et 
a l 1998).
A second rab protein, rab2, is also required for ER to Golgi transport in metazoan 
cells (Tisdale et a l  1992; Tisdale and Balch 1996). There does not appear to be a 
homologue in yeast, indicating that metazoan transport pathways are more 
complicated and differently regulated. This would partially explain the large 
evolutionary expansion of rab proteins between yeast and mammals (from 12 to over 
60 members) since there is not a corresponding increase in the number of 
secretory/endocytic organelles in mammals (Bock et a l 2001),
The Golgi-localised rab protein rab6, on the other hand, does have a homologue in 
budding yeast, Ypt6p. There are, however, 3 isoforms of rab6 in mammalian cells -  
rab6a, a% and b. Rab6a and a’ differ by only 3 amino acids, are generated by 
alternative splicing, and are ubiquitously expressed (Echard et a l  2000). Rab6b is 
more divergent and is primarily expressed in neurons (Opdam et a l  2000). All 3 
proteins are localised to the Golgi apparatus and the TGN although it has been 
suggested they may play different roles in vivo.
Rab6a appears to be involved in retrograde Golgi-to-ER transport since 
overexpression of wild type or GTP-restricted rab6a stimulates the redistribution of 
Golgi-localised glycosylases to the ER (Martinez et a l 1994; Martinez et a l  1997) 
while a GDP-restricted mutant blocks this recycling pathway and also inhibits the 
transport of Shiga toxin from the Golgi to the ER (Girod et a l  1999). Recycling of 
other proteins, such as the KDEL receptor, is not affected by rab6a. This pathway 
would appear to be COPI-independent, since anti-COPI antibodies and ARFl mutants 
do not affect the retrograde transport of Shiga toxin or glycosylases while they do 
inhibit the recycling of the KDEL receptor (Girod et a l 1999).
Rab6a% on the other hand, appears to be involved in endosomes to TGN transport, as 
assessed by the inhibitory effects of GDP-locked rab6a’ on the transport of Shiga 
toxin to the TGN - although GDP-locked rab6a partially inhibits this assay as well 
(Mallard et a l  2002). Thus, the retrograde transport of proteins from endosomes.
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through the Golgi, to the ER may be mediated by the sequential activity of rab6a’ and 
rab6a. To date, however, no specific effectors of either rab6 isoform have been 
identified with the exception of rabkinesin-6, a motor protein proposed to interact 
specifically with rab6a in Golgi to ER transport (Echard et al. 1998). More recently, 
however, the veracity of this interaction and the involvement of rabkinesin-6 in 
transport events has been called into question (Hill et al. 2000).
Rab6 proteins are, nevertheless, clearly involved in transport steps in and around the 
Golgi, along with rabs 1 and 2 and other Golgi-localised rabs. The question remains 
of how rabs regulate these processes and how they interact with other proteins 
involved in transport events at the Golgi apparatus.
1.7 Characterisation of Rab-Effector Complexes
As discussed above, many proteins are known to be involved in regulating vesicle 
transport events through the Golgi apparatus, and in maintaining Golgi structure. 
There is evidence to suggest that many of these proteins, such as the rabs and golgins, 
may interact with each other. For example, the vesicle tethering factor p i 15 and rabl 
and their yeast homologues, Usolp and Yptlp, clearly act at the same stage of the 
secretory pathway. Not only do USOl and YPTl show a strong genetic interaction 
(not in itself an indicator of a physical interaction) but the recruitment of Usolp to 
membranes in an in vitro COPII vesicle docking assay shows a clear dependence on 
the amount of Yptlp added to the assay (Cao et al. 1998).
The interaction of rabs with coiled-coil tethering proteins has already been found in 
other cases. The endosomal rab, rab5, interacts with several effector molecules in a 
nucleotide-dependent manner, including EEAl and rabaptin-5, which are required for 
the docking and fusion of endosomes (Christoforidis et al. 1999). These effectors in 
turn interact with other proteins such as the SNARE molecules and SM proteins 
involved in endosome fusion (McBride et al. 1999; Nielsen et al. 2000).
It therefore seems likely that Golgi-localised rab proteins act similarly to recruit 
members of the golgin family as effectors. These effectors are likely to include 
proteins such as p i 15 and GM130 but, given the large number of effectors found to 
interact with rab5, may also include as yet uncharacterised proteins.
I therefore set out to characterise rab-effector complexes located at the Golgi 
apparatus using a combination of approaches, including yeast two-hybrid and
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pulldowns from cytosol. In this thesis, I present data identifying and characterising a 
number of effectors of rabs 1, 2, 6, and 33b. In addition, I characterise a family of 
serine/threonine kinases that interact with the cw-Golgi golgin GM130, itself a rab 
effector. Together, this data provides insight into the various ways in which rab 
proteins and their effectors control aspects of membrane trafficking events at the 
Golgi apparatus.
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2.1 Materials
2.1.1 Reagents
Reagents were obtained from Sigma (Sigma-Aldrich, Poole, UK), BDH (BDH 
Laboratory Supplies, Poole, UK), Fisher (Fisher Scientific, Loughborough, UK), or 
Merck (Daimstadt, Germany) unless stated in the text.
2.1.2 Equipment
A list of commonly used equipment and its suppliers is given in the table below:
Benchtop centrifuge Eppendorf Centrifuge 5417C
Benchtop refrigerated centrifuge Eppendorf Centrifuge 5417R
Cell Culture Incubators Heraeus HeraCell
Cell Culture Safety Hoods Heraeus HeraSafe
Centrifuge Heraeus Multifuge 3 L-R
Film Developer Kodak X-OMAT 2000 Processor
Heating block/mixer Eppendorf Thermomix Compact
Incubators Heraeus Function Line
Shakers Infors AG Multitron
Sonicator Bandelin Sonopuls
SW28 rotor Beckman
SW40 rotor Beckman
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Transilluminators UVP 2UV Transilluminator
UVP Mini Darkroom and UV transilluminator
UVP Gel Documentation System
Ultracentrifuge Beckman Optima™ LE-80K
UV/Visible Spectrophotometer Amersham-Pharmacia Ultrospec BOOOpro
Waterbath Haake DCIO
2.1.3 Solutions
The composition of many common solutions not given in the text is given in the table
below. The solvent is water, unless otherwise stated. Many of these solutions were
prepared by Marianne Siebert and other technical staff of the Cell Biology
Department, MPI For Biochemstry.
DNA Loading Dye (6x) 0.25% (w/v) bromopheridl blue 
40% (w/v) sucrose in TE
LB 10 g/L Bacto-tryptone 
5 g/L Bacto-yeast extract 
lOg/LNaCl
LB-Agar LB plus 15 g/L Bacto-agar
Milk-PBS (Blocking Buffer) 4% milk powder in PBS plus 0.2% (w/v) 
Tween-20
PBS gg/LNaCl 
0.2 g/L KCl 
1.44 g/L Na^HPO^ 
0.24 g/L KH2PO4 
(pH 7.4)
Ponceau 0.2% Ponceau red in 1 % acetic acid
RIPA-buffer 10 mM Tris-HCl pH 7.5
150 mM NaCl
1% (w/v) Triton-X 100
0.1% (w/v) SDS
1% (w/v) sodium deoxycholate
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SDS-PAGE Lower Buffer (4x)
SDS-PAGE Running Buffer (lOx)
SDS-PAGE Sample Buffer (3x)
SDS-PAGE Transfer Buffer
SDS-PAGE Upper Buffer (4x)
TAE (50x)
TE
TNE
TNTE
181.72 g/L Tris base
4 g/L Na.SDS
30.2 g/L Tris base 
188 g/L glycine 
10g/LNa.SDS 
For 100 ml:
2.3 g Tris base 
9.0 g SDS 
30 ml glycerol
Adjust pH to 6.8 with HCl, then adjust volume
to 90 ml with dHgO
50 mg bromophenol blue
Add 10% 6-mercaptoethanol prior to use
Ix SDS-PAGE running buffer
10% methanol
60.6 g/L Tris base
4g/LNa.SDS
242.4 g/L Tris base
57.2 ml/L glacial acetic acid 
100 ml/L 0.5M EDTA, pH 8.0 
10 mM Tris-HCl pH 8.0
1 mM EDTA 
10 mM Tris-HCl pH 7.4 
150 mM NaCl 
1 mM EDTA 
1% (w/v) IGEPAL 
10 mM Tris-HCl pH 7.5 
150 mM NaCl 
0.3% (w/v) Triton-X 100
5 mM EDTA
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2.1.4 Plasmids
The plasmids used in this thesis are listed in the table below. Unless otherwise stated, 
they were generated by myself in the course of this work. CP indicates plasmids 
made by Christian Preisinger, EF by Evelyn Fuchs, FAB by Francis Barr, JS by Julia 
Schaletzky.
pBS21 PQE32 p ll5  full length
pBS24 PQE32 GM130 full length
pBS25 pQE32 GM130AN433
pBS74 pGBT9 pi 15 full length
pBS81 pACT2 pi 15 full length
pBS82 pACT2 pi 15 aa’s 1-606
pBS83 pACT2 pi 15 aa’s 772-959
pBS84 pACT2 GM130 full length
pBS85 pACT2 GM130AN433
pBS86 pACT2 GM130AC271
pBS102 pGAT2 RablQ70L
pBS103 pGAT2 Rab2Q65L
pBS113 pGBT9 Rab2 wt
pBS114 pGBT9 Rab2Q65L
pBS119 pGBT9 RablQ70L
pBS137 pACT2 pi 15 aa’s 124-437
pBS147 pGAT2 Rab6aQ72L
pBSlSO pGBT9 Rab5Q79L
pBS151 pGBT9 Rab6aQ72L
pBS154 pGBT9 Rab33bQ92L
pBS157 pACT2 pi 15 aa’s 1-437
pBS158 pACT2 p ll5  aa’s 124-606
pBS166 pACT2 p ll5  aa’s 1-123
pBS167 pACT2 Golgin-45 aa’s 123-282
pBS170 pACT2 Golgin-45 full length
pBS171 pEGFP-C2 Golgin-45 full length
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pBS173 pACT2 Golgin-45 aa’s 1-282
pBS174 pACT2 Golgin-45 aa’s 123-403
pBS179 pACT2 Golgin-45 aa’s 1-122
pBSlSO pACT2 Golgin-45 aa’s 283-403
pBS201 pACT2 p ll5  aa’s 607-772
pBS216 pACT2 pi 15 aa’s 1-772
pBS220 pACT2 GM130 aa’s 433-679
pBS221 pACT2 GM130 aa’s 679-986
pBS258 PQB32 YSKl full length
pBS329 pEGFP-C2 YSKl full length
pBS331 pGBT9 YSKl full length
pBS375 pEGFP-C2 MTMR6
pBS378 pEGFP-Nl MTMR6
pBS383 pEGFP-C2 Centaurin62
pBS384 pEGFP-N3 Centaurin62
pBS394 pcDNA3.1mycA GM130 full length
pBS407 pcDNA3.1mycA GM130S25D
pBS417 pFBT9 YSKl full length
pBS449 pFBT9 YSKl aa’s 1-302
pBS457 pACT2 GM130AN74
pBS460 pACT2 GM130 aa’s 75-271
pBS469 pGEX5Xl GM130 aa’s 75-271
pBS481 pGBT9 Rab6a’Q72L
pBS482 pGBT9 Rab6a’T27N
pBS484 pFAT2 Rab6a’Q72L
pBS485 pFAT2 Rab6a’T27N
pBS501 pFAT2 Rab6a’D129N
pBS502 pGAT2 Rab6aD129N
pBS506 pACT2 pl50«'"'‘^ aa’s 1-904
pBS507 pACT2 plSOs'"'"^  aa’s 540-1278
pBS512 pFBT9 YSKl aa’s 1-270
pBS513 pFBT9 YSKl aa’s 20-302
pBS517 pcDNA3.1mycA YSKl aa’s 303-426
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pBS518 pFBT9 YSKl aa’s 303-426
pBS523 pACT2 pl50G'"‘=‘' aa’s 1-539
pBS524 pACT2 pl508^ ""'^  aa’s 540-904
pBS525 pACT2 pl50^'"'" aa’s 905-1278
pBS529 pGBT9 Rab6a wt
pBS530 pGBT9 Rab6aQ72L
pBS531 pGBT9 Rab6aT27N
pBS535 pFAT2 Rab6aT27N
pBS539 pEGFP-C2 BicDl aa’s 1-703
pBS540 pEGFP-C2 BicDl aa’s 704-975
pBS541 pEGFP-C2 BicD2 aa’s 1-705
pBS542 pEGFP-C2 BicD2 aa’s 706-824
pBS543 PQE32 pl50®'“‘* aa’s 540-1278
pBS568 pEGFP-C2 BicD2 full length
pBS590 pcDNA3.1mycA MTMR6
pBS591 pcDNA3,lmycA CentaurinB2
pBS603 PQE32 GOPC
pBS606 pACT2 GOPC
pBS607 pEGFP-C2 GOPC
pBS608 pcDNA3.1mycA GOPC
pBS613 pFAT2 Rab33b wt
pBS614 pFAT2 Rab33bQ92L
pBS624 PQE32 BicD2 aa’s 706-824
pBS625 pcDNA3.1mycA GM130AN74
pBS626 pACT2 BicDl aa’s 1-703
pBS627 pACT2 BicDl aa’s 704-975
pBS628 pACT2 BicD2 aa’s 1-705
pBS629 pACT2 BicD2 aa’s 706-824
pFB191 pGAT2 Rabl wt, FAB
pFB193 pGAT2 Rab2 wt, FAB
pFB206 pGAT2 Rab6a wt, FAB
pFB208 pGAT2 R abll wt, FAB
pFB226 NAGT-I-GFP, FAB
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pFB648 pFBT9 GRASP55, CP
pFB732 pGEX5Xl Golgin-45 aa’sl-122, FAB
pFB1072 pVL1393N6H YSKl full length, CP
pFB1289 pACT2 pl50giued length, FAB
pFB1346 pFBT9 MST3, FAB
pFB1350 pEGFP-C2 MST3, FAB
pFB1351 pcDNA3.1mycA MST3, FAB
pFB1360 pFBT9 MST4, FAB
pFB1364 pEGFP-C2 MST4
pFB1365 pcDNA3.1mycA MST4, FAB
pFB1366 pAcHis MST4, FAB
pFB1374 pEGFP-C2 BicDl full length, FAB
pFB1376 pACT2 BicDl full length, FAB
pFB1380 pACT2 BicD2 full length, FAB
pFB1381 PQE32 BicD2 full length, FAB
pFB1440 pGAT2 RabllQ70L, JS
pFB1518 pcDNA3.1mycA YSKl full length, FAB
pFB1519 pcDNA3.1mycA YSK1K49R, FAB
pFB1520 pcDNA3.1mycA YSKl aa’s 1-270, FAB
pFB1521 pcDNA3.1mycA YSKl aa’s 1-302, FAB
pFB1522 pcDNA3.1mycA YSKl aa’s 20-302, FAB
pFB1523 pcDNA3.1mycA YSKl aa’s 275-426, FAB
pFB1606 pcDNA3.1mycA MTMl, FAB
pFB1648 pAcHis Rabkinesin-6, FAB
pFB1803 pACT2 GOPC aa’s 256-454, EF
pFB1809 pEGFP-C2 GOPC aa’s 1-255, EF
pFB1810 pEGFP-C2 GOPC aa’s 142-454, EF
pFB1811 pEGFP-C2 GOPC aa’s 1-141, EF
pFB1812 pEGFP-C2 GOPC aa’s 142-255, EF
pFB1813 pEGFP-C2 GOPC aa’s 256-454, EF
pFB1814 pFBT9 GOPC aa’s 1-255, EF
pFB1815 pFBT9 GOPC aa’s 142-454, EF
pFB1816 pFBT9 GOPC aa’s 1-141, EF
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pFB1817
pFB1880
pFB1881
pFBT9
pACT2
pACT2
GOPC aa’s 142-255, EF 
Rab6a’Q72L, EF 
Rab6aQ72L, EF
2.1.5 siRNA oligonucleotides
The RNA oligonucleotides used in the course of this work for siRNA-mediated 
depletion of specific mRNAs are listed in the table below along with the target 
sequence. Oligonucleotides were obtained from Dharmacon Inc. Oligos were 
generally designed to a target sequence of AA(N19)TT with the sense oligo sequence 
reading (N19)dTdT, and the antisense oligo reading (N19 reverse 
complemented)dT dT.
Human GM130 
Human golgin-45 
Human lamin-A 
Human pi 15 
Human rabl 
Human rab2
AACCCTGAGACAACCACTTCTTT
AATCCGAGGAGCAGGAGATGGAA
AACTGGACTTCCAGAAGAACATC
AAGCCGAGACGATTCAAAAGCTT
AACAGCGAAGGAATTTGCTGATT
AAATCATGCTTATTGCTACAGTT
2.1.6 Antibodies
The antibodies used in the course of this work are listed in the tables below, along 
with their typical dilutions used for western blotting and immunofluorescence.
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2.1.6.1 Primary antibodies
1E7 Mouse Ratrablb C- 1:200 1:250 Gift from
terminal (culture (purified) Angela
peptide supernatant) 1:2 (culture 
supernatant)
Barnekow,
Munster,
Germany
9E10 Mouse c-myc 1:1000 1:1000 -
Biogenes Rabbit His-human 1:1000 1:1000 -
#4256 YSKl
FBA34 Sheep His-rat
GRASP55
1:2000 1:2000 -
FBA35 Sheep His-GFP 1:2000 1:2000 -
FBA36 Sheep Human golgin- 
97 aa’s 589- 
769
1:500 1:500
FBA37 Sheep His-rat p i 15 
aa’s 772-959
1:2000 1:2000 -
FBA40 Sheep His-rat GM130 1:2000 1:2000 -
FBA44 Rabbit His-GST- 
mouse golgin- 
45
1:1000 1:1000
Rabbit His-GST- 
human rab2
- 1:1000 -
NN5-1 Rabbit Rat GM130 1:1000 1:1000 Nobohiro
Nakamura,
Kanazawa,
Japan
a-c-myc Rabbit Human c-myc 1:150 1:150 Santa Cruz
(A-14) C-terminus Biotech
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a-p50/ Mouse Human 1:100 1:100 BD
dynamitin p50/dynamitin Biosciences,
Pharmingen
a-dynein Mouse Chicken 1:100 - Sigma
(intermedi­ cytoplasmic
ate chain) dynein
(70.1)
ct-golgin- Rabbit Human golgin- 1:1000 1:1000 -
160 160
ct-golgin- Mouse Human golgin- - 1:100 Molecular
97 97 Probes
a-Histidine Mouse Hexahistidine 
epitope tag
1:1000 - Dianova
a-Lamin Mouse Human Lamin 1:1000 1:1000 -
a-pl50G'""^ Mouse Rat pl50^‘“^^ 1:100 1:100 BD
Biosciences,
Pharmingen
a-rab6 (C- Rabbit Human rab6 - 1:100 Santa Cruz
19) C-terminal
peptide
Biotech
a-tubulin Mouse Tubulin 1:1000 1:1000 Sigma
a-Y SK l Goat Human YSKl 1:100 1:100 Santa Cruz
(C-19) C-terminal
peptide
Biotech
a-Y SK l Goat Human YSKl 1:100 1:100 Santa Cruz
(N-19) N-terminal
peptide
Biotech
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2.1.6.2 Secondary antibodies
Cy3 -a- Donkey Mouse IgG - 1:1000 Jackson
mouse Laboratories
Alexa- Donkey Mouse IgG - 1:1000 Jackson
488-a- Laboratories
mouse
HRP-a- Sheep Mouse IgG 1:2000 - Amersham-
mouse Pharmacia
Cy3-a- Donkey Rabbit IgG - 1:1000 Jackson
rabbit Laboratories
Alexa- Donkey Rabbit IgG - 1:1000 Jackson
488-a- Laboratories
rabbit
HRP-a- Donkey Rabbit IgG 1:2000 - Jackson
rabbit Laboratories
Cy3-a- Donkey Sheep IgG - 1:1000 Jackson
sheep Laboratories
Cy2-a- Donkey Sheep IgG - 1:1000 Jackson
sheep Laboratories
HRP-a- Donkey Sheep IgG 1:10000 - Jackson
sheep Laboratories
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2,2 Bacterial Methods
2.2.1 Growth and maintenance of E,coU
Bacteria were grown in LB medium containing an appropriate antibiotic for selection 
(typically either 100(xg/ml ampicillin, 50p,g/ml kanamycin, or 34p,g/ml 
chloramphenicol). Short-term storage was on LB-agar plates plus antibiotic at 4°C.
2.2.2 Bacterial strains
The following E.coli strains were used in the course of this work:
XLl-blue F’::TnlO proA+B+ lacH 
A(lacZ)M 15/recA 1 endAl 
gyiA96 (NaT) thi hsdRlV (r^ 
m^^) glnV44 relAl lac
General cloning applications
GM2163 F‘ ara-14 leuB6 fhuA31 lacYl 
tsx78 glnV44 galK2 galT22 
mcrA dcm-6 hisG4 rfbDl 
rpsL136 daml3::Tn9 xylA5 mtl- 
1 thi-1 mcrBl hsdR2
Cloning of non-methylated DNA 
for digestion with Dam or Dcm- 
sensitive restriction enzymes
BL21(DE3)* F  ompT gal [dcm] [Ion] hsdSg 
(i'b" mg'; an E.coli B strain) with 
DE3, a X prophage carrying the 
T7 RNA polymerase gene
Recombinant protein expression
JM109^ F’ traD36 proA^B^ lacL 
A(lacZ)M15/ A(lac-proAB) 
glnV44 el4 ' gyrA96 recAl 
relAl endAl thi hsdR17
Recombinant protein expression
TOPIO F" mcrA A(mrr-hsdRMS-mcrBC) 
<E>801acZAM15 AlacX74 recAl 
deoR ai'aD139 A(ara-leu)7697 
galU galK rpsL (Str*^ ) endAl 
nupG
TA-cloning of PCR products
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some cases, BL21(DE3) and JM109 strains carrying the pRIL plasmid 
(Stratagene) were used. This plasmid encodes the tRNA genes for rare arginine, 
isoleucine, and leucine codons and conveys chloramphenicol resistance.
2.2.3 Preparation and transformation of chemically competent bacteria
To prépaie chemically competent E.coli, a single colony was picked from a fresh plate 
and used to inoculate 50 ml of LB (with selection, if necessary) and grown overnight 
at 37°C with shaking. 1 ml of overnight culture was then used to inoculate 100 ml of 
fresh LB and the cells were grown at 37°C until 00 0^0= 0.5. The culture was then 
chilled on ice for 15 minutes before being transferred to sterile centrifuge tubes and 
centrifuged at approximately 5000 x g for 10 minutes at 4°C. The supernatant was 
discarded and the cell pellet resuspended in 0.4 total culture volume of Tfbl (30 mM 
KO Ac, 100 mM RbCl^, 10 mM CaClg, 50 mM MnCl^, 15% (v/v) glycerol, pH 
adjusted to 5.8 with dilute acetic acid). The cells were incubated on ice for 15 
minutes and then pelleted as before. The cell pellet was then resuspended in 0.04 
volume Tfbll (10 mM MOPS, 75 mM CaClj, 10 mM RbClj, 15% (v/v) glycerol, pH 
adjusted to 6.5 with dilute NaOH). After storing on ice for 15 minutes, the cells were 
aliquoted into 50 [a1 aliquots in sterile Eppendorfs, frozen in dry ice or liquid nitrogen, 
and stored at -80°C until needed.
For transformation, aliquots were thawed on ice before adding the DNA to them. In 
general, 5 p.1 of a ligation reaction was used for a transformation, or 1 \xl of plasmid 
DNA. The cells and DNA were mixed and left on ice for 15 minutes before being 
heat-shocked in a 42°C water bath for 45-90 seconds. Cells were placed back on ice 
for 1 minute before the addition of either 250 pi (ligation transformation) or 700 pi 
(plasmid transformation) LB. The cells were then allowed to recover for 30-60 
minutes at 37“C with shaking before being plated on LB-agar plates containing an 
appropriate selection antibiotic with a glass spreader. All of a ligation transformation 
was plated while only 80 pi of a plasmid transformation was plated. Plates were then 
incubated at 37°C.
2.2.4 Preparation and transformation of electrocompetent bacteria
To prepare electrocompetent E.coli, a single colony was picked from a fresh plate and 
used to inoculate 5 ml of LB and grown overnight at 37°C with shaking, 2.5 ml of the
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overnight culture was then used to inoculate 500 ml of fresh LB in a 2 L flask and 
grown at 37°C until an OD^ oo of between 0.5 and 0.6. The culture was then chilled on 
ice for 15 minutes before being transferred to sterile centrifuge tubes and centrifuged 
at approximately 5000 x g for 10 minutes at 4°C. The supernatant was removed and 
the cells resuspended in 5 ml of sterile, ice-cold water. Centrifuge tubes were then 
filled with ice-cold water and centrifuged as before. The supernatant was removed 
and the cell pellets resuspended in the residual water. The pellets were pooled and the 
volume adjusted to 50 ml with ice-cold 10% (v/v) glycerol before centrifuging as 
above. The cell pellet was resuspended in an equal volume of ice-cold 10% (v/v) 
glycerol and the cells were aliquoted into 40 pi aliquots in sterile Eppendorfs, frozen 
in dry ice or liquid nitrogen, and stored at -80°C until needed.
For electroporation, sterile 2 mm electroporation cuvettes were placed on ice to chill 
while cells were thawed on ice. 1-2 pi of yeast miniprep DNA or 1-10 ng plasmid 
DNA was added to the cuvette followed by 40 pi of electrocompetent cells. The 
cuvette was flicked to mix the DNA and cells and left on ice for 5 minutes. The 
electroporator was set to 2.5 kV, 25 pFarads. Cuvettes were dried with a tissue wipe 
and placed into the chamber and the cells electroporated (ideally, with a time constant 
of 4.7). 1 ml of LB medium was then added to the cuvette and the cells were 
transferred to a sterile Eppendorf tube and incubated at 37°C for 1 hour. Cells were 
then pelleted at 4000 rpm in a microfuge and resuspended in 100 pi LB before being 
plated on LB-agar plates containing an appropriate selective antibiotic and grown at 
37°C.
2.2.5 Plasmid DNA preparation from bacteria
Plasmid DNA was prepared using either miniprep or maxiprep kits (Qiagen, Hilden, 
Germany) according to the manufacturers instructions. Typically, minipreps were 
prepared from 2 ml of overnight cultures grown in LB plus selective antibiotic at 
37°C and maxipreps were prepared from 150 ml overnight cultures.
2.2.6 Purification of recombinant His-tagged proteins from bacteria
A single colony was picked from a fresh plate and used to inoculate 25 ml of LB plus 
selective antibiotics and grown overnight at 37°C with shaking. 10 ml of the 
overnight culture was then used to inoculate 1 L of fresh LB plus antibiotics and
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grown at 37°C until an OD^ oo of 0.5-0.6 was reached. Depending upon the protein 
being expressed, cultures were either shifted to 18°C, 23°C, or 30°C for 30 minutes 
before being induced with 0.5 mM Isopropyl p-D-thiogalactoside (IPTG) from a 1 M 
stock or induced immediately at 37°C. Cultures were then left for either 3 hours 
(37°C), 5 hours (30°C), or overnight (23°C and 18°C). Bacteria were then harvested 
by centrifugation at 3000 x g for 15 min at 4°C and cell pellets were frozen on dry ice 
for 20 min.
For protein purification, cell pellets were thawed by the addition of 10 ml of lysis 
buffer per litre of original culture. Lysis buffer consisted of 0.5 mg/ml lysozyme 
added to IMAC5 (20 mM Tris-HCl pH 8.0, 300 mM NaCl, 5 mM imidazole). The 
cell pellet was resuspended and incubated at 37°C for 15 minutes or until the lysate 
became extremely viscous. The lysate was sonicated on ice using a Bandelin 
Sonopuls sonicator (Bandelin, Berlin, Germany) until the DNA was sheared and the 
lysate became much less viscous. The lysate was then centrifuged at 28000 rpm for 
30 minutes at 4°C in an SW28 rotor in a Beckman Optima LE-80K Ultracentrifuge 
(Beckman, USA) to pellet the cell debris. The cleared lysate supernatant was 
removed into a clean falcon tube. 0.5 ml of Ni-NTA agarose (Qiagen) per litre of 
original culture, washed in IMAC5, was added to the cleared lysate and the tube was 
rotated for 2 hours at 4°C to allow protein binding to occur. The resin was then 
pelleted by centiifugation at 1000 x g for 5 minutes at 4°C and washed in 2 x 30 ml of 
1MAC20 (20 mM Tris-HCl pH 8.0, 300 mM NaCl, 20 mM imidazole). The resin was 
then transferred to a clean column and washed in a further 30 ml of 1MAC20. Bound 
protein was then eluted by the addition of 10 ml 1MAC200 (20 mM Tris-HCl pH 8.0, 
300 mM NaCl, 200 mM imidazole). The eluate was collected in 1.5 ml fractions. 
After SDS-PAGE analysis of these fractions, peak fractions containing recombinant 
protein were pooled and dialysed overnight at 4°C into a suitable buffer (usually 
PBS). Protein concentration was then determined, before aliquoting and storage,
2.2.7 Purification of recombinant GST-tagged proteins from bacteria
A single colony was picked from a fresh plate and used to inoculate 25 ml of LB plus 
selective antibiotics and grown overnight at 37°C with shaking. 10 ml of the 
overnight culture was then used to inoculate 1 L of fresh LB plus antibiotics and 
grown at 37°C until an OD^ oo of 0.5-0.6 was reached. Depending upon the protein
39
Chapter 2: Materials & Methods
being expressed, cultures were either shifted to 18°C, 23°C, or 30°C for 30 minutes 
before being induced with 0.5 mM Isopropyl (3-D-thiogalactoside (IPTG) from a 1 M 
stock or induced immediately at 37°C. Cultures were then left for either 3 hours 
(37°C), 5 hours (30°C), or overnight (23°C and 18°C). Bacteria were then harvested 
by centrifugation at 3000 x g for 15 min at 4°C and cell pellets were frozen on dry ice 
for 20 min.
For protein purification, cell pellets were thawed by the addition of 10 ml of lysis 
buffer (PBS plus 0.5 mg/ml lysozyme) per litre of original culture. The cell pellet was 
resuspended and incubated at 37°C for 15 minutes or until the lysate became 
extremely viscous. The lysate was sonicated on ice using a Bandelin Sonopuls 
sonicator (Bandelin, Berlin, Germany) until the DNA was sheared and the lysate 
became much less viscous. The lysate was then centrifuged at 28000 rpm for 30 
minutes at 4°C in an SW28 rotor in a Beckman Optima LE-80K Ultracentrifuge 
(Beckman, USA) to pellet the cell debris. The cleared lysate supernatant was 
removed into a clean falcon tube. 0.5 ml of glutathione-sepharose (Amersham- 
Pharmacia, USA) per litre of original culture, washed in PBS, was added to the 
cleared lysate and the tube was rotated for 2 hours at 4°C to allow protein binding to 
occur. The resin was then pelleted by centrifugation at 1000 x g for 5 minutes at 4°C 
and washed in 2 x 30 ml of PBS. The resin was then transferred to a clean column 
and washed in a further 30 ml of PBS. Bound protein was then eluted by the addition 
of 10 ml Elution Buffer (100 mM Tris-HCl pH 7.4, 150 mM NaCl, plus 15 mM 
reduced gluitathione added immediately prior to use). The eluate was collected in 1.5 
ml fractions. After SDS-PAGE analysis of these fractions, peak fractions containing 
recombinant protein were pooled and dialysed overnight at 4°C into a suitable buffer 
(usually PBS). Protein concentration was then determined, before aliquoting and 
storage.
2,3 DNA Methods
Standard DNA manipulations were performed essentially as described (Sambrook et 
al. 1989). Enzymes for DNA modification were obtained from New England Biolabs 
(Beverly, MA, USA), Promega (Madison, Wl, USA), or Invitrogen (Leek, 
Netherlands) and used according to the suppliers instructions.
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2,3.1 General cloning strategies
As far as possible, a standard cloning strategy, referred to as the “Shortway” system, 
was used when generating constructs, in order to make all inserts compatible with a 
wide range of different vectors. This involved generating (by PCR) inserts with a 
BamHI, Bglll, or Bell site at the 5’ end and a Sail or Xhol site at the 3’ end. The 
ATC of the BamHI/Bglll/BclI site was designed to be in frame with the start codon of 
the insert i.e.
GGGATCCCC ATG (BamHI)
GAG ATC TCC ATG (Bglll)
GTG ATC ACC ATG (Bell, dam sensitive)
where the restriction site is underlined and the start codon is in italics.
These restriction sites were added by PCR and the insert was TA-TOPO cloned into 
pCRIITOPO. This construct was then sequenced. The insert DNA could then be sub­
cloned, in frame, into the following vectors:
Yeast 2-hybrid vectors (pGBT9, pFBT9, pACT2)
N-terminal His-tagging vectors (pQE32, pTrcHisC)
N-terminal GST-tagging vectors (pFAT2, pGEX-5X-l)
N-terminal GFP-tagging vectors (pEGFP-C2)
C-terminal GFP-tagging vectors (without STOP codon) (pEGFP-Nl, 2, or 3) 
N-terminal tagged mammalian expression vectors (pcDNA3.1/HisA, or /MycA)
Non-tagged mammalian expression vectors (pcDNA3.1+)
If a sequence of interest was not clonable using this approach, alternative restriction 
sites were added to the 5’ and 3’ ends.
2.3.2 Restriction digests and agarose gel electrophoresis of DNA
Analytical restiiction digests were carried out in a total volume of 20 p,l using 1 p,l of 
each enzyme in an appropriate buffer to digest approximately 500 ng of DNA. 
Digests were carried out for 2 hours at an appropriate temperature before being mixed 
with DNA loading buffer and loaded for electrophoresis onto a 1% agarose gel (1% 
(w/v) agai'ose dissolved in 1 x TAE containing 0.8 p,g/ml ethidium bromide). The gel
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was run in 1 x TAE at a constant voltage of 80 V. DNA was visualized on a UV 
transilluminator.
Preparative restriction digests were performed similarly except that 2-3 pig DNA was 
used. Vector DNA was usually treated with alkaline phosphatase by the addition of 1 
pil enzyme to the digestion mix for 15 minutes immediately prior to loading on the 
gel. Following electrophoresis, appropriate bands were excised using a clean scalpel 
blade and purified using a gel extraction kit (Qiagen) according to the manufacturers 
instructions.
2.3.3 Cloning digested DNA fragments
Ligations were performed in a total volume of 20 pil using 1 pil of T4 DNA ligase in 
its buffer. 100 ng of vector DNA was used along with enough insert DNA to make a 
3:1 molar ratio of insert:vector DNA. Ligations were incubated for 2 hours at room 
temperature before transformation of 5 pil into bacteria for cloning.
2.3.4 Polymerase Chain Reaction (PCR)
Oligonucleotides for PCR reactions were obtained either in-house (MPI for 
Biochemistry or Beatson Institute), or from one of the following companies: MWG- 
Biotech (Ebersberg, Germany), Metabion (Martinsried, Germany), or Thermohybaid 
(Ulm, Germany). 100 piM stock solutions were prepared by dissolving the 
oligonucleotides in 1 x TE.
For all PCRs a GeneAmp PCR System 2400 thermocycler (Perkin-Elmer) was used. 
Reactions were carried out in a total volume of 50 pil. Reactions contained 1 x 
polymerase reaction buffer, 1.25 piM forward and reverse primers, 0.25 mM dNTPs, 
and 1 pil (2.5 U) Pfu turbo polymerase (Stratagene, Amsterdam, Netherlands) (often 
added after the mix had been pre-heated to 94°C). As a template, either 10 ng 
plasmid DNA or 5 p,l maiathon-ready cDNA library (Clontech, Palo Alto, CA, USA) 
was used. Typically, 25 cycles of dénaturation at 94°C for 15 seconds, annealing at 
55°C for 30 seconds, and extension at 68°C for 2 minutes per kb to be amplified, were 
used with an initial dénaturation step of 2 minutes and a final extension step of 2 
minutes per kb. PCR products were then analysed by agarose gel electrophoresis and, 
if required, bands were excised, gel extracted, and used for cloning. In the case of 
PCR cloning from cDNA libraries, a Nested approach was generally used. A first
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round of PCR was performed as described above. The PCR product was then directly 
purified using a PCR nucleotide removal kit (Qiagen) according to the manufacturers 
instructions. 5 p.1 of the purified PCR product was then used in a second round of 
PCR using a set of primers designed internally to the primers used in the first round. 
This PCR product was then purified by agarose gel electrophoresis and used for 
cloning.
2.3.5 Cloning of PCR products
Following gel extraction of PCR products, cloning was performed into the 
pCRIITOPO vector using the TA-TOPO cloning system (Invitrogen). Adenosine 
overhangs were added to the 3 ’ ends of the PCR product by incubation of the product 
with 1 jrl Taq polymerase (Promega) at 72°C for 30 minutes in the presence of 
polymerase buffer and 0.25 mM dNTPs in a total volume of 50 pi.
2 pi of this mix was then added to a sterile Eppendorf along with 0.5 pi TA-TOPO 
cloning mix and incubated for 5 minutes at room temperature. This mix was then 
transformed into TOPIO bacteria.
2.3.6 Site-directed mutagenesis
Point mutagenesis was carried out using the Quickchange method. Forward and 
reverse mutagenic primers were designed to be 33 bases long with the codon to be 
altered in the middle, with 15 unchanged bases on either side. The quickchange 
reaction was then set up in a total volume of 50 pi with I x pfu polymerase buffer, 
1.25 pM forward and reverse primers, 0.25 pM dNTPs, 25 ng DNA template, and 1 
pi (2.5 U) pfu turbo polymerase. The following cycling parameters were then used: 
95°C for 30 seconds followed by 18 cycles of 95°C for 30 seconds, 53-55°C for 30 
seconds, and 68°C for 2 minutes per kb of plasmid. After cooling to 4°C, 1 pi of the 
restriction enzyme Dpnl was then added to the reaction mix for 1 hour at 37°C to 
digest methylated (parental) DNA. 5 pi of the reaction mix was then transformed into 
XLl-blue bacteria.
2.3.7 DNA sequencing
All insert DNAs generated by PCR or mutagenesis, were sequenced commercially by 
either Medigenomix (Martinsried, Germany), or in house at the Beatson Institute.
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2.4 Protein Methods
2.4.1 SDS-PAGE (polyacrylamide gel electrophoresis)
Small ( 8  X 6.5 cm) SDS polyacrylamide gels were prepared as described (Sambrook 
et al. 1989). Samples were prepared in SDS-PAGE sample buffer and boiled for 5 
minutes. Gels were run in a BioRad Mini-PROTEAN 3 gel chamber (BioRad, Hemel 
Hempstead, UK) in SDS-PAGE running buffer at 180 V, 50 mA.
2.4.2 Coomassie staining of SDS-PAGE gels
Protein gels were Coomassie stained by immersion in 0.01% Coomassie Brilliant 
Blue R-250 in 50% methanol, 10% acetic acid for 20 minutes, with shaking. Gels 
were then destained in 20% isopropanol, 20% acetic acid.
2.4.3 Mass-spectrometry
Sample preparation and analysis was carried out by Christian Preisinger (MPI For 
Biochemistry, Martinsried) according to a protocol adapted from Shevchenko et al.
1996). Briefly, Coomassie stained bands from protein gels were excised with a clean 
scalpel and cut into 1 mm cubes. The gel pieces were washed with 100 pi 50 mM 
NH4HCO3 for 10 minutes at 22°C, with shaking at 1000 rpm then shrunk in 100 p\ 
acetonitrile for 10 min at 22°C. This was repeated once. Gel pieces were then dried in 
a speed vac for 5 min at 35°C. 10-15 p\ of 10 mM DTT in 50 mM NH4HCO3 was 
added to the dried gel pieces and the mixture was incubated at 56°C for 45 min. The 
gel pieces were returned to room temperature and overlaid with 10-15 pi 55 mM 
iodoacetamide in 50 mM NH4HCO3. The reaction was left for 30 min at room 
temperature in the dark. The supernatant was removed and replaced with 100 pi 50 
mM NH4HCO3 and washed as above. The gel pieces were dried again for 5 minutes. 
10-15 pi trypsin solution (12.5 ng/pl trypsin in 50 mM NH4HCO3; Sequencing-grade 
modified trypsin, Promega) was added to the dried gel cubes and left on ice for 30 
minutes. Additional 50 mM NH4HCO3 (5-15 pi) was added to the mixture and the 
digest reaction was performed for 16 hours at 37°C.
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2 pi 10% TFA was added to the digest. 1 pi of acidified sample was spotted onto the 
sample matrix (l-Cyano-4-hydroxycinnamic acid, Bruker Daltonik GmbH, Germany). 
The spot was washed once with 0.2% TFA.
Mass spectrometry of the samples was performed on a ReflexIII instrument (Bruker) 
MALDI TOF mass spectrometer, equipped with a Scout 384 Ion source. The spectra 
were processed with Xmass 5.1.1 software (Bruker). Proteins were identified using 
the database programs MASCOT (http://www.matrixscience.com) and ProFound 
(http://129.85.19.192/profound_bin/WebProFound.exe).
2.4.4 Western blotting
Proteins run on SDS-PAGE gels were transferred to 45 |rm Hybond-C Extra 
Nitrocellulose (Amersham Pharmacia Biotech, UK) by semi-dry blotting in transfer 
buffer (1 X SDS-PAGE running buffer plus 10% methanol) using a Trans-Blot SD 
Transfer Cell (BioRad, UK) at 15 V, 200 mA, for 45 minutes. Blots were then 
blocked in milk solution (4% milk powder in PBS, plus 0.1% Tween-20) for at least 1 
hour before addition of the primary antibody.
Blots were usually incubated with the primary antibody in milk solution for 1 hour at 
room temperature before being washed 3 x 10 minutes in milk solution. Secondary 
antibodies linked to horseradish peroxidase were then also incubated with the blot for 
1 hour before the blots were washed for a further 3 x 10 minutes in milk. Bound 
antibodies were then detected by chemiluminescence using ECL Western Blot 
Detection Reagents (Amersham) according to the manufacturers instructions, and 
exposed to Kodak X-Omat XAR-5 film for an appropriate length of time.
2.4.5 Determination of protein concentration
Protein concentrations were determined using the BioRad Protein Assay kit (BioRad), 
a modified version of the Bradford Assay. The dye reagent was diluted 1:5 in water 
and 1 mi 1 X reagent was used per assay point. Different concentrations of bovine 
serum albumin (BSA) were used to construct a standard curve by addition to 1 ml 
aliquots of the dye reagent, vortexing, and transferal to disposable cuvettes for 
measurement of the ODggj in an Ultrospec 3000 Pro spectrophotometer (Amersham 
Pharmacia). Protein samples to be measured were then analysed in the 
spectrophotometer and the concentration determined.
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2.4.6 Protein precipitation
Proteins were sometimes precipitated, using trichloroacetic acid (TCA), for loading 
on SDS-PAGE gels. Typically, protein samples were adjusted to 1 ml with water. 7.5 
jrl 10% sodium deoxycholate was then added and the sample vortexed. 300 p.l 55% 
TCA was then added, the sample vortexed, and left on ice for 45 minutes. 
Precipitated proteins were then recovered by centrifugation at 20000 x g for 20 
minutes at 4°C. The supernatant was discarded and the pellet washed in 1 ml -20°C 
acetone before being centrifuged for a further 10 minutes. The supernatant was 
discarded and the pellet resuspended in an appropriate amount of 1.5 x SDS-PAGE 
sample buffer with a small amount of 1 M Tris-HCl pH 8.0 added, as necessary, to 
adjust the pH of the sample.
2.4.7 Rab-effector pulldowns
Pulidowns from rat liver cytosol and rat liver golgi using GST-tagged rab proteins 
were performed throughout the course of this work and the protocol was modified 
over time. The final and most-commonly used protocol is presented below and is an 
adaptation of protocols presented in, for example, (Christoforidis and Zerial 2000). 
Deviations from this standard protocol will be noted in the experimental chapters of 
this thesis.
Rat liver cytosol was prepared according to a published method (Levine et al. 1996) 
and dialysed into HNTM (50 mM HEPES-KOH pH 7.5, 100 mM NaCl, 0.5% Triton 
X-100, 5 mM M gCy. 2 mg (an excess) of recombinant GST-tagged rab protein was 
bound to 50 p.1 glutathione-sepharose beads (Amersham Pharmacia) for 1 hour at 4°C 
in PBS. The beads were then recovered and washed 3 x 1ml HNTM. The beads were 
then incubated in the presence of 12 mg cytosol plus either 100 p.M GDP (wild type 
or GDP-locked rabs) or 100 [iM GTP-y-S or GMP-PNP (GTP-locked rabs) in a total 
volume of 1.8 ml overnight at 4°C. Beads were then washed in 3 x 1ml HNTM and 
bound proteins were eluted in 1 ml NE500 buffer (20 mM HEPES-KOH pH 7.5, 500 
mM NaCl, 0.1% Triton X-100, 20 mM EDTA) for 30 minutes at room temperature. 
An excess of glutathione-sepharose beads was then added to the eluate for 2 x 30 
minutes to rebind as much rab protein from the eluate as possible. The eluate was
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then TCA precipitated and analysed by western blotting or coomassie brilliant blue 
staining as required.
2.4.8 Rab-effector binding assays
Direct binding between recombinant GST-tagged rab proteins and his-tagged effector 
proteins was assessed by immobilizing 4 qg rab protein on 15 p.1 glutathione- 
sepharose and then incubating the beads for 1 hour at 4°C with 10 pig effector protein 
in the presence of 100 qM GDP, GTP-y-S or GMP-PNP in a total volume of 400 p.1 
HNTM. Beads were washed in 3 x 1ml HNTM and then eluted directly in 1.5 x SDS- 
PAGE sample buffer for analysis either by western blotting or coomassie brilliant 
blue staining.
2.5 Yeast Methods
2.5.1 Strains, growth, and media
The S.cerevisiae strain PJ69-4A (James et al. 1996) was used for all two-hybrid 
experiments, the genotype of which is:
MATa, trpl-901, leu2-3, 112, uj'a3~52, his3-200, gal4A, galSOA, LYS2::GALly^s~ 
GAL1tata-H1S3, GAL2yAs‘GAL2TATA-^E2, MELl met2^ GAL74acZ 
Yeast were grown in either YPDA or SC Dropout media selecting for appropriate 
plasmids at 30°C. Short-term storage was on plates at 4°C.
YPDA media consisted of 20 g/1 peptone (Difco/Becton-Dickinson), 10 g/1 yeast 
extract (Difco), and 20 g/1 glucose (plus 20 g/1 Bacto-agar for YPDA-agar). The 
media was then sterilised in an autoclave and, after cooling to approximately 55°C, 6 
ml 0.2% sterile filtered adenine hemisulphate was added.
Synthetic complete (SC) dropout media was prepared as follows:
Amino acid base (-His/-Trp/-Leu/-Ura) was prepared by mixing 20 g alanine, 
arginine, asparagine, aspartic acid, cysteine, glutamine, glutamic acid, glycine, 
inositol, isoleucine, lysine, methionine, phenylalanine, proline, serine, threonine, 
tyrosine, and valine with 5 g adenine and 2 g para-aminobenzoic acid. To prepare 
dropout mixes, 36.7 g of amino acid base was mixed with either 2 g histidine, 4 g 
leucine, 2 g tryptophan, or 2 g uracil, as appropriate to form the correct dropout mix. 
SC dropout media consisted of 6.7 g/1 nitrogen base (without amino acids, Difco), 2
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g/1 appropriate dropout mix, 20 g/1 glucose and pH adjusted to between 5.5 and 6.5 
(plus 20 g/1 Bacto-agar for SC dropout agar). After autoclaving and cooling to 
approximately 55°C, 6 ml 0.2% sterile filtered adenine hemisulphate was added, 
unless dropout media was also to be -adenine.
2.5.2 Yeast transformation (frozen cell method)
To prepare frozen competent yeast cells, several colonies were picked from a freshly 
grown plate and grown overnight in YPDA at 30°C with shaking. The following 
morning, the overnight culture was diluted to an ODgoo of 0.15 in fresh medium and 
grown at 30°C to an OD^ oo of 0.5-0.6 (1.2-1.5 x 10^  cells). The cells were then 
harvested at 3000 rpm for 2 minutes at room temperature in a Heraeus centrifuge. 
The cells were then washed in one half culture volume sterile water and spun as 
before. The cells were then resuspended in 1/8“’ culture volume of LiSorb (100 mM 
LiOAc, 10 mM Tris-HCl, pH 8.0, 1 mM EDTA pH 8.0, 1 M sorbitol (molecular 
biology quality, filter sterilized). The resuspended pellet was incubated for 5 minutes 
at room temperature before being spun as before. An additional spin was made to 
remove residual supernatant. The cell pellet was again resuspended in LiSorb (600 yd 
per 100 ml original culture). Carrier DNA was then added (10 p,l per 100 p.1 yeast of 
10 mg/ml salmon sperm DNA (Gibco), heat-treated at 95°C for 5 minutes). Cells 
were then aliquoted and frozen directly in a -80° C freezer where they were stored 
until use.
To transform frozen yeast cells, the cells were thawed at room temperature. 25 yd 
cells were used per transformation. 0.5 yd plasmid DNA for transformation was 
added to the cells, followed by 150 yd LiPEG (100 mM LiOAc, 10 mM Tris-HCl, pH 
8.0, 1 mM EDTA, pH 8.0, 40% PEG3350, filter sterilized). The cells were then 
vortexed and incubated for 20 minutes at room temperature. 17.5 p.1 DMSO was then 
added and the cells were heat-shocked for 15 minutes in a 42°C waterbath. The cells 
were then pelleted at low speed in a microfuge, the supernatant removed, and the cells 
resuspended in 200 p,l sterile PBS. 80 p,l were the plated onto appropriate selective 
plates and grown at 30°C.
In the case of directed yeast two-hybrid experiments, transformed cells were 
originally grown on SC-Leu/-Trp plates to select for both the bait and prey plasmids. 
After 2-3 days growth, colonies were picked and restreaked onto SC-Leu/-Trp/-His
48
Chapter 2: Materials & Methods
and/or SC-Leu/-Trp/-His/-Ade plates to assess the strength of the two-hybrid 
interaction.
2.5.3 DNA minipreps from yeast cells
To prepare plasmid DNA from yeast cells, either 1 ml of an overnight culture or a 
matchhead-sized ball of cells scraped from a fresh plate into 1 ml water, was pelleted 
at low-speed in a microfuge. The cell pellet was then resuspended in 500 p.1 buffer S 
(10 mM K2HPO4, pH 7.2, 10 mM EDTA, 50 mM p-mercaptoethanol (i.e. 100 yd per 
25 ml added immediately prior to use), and 50 p,g/ml zymolyase). The cells were then 
incubated at 37°C for at least 1 hour. 100 yd lysis buffer (25 mM Tris-Hcl, pH 7.5, 25 
mM EDTA, 2.5% (w/v) SDS) was then added, vortexed, and the lysate incubated at 
65°C for 30 minutes. 166 pil 3 M KO Ac, pH 5.5 was then added to stop the lysis 
reaction, tubes were inverted to mix, and incubated on ice for 10 minutes. They were 
then centrifuged at 20000 x g in a microfuge at 4°C for 15 minutes and the 
supernatant was transferred to a clean Eppendorf tube. 800 \il cold ethanol was 
added, tubes were inverted to mix, and incubated on ice for 10 minutes before 
centrifugation as before for a further 10 minutes. The supernatant was removed and 
the pellet washed in 1 ml 70% ethanol. The pellet was allowed to air dry before 
resuspension in 40 pi sterile water.
2.6 Cultured Mammalian Cell Methods
2.6.1 Cell culture
Hela L cells were cultured at 37°C and 5% CO2 atmosphere in Dulbeccos Modified 
Eagle Medium (DMEM) containing 10% fetal calf serum, 100 U/ml penicillin and 
100 pg/ml streptomycin (all Life Technologies).
2.6.2 Immunofluorescence
For immunofluorescence, cells were normally cultured on ethanol-flamed 15 mm 
coverslips in 6-well plates. Cells were fixed in either 3% paraformaldehyde or 
methanol, as indicated in the text.
For paraformaldehyde fixation, 3% paraformaldehyde was prepared by dissolving 3 g 
paraformaldehyde in 100 ml PBS at 80°C in a fume hood. 10 pi 1 M CaClg and 10 pi
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1 M MgCl2 were added while stirring before the solution was allowed to cool to room 
temperature and pH adjusted to 7.4. The solution was then vacuum-filtered through a 
0.45 pm filter and 15 ml aliquots were stored at -20°C. Coverslips were washed 
twice in 2 ml PBS and then fixed in 3% paraformaldehyde for 20 minutes. Coverslips 
were then washed once in 2 ml quench solution (50 mM NH4CI in PBS made 
immediately prior to use) before incubation in a further 2 ml quench solution for 10 
minutes. The coverslips were then washed in 3 x 2ml PBS. If the cells were to be 
permeabilised, the coverslips were incubated for 5 minutes in permeabilisation 
solution (0.2% Triton X-100 in PBS) before washing in 3 x 2ml PBS.
For methanol fixation, coverslips were washed twice in 2 ml PBS before adding 2 ml 
-20°C methanol and placing them in a -20°C freezer for 4 minutes. The coverslips 
were then removed from the freezer and washed in 3 x 2ml PBS.
For antibody labeling, primary antibodies were diluted appropriately in PBS. A strip 
of parafilm was placed on a flat surface and 50 pi drops of the antibody solution were 
placed on the strip. Coverslips with fixed cells were then transferred, cell face down, 
onto the antibody drops. The coverslips were then covered with a moist, dark 
chamber and left for 1 hour at room temperature. After this incubation, the coverslips 
were floated by pipetting 200 pi under each one, before transferring them back, cell 
face up, to the 6-well plate. They were then washed in 3 x 2ml PBS. The same 
procedure was then followed for incubation with secondary antibodies conjugated to 
appropriate fluorophores. After washing in PBS for the final time, coverslips were 
mounted onto clean microscope slides by placing them, cell face down, onto a 10 pi 
drop of Moviol mounting medium. (Prepared as follows: 2.4 g Moviol 4-88 added to 
6 g analytical grade glycerol while stirring. 6 ml of dH20 then added and the solution 
was left for 2 hours at room temperature. 12 ml of 0.2 M Tris-HCl pH 8.5 was then 
added while stirring and the solution was mixed for 10 minutes at 50°C. The Moviol 
solution was then clarified by centrifugation at 3000 x g for 15 minutes and stored at 
-20°C aliquoted into glass vials.) The mounting medium used usually contained 1 
pg/ml DAPI stain. The coverslips were then left for at least 30 minutes at room 
temperature to allow the Moviol to dry.
Images were collected using a ZEISS Axioskop-2 with a 63x Plan Apochromat oil 
immersion objective with a 1.4 NA, a 1300 by 1030 pixel cooled CCD camera 
(Princeton Instruments) and Metaview software (Universal Imaging Corp.).
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2.6.3 Transient transfection of mammalian cells
DNA consti'ucts were transiently transfected into mammalian cells using lipid-based 
transfection reagents. Specifically, either FuGENE 6 (Roche Diagnostics) or 
Effectene (Qiagen) were used according to the manufacturers instructions.
2.6.4 RNA interference
In order to selectively knockdown the expression levels of particular proteins, small 
interfering RNA duplexes (siRNAs) were transfected into cultured Hela L cells. The 
protocol used was essentially that of Elbashir et al, 2001. The open reading frames of 
target cDNAs were analysed for regions at least 100 bases downstream of the start 
codon containing the sequence AA(N19)TT. This sequence was then used to design 
an siRNA duplex consisting of 21 nucleotide sense and antisense RNA 
oligonucleotides paired to have a 2 nucleotide 3’ overhang. RNA oligonucleotides 
were synthesized by Dharmacon Inc. To anneal the oligonucleotides, 20 pM single­
stranded RNAs were incubated in annealing buffer (100 mM KOAc, 30 mM HEPES- 
KOH, pH 7.4, 2 mM MgOAc) in a total volume of 100 pi for 1 minute at 90°C 
followed by 1 hour at 37°C. This solution could then be stored at -20°C until needed. 
Hela L cells were usually passaged and allowed to grow and attach 24 hours before 
transfection with the siRNA duplex. For transfection, the lipid-based transfection 
reagent Oligofectamine (Invitrogen) was used. For the transfection of a single well of 
a six-well plate, the following amounts were used: 3 pi of 20 pM siRNA duplex and 3 
pi Oligofectamine were added to 200 pi OptiMEM medium (Invitrogen) in a clean, 
RNAse-free Eppendorf tube. The mixture was pipetted up and down to mix and left 
for 25 minutes at room temperature. The entire mixture was then added, drop-wise, to 
the cells which were then incubated at 37°C, 5% COj in DMEM until being processed 
for western blotting or immunofluorescence.
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Complexes At The Early Golgi
3.1 Introduction
Secretory material exits the ER in COPII vesicles, that fuse together to form vesicular 
tubular clusters, which then act as transport vehicles to the c/^'-Golgi (Presley et al.
1997). The ER-Golgi Intermediate Compartment (ERGIC) was originally thought to 
be a separate stable compartment from which material was transported to the Golgi by 
small budded vesicles (Lotti et al. 1992). It was later demonstrated, however, by 
visualizing GFP-tagged VSV-G protein in live cells, that fluorescent protein 
accumulated in the intermediate compartment, which then moved to the cis-Golgi 
(Presley et al. 1997). This movement is directed to the minus-end of microtubules 
and was dependent on the dynactin/dynein motor (Presley et al. 1997). Proteins are 
also recycled back to the ER from the intermediate compartment (Hauri and 
Schweizer 1992; Tang et al. 1995; Klumperman et al. 1998).
Once at the ci.y-Golgi, cargo is then moved on to the medial Golgi and later 
compartments either by anterograde transport vesicles or by the successive recycling 
of Golgi components in retrograde vesicles (see section 1.2).
Many of the proteins mediating targeting events at the early Golgi have been 
identified. Rabs 1 and 2 are involved in ER to Golgi transport and rabl is also 
required for cis- to medial-Golgi transport in mammalian cells (Plutner et al. 1991; 
Tisdale et al. 1992). Accordingly, rabl has been localised to the ER, ERGIC, and 
early Golgi (Plutner et al. 1991), while rab2 has been detected at the ERGIC 
(Chavrier et al. 1990). Another rab protein of potential relevance to transport events 
at the early Golgi is rab33b, which localizes to the medial Golgi and is implicated in 
retrograde transport (Zheng et al. 1998; Valsdottir et al. 2001).
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The eai'ly Golgi coiled-coil proteins p i 15, GM130, and giantin are also implicated in 
ER to Golgi and intra-Golgi transport, p i 15 was originally identified as a protein 
required for an in vitro intra-Golgi transport assay (Waters et a l  1992), and is 
required in vitro for COPI vesicle docking (Sonnichsen et a l  1998). Usolp, the 
budding yeast homologue of p i 15, is also essential for the docking of ER-derived 
COPII vesicles with the c/.s-Golgi (Barlowe 1997). The cis-Go\gi matrix proteins 
GM130 and giantin both bind pi 15 (Nakamura et a l 1997; Sonnichsen et a l  1998), 
are both required for COPI vesicle docking in vitro (Sonnichsen et a l  1998), and are 
both involved in ER-to-Golgi transport in vivo (Alvarez et a l  2001).
Two other important proteins in the early Golgi are GRASP65 and GRASP55 (Barr et 
a l  1997; Shorter et a l  1999). GRASP65 is a peripheral membrane protein associated 
with the cw-Golgi, required for the post-mitotic reassembly of Golgi stacks (Barr et 
a l  1997). It is tightly bound to GM130, an interaction required for the targeting of 
both proteins to Golgi membranes (Barr et a l  1998).
The related protein, GRASP55, on the other hand, is localised to the medial Golgi 
and, though also required for the post-mitotic reassembly of the Golgi, it does not 
appear to bind GM130 (Shorter et a l  1999). GRASP55 and GRASP65 show a high 
degree of homology in their N-termini, with the first 212 amino acids of GRASP65 
and 213 amino acids of GRASP55 showing 66% identity and 14% conservation. The 
C-termini are more divergent (Shorter et a l  1999). The conserved region includes the 
site on GRASP65 responsible for GM130 binding (Barr et a l  1998) suggesting that, 
although GM130 does not appear to bind GRASP55, a related protein may do so and 
fulfil a role at the medial Golgi similar to that of GM130 at the cw-Golgi.
A two-pronged approach was used to identify potential binding partners for 
GRASP55: a yeast two hybrid screen using GRASP55 as bait, and the 
immunoprécipitation of GRASP55 complexes from Golgi membranes. As shown in 
Figure 3.1, both approaches led to the identification of golgin-45 as an interactor of 
GRASP55. This protein, previously known as JEM-1, had been identified as a 
putative nuclear-localised transcription factor (Duprez et a l  1997), but was also 
identified as a resident of the Golgi apparatus in a mass spectrometric proteomic 
screen of purified Golgi membranes (Taylor et a l  2000).
The yeast two hybrid screen identified clones encoding amino acids 12-402 of human 
JEM-1/golgin-45, the only obvious sequence feature of which was a predicted coiled-
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Figure 3.1 Golgin-45 is a novel GRASP55 interacting protein
(A) Amino acids 12-404 of golgin-45 were identified using the yeast two-hybrid system by 
screening GRASP55 against a human testis cDNA library. Golgin-45 and a C-terminal 
deletion mutant were tested for interaction with GRASP55 and GRASP65 in the yeast two 
hybrid system compared with GM130 and empty vector as positive and negative controls 
respectively. (B) Co-immunoprecipitations of in v/rro-translated GRASP55 and GRASP65 
with golgin-45 and GM130. (C) GRASP55 complexes were affinity purified from detergent 
extracts of Golgi membranes. Specifically interacting proteins were excised (arrowheads) and 
tryptic digests of the proteins contained therein analysed by mass spectrometry. (D) Golgi 
membranes (10 pg) were western blotted with antibodies to golgin-45 in the presence (+) or 
absence (-) of 10 pg/ml of recombinant golgin-45. Control blots are also shown for the 
antibodies to GRASP65, GRASP55, and GM 130. (E) Immunoprécipitations were performed 
from 20 pg Golgi membranes with either sheep anti-GRASP55, mouse anti-GRASP65, sheep 
anti-GM130, or rabbit anti-golgin-45. GRASP55 and GRASP65 IPs were blotted with rabbit 
anti-GM130 and rabbit anti-golgin-45, GM130 IPs were blotted with rabbit anti-GRASP55 
and mouse anti-GRASP65, and golgin-45 IPs were blotted with sheep anti-GRASP55 and 
mouse anti-GRASP65. Asterisks indicate a non-specific cross-reactivity of the rabbit anti- 
GRASP55 antibody to the sheep anti-GM130 antibody used for the IP.
The data in this figure was kindly provided by Francis Barr.
coil region between amino acids 123 and 282 (Figure 3.1 A). The GRASP55-golgin- 
45 interaction was dependent upon the last 7 amino acids of golgin-45, since deletion 
of these amino acids abolished the interaction. Golgin-45 also showed an interaction 
with GRASP65, (Figure 3.1 A), just as GM130 is able to interact with both GRASP 
proteins by yeast two hybrid (Shorter et al. 1999). These interactions were confirmed 
by immunoprécipitation of in vifro-translated proteins (Figure 3.1 B), with golgin-45 
binding more GRASP55 than GRASP65 and GM130 binding more GRASP65 than
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GRASP55 in vitro (Figure 3.1 B). Golgin-45 could also be co-immunoprecipitated 
with GRASP55 from Golgi membranes and identified by mass spectrometry (Figure
3.1 C) confirming the interaction in vivo. A  polyclonal antibody was raised against 
golgin-45, which recognised a protein of the correct size in Golgi membranes by 
western blot (Figure 3.1 D). Immunoprécipitations from Golgi membranes with 
GRASP55, GRASP65, GM130, and golgin-45 antibodies, further confirmed the in 
vivo interaction and suggested that, in vivo, the main GRASP complexes are 
GRASP65-GM130 and GRASP55-golgin-45 (Figure 3.1 E).
This suggested that JEM-1/golgin-45 might, in fact, be a golgi-localised coiled-coil 
protein functioning in vesicle transport and maintenance of Golgi structure in a 
similar manner to GM130. I therefore set out to characterise the role of golgin-45 in 
transport events at the early Golgi, and to determine whether it and other early Golgi 
coiled-coil proteins were able to interact with the rab proteins thought to be involved 
in these steps.
3.2 Experimental Methods
3.2.1 Rab pulldowns from Golgi extract
0.5 mg recombinant GST-tagged rab proteins were bound to 50 pi glutathione- 
sepharose beads (Amersham Pharmacia Biotech). Wild type proteins in the presence 
of 10 pM GDP were used for rab-GDP samples, and proteins bearing activating point 
mutations (rablQ70L, rab2Q65L, and rab6aQ72L) in the presence of 10 pM GTPyS 
were used for rab-GTP samples. The beads were incubated with 200 pg Golgi extract 
in HNTM (50 mM HEPES-KOH, pH7.2, 200 mM NaCl, 0.5% TX-lOO, 5 mM 
MgCli) in a total volume of 400 pi for 1 hour at 4°C. Beads were then washed three 
times in 500 pi HNTM containing 10 |M nucleotide before bound proteins were 
eluted in HNT containing 20 mM EDTA. Bound proteins were then precipitated with 
12% (w/v) TCA and analysed by western blotting.
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3.3 Experimental Results
3.3.1 Golgin-45 localises to the Golgi apparatus and behaves as a Golgi matrix 
protein
In accordance with its detection in Golgi membrane extract (Figure 3.1 D), golgin-45 
was also localised to the Golgi apparatus by immunofluorescence (Figure 3.2). 
Staining of normal rat kidney (NRK) cells with anti-golgin-45 and anti-GRASP55 
antibodies showed extensive co-localisation of the two proteins at the Golgi, 
consistent with their existence together in a complex similar to GRASP65/GM130 
(Figure 3.2 A). Golgi matrix proteins such as GM130 remain in Golgi remnant 
structures when cells are treated with the drug brefeldin A (BFA), in contrast to 
resident Golgi enzymes, which redistribute back to the ER (Seemann et al. 2000). 
Staining for golgin-45 following BFA treatment reveals that golgin-45 behaves as 
expected for a matrix protein: its localisation becomes vesiculated and dispersed 
throughout the cytoplasm but the protein does not re-localise to the ER (Figure 3.2 B). 
Similarly, treatment of cells with the microtubule depolymerising drug, nocodazole, a 
treatment that disrupts the Golgi into 'mini-stacks' (Rogalski et al. 1984), also causes 
golgin-45 staining to become dispersed throughout the cytoplasm (Figure 3.2 B). 
Dispersal of golgin-45 and GRASP55 can also be induced by the overexpression of 
full length golgin-45 (Figure 3.2 C). Golgin-45 therefore displays the characteristics 
of a Golgi matrix protein and may be important for maintaining Golgi structure.
3.3.2 Golgiii-45 is a rab2 effector
The Golgi matrix proteins pi 15 and GM130 have recently been identified as rabl 
effector proteins, which specifically bind to the active, GTP-bound form of rabl 
(Allan et al. 2000; Moyer et al. 2001; Weide et a l 2001). Since golgin-45 has several 
features in common with GM130, I tested the possibility that it, too, would 
specifically interact with a Goigi-localised rab protein. The GTP-restricted mutants of 
rabs 1 ,2 ,5 ,6a , and 33b were cloned into the yeast two hybrid bait vector pGBT9 and 
screened against full length pi 15, GM130, and golgin-45 cloned into the prey vector 
pACT2 (Figure 3.3 A). Golgin-45 displayed a specific interaction with the GTP- 
restricted mutant of rab2 as assessed by growth on selective media. No interaction 
was seen with the other rab proteins tested, p i 15 showed an interaction with the
56
golgin-45
Chapter 3: Early Golgi Rab-Effector Complexes
G R A SP55 Merge + DAP!
B
+BFA
+Noc
GFP-
golgin-45
Figure 3.2 Golgin-45 behaves like a Golgi matrix protein
(A) NRK cells were fixed with 3% PFA and stained with rabbit anti-golgin-45 and sheep 
anti-GRASP55. (B) NRK cells were treated with either 5 pg/ml BFA for 30 minutes or 200 
ng/ml nocodazole for 60 minutes prior to fixation and staining as in (A). The merged 
images in (A) and (B) show DNA (DAPI staining) in blue, golgin-45 in red, GRASP55 in 
green, and areas of overlap between golgin-45 and GRASP55 in yellow. (C) NRK cells 
were transfected with GFP-golgin-45 for 12 hours then fixed and stained with anti- 
GRASP55 (red in merged image).
Bar, 10pm.
activated mutant of rabl, confurming the interaction reported by Allan et al., (2000). 
We also observed an interaction with the GTP-form of rab33b (Figure 3.3 A). GM130 
interacted with rabl in the yeast two hybrid system, consistent with the reports of 
Moyer et al., and Weide et al., (both 2001) but we also observed an interaction with 
rab2 and rab33b, suggesting that GM130 is capable of interacting with multiple rab 
proteins (Figure 3.3 A).
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Figure 3.3 Golgin-45 is a 
specific binding partner of 
rab2
(A) Full length golgin-45, 
GM130, and p l l5  were tested in 
the yeast two hybrid system for 
interactions with the activated 
rab  m u ta n ts  r a b lQ 7 0 L , 
r a b 2 Q 6 5 L ,  r a b 5 Q 7 5 L , 
rab6aQ72L, and rab33bQ92L. 
Interactions were assessed by 
growth on quadruple dropout 
media. (B) Rabl, 2, and 6 beads 
loaded with either GDP or 
G T PyS were incubated with 
Golgi extract and the specifically 
eluted proteins were analysed by 
western blotting.
To confirm the specific interaction of golgin-45 with rab2-GTP, pulldowns were 
performed from Golgi membranes using GST-tagged rab proteins in either the GDP- 
or GTP-bound forms (Figure 3.3 B). Golgin-45 was specifically bound by activated 
rab2 but not rab2-GDP or GTP-loaded rabl and rabba. The protein was 
correspondingly depleted in the unbound fractions (Figure 3.3 B). GRASP55 was 
also pulled down by rab2-GTP (Figure 3.3 B), consistent with its interaction with 
golgin-45 since no interaction was detected between GRASPS5 and rab2 in the yeast 
two hybrid system (data not shown), pi 15 and GM130 were pulled down by 
activated rabl and rab2 (Figure 3.3 B). This supports the finding by yeast two hybrid 
(Figure 3.3 A) that GM130 interacts with both of these rab proteins. Since full length
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pi 15 does not interact with activated rab2 by yeast two hybrid, its presence in the 
rab2-GTP pulldown is presumably due to binding to GM130.
3.3.3 p i 15 binds rabl directly
Since neither the yeast two hybrid system nor pulldowns from Golgi extract are proof 
of a direct interaction between a rab protein and a putative effector, I performed a 
direct binding assay between rabs 1,2,6a and pi 15 using recombinantly expressed 
proteins (Figure 3.4). pi 15 could be specifically and quantitatively bound to rabl- 
GTP (rablQVOL GTP-restricted mutant in the presence of GMP-PNP) but not to rabl- 
GDP (wild type rabl in the presence of GDP) nor to either mutant or wild type rab2 
and rabba proteins (Figure 3.4).
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Figure 3.4 pi 15 binds directly to rabl
4 pg recombinantly expressed GST-tagged rab proteins were incubated with 10 pg His- 
tagged pi 15 and 15 pi glutathione-sepharose beads in the presence of either 10 pM GDP or 
GMP-PNP in a total volume of 400 pi HNTM for 1 hour at 4°C. Bound proteins were 
eluted in SDS-PAGE sample buffer and analysed by SDS-PAGE. pi 15 was specifically 
bound by activated rabl only. Gels have been scaled to match.
3.3.4 p i 15 contains distinct rab binding sites
Due to problems with the expression and purification of functional rab33b protein 
from E.coli, we were unable to assess direct binding between pi 15 and rab33b to 
confirm the yeast two hybrid interaction seen in Figure 3.3 A. However, I used the 
yeast two hybrid system to further investigate this potential interaction and map the 
rab33b binding site on pi 15 as well as the rabl binding site (Figure 3.5).
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Figure 3.5 Mapping of rab binding sites on pi 15 by yeast two hybrid
Deletion mutants of pi 15 were cloned into the yeast two hybrid prey vector pACT2 and 
were screened against the GTP-restricted point mutants rablQ 70L, rab2Q65L, and 
rabS3bQ92L cloned into the bait vector pGBT9. Interactions were assessed by growth on 
quadruple dropout media.
pi 15 consists of a globular head domain at the N-terminus, a coiled-coil tail, and an 
acidic C-terminus. The head domain contains two regions particularly homologous to 
Usolp, the yeast homologue of pi 15 (Sapperstein et al. 1995).
Yeast two hybrid analysis suggests that the rabl binding site lies in this region of 
pi 15 (Figure 3.5). The smallest fragment of pi 15 able to interact with rabl by yeast 
two hybrid encompasses amino acids 1-437. This contains both of the regions highly 
conserved between pi 15 and Usolp. Deletion of either of these two regions abolishes 
the interaction (e.g. neither pi 15 1-123 nor pi 15 124-437 demonstrates an interaction 
with activated rabl). Surprisingly, even though full length pi 15 shows no interaction 
with activated rab2 by yeast two hybrid, the same pi 15 fragments that interact with 
rabl are also able to interact with rab2 (Figure 3.5). The significance of this is 
unclear and may simply be an artefact of expressing deletion mutants of the protein. 
These fragments do not, however, interact with GTP-restricted rab33b. The rab33b 
binding site instead maps to amino acids 607-772 of pi 15, corresponding to the neck 
region of the protein linking the head and tail domains (Figure 3.5). pi 15 therefore 
appears to have two distinct rab binding sites in its sequence: a rabl binding site (also 
capable of interacting with rab2 in the yeast two hybrid system) in the head domain of 
the protein, and a rab33b binding site in the neck region.
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Figure 3.6 GM130 binds 
directly to rabl and rab2
4 p g  re c o m b in a n tly  
expressed GST-tagged rab 
proteins were incubated 
with either 10 pg  His- 
ta g g e d  G M 130 or 
GM130AN433 and 15 pi 
glutathione-sepharose 
beads in the presence of 
either 10 pM  GDP or 
GM P-PN P in a total 
volume of 400 pi HNTM 
for 1 hour at 4®C. Bound 
proteins were eluted in 
SDS-PAGE sample buffer 
and analysed by SDS- 
PAGE. Both GM130 and 
G M  1 30  A N 433 were 
specifically  bound by 
activated rabl and rab2 as 
indicated by the arrows. 
Gels have been scaled to 
match.
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3.3.5 GM130 binds rabs 1 and 2 directly
Direct binding assays were also performed between recombinantly expressed His- 
tagged GM130 protein and GST-tagged rab proteins (Figure 3.6). The C-terminal 
half of GM130 (GM130AN433) was also expressed and used in binding assays. As 
shown in Figure 3.6, both full length GM130 and GM130AN433 were able to bind to 
activated rabl and rab2 but not to rabl-GDP or rab2-GDP. Neither protein was able 
to bind rab6a (Figure 3.6). This supports the data from Figure 3.3 in which GM130 
demonstrated interactions with rabs 1 and 2 by yeast two hybrid and by pulldowns 
from Golgi membranes. Additionally, the binding of GM130AN433 suggests that the 
binding sites for rabs 1 and 2 lie in the C-terminus of GM130.
3.3.6 GM130 contains distinct rab binding sites
To further define the binding site for rabs 1 and 2 on GM130 as well as to map the 
potential binding site for GM130, deletion mutants of GM130 were cloned into 
pACT2 and screened in the yeast two hybrid system against rab GTP-restricted point 
mutants cloned into pGBT9 (Figure 3.7). In agreement with the binding data from 
Figure 3.6, GM130AN433 interacts with activated rabl and rab2. This region also 
interacts with activated rab33b. The N-terminus of GM130 (GM130AC271) showed 
no interaction with any of the rabs tested.
GM130
rab 1, 2. & 33b rab2 & 33b binding___________ binding
Iccil CC2 II CC3 I iCC4| Iccglocel ~
*986 pGBT9
GM 130wt □
GM130AC271 [ ]  
GM130AN433 
GM 130 433-679 
GM130 679-986
rab1Q70L
-LWQDO
rab2Q65L 
-LW QDO
rab6a072L rab33b092L 
-LW QDO -LW QDOMIIIPm ii illB■■ ■ ■ 11 11WHS wia 11 ilimw ■DP 11 Hiiin■■ iW 11 11
m  = Basic p115 binding domain 
Iccj = Coiled-coil 
H  = GRASP65 binding
Figure 3.7 Mapping of rab binding sites on GM130 by yeast two hybrid
Deletion mutants of GM 130 were cloned into the yeast two hybrid prey vector pACT2 and 
were screened against the GTP-restricted point mutants rablQ70L, rab2Q65L, rab6aQ72L, 
and rab33bQ92L cloned into the bait vector pGBT9. Interactions were assessed by growth 
on quadruple dropout media. Rab6aQ72L shows a slight interaction with GM130AN433 
and GM130 433-679 but this is most likely background activation since levels of growth are 
much less than that seen for the same GM130 fragments with the other 3 rabs.
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The C-terminus of GM130 is predicted to contain 4 coiled-coil regions as shown in 
Figure 3.7. Analysis of further deletion mutants of GM130 suggested that rabs 1, 2, 
and 33b were all able to bind to amino acids 433-679 of GM130, a region predicted to 
form one long coiled-coil. Additionally, GM130 amino acids 679-986, encompassing 
three short stretches of coiled-coil, was able to interact with activated rab2 and 
rab33b, but not with activated rabl. This suggests the presence of at least two distinct 
rab binding sites in the C-terminus of GM130, both of which consist extensively of 
coiled-coil. These binding sites appear to be able to interact with more than one rab 
protein but the two sites have slightly different specificities with amino acids 433-679 
able to bind rabs 1, 2, and 33b and amino acids 679-986 only binding rabs 2 and 33b.
pACT2.golgin-45
rab2 wt w
rab2Q65L
GRASP55
I  ^ I(SI yr- y -
-LW QDO
123
golgin-45 
rab2 binding 282 403
r~ | = coiled-coil 
0 1  = GRASP55 binding
Figure 3.8 Rab2 binds to tbe coiled-coil region of golgin-45
Deletion mutants of golgin-45 were cloned into the yeast two hybrid prey vector pACT2 and 
were screened against rab2 wild type, the GTP-restricted point mutant rab2Q65L, and 
GRASP55 cloned into the bait vector pGBT9. Interactions were assessed by growth on 
quadruple dropout media.
3.3.7 Rab2 binds tbe coiled-coil region of golgin-45
It was not possible to express and purify soluble golgin-45 in E.coli^ and so we were 
unable to perform a direct binding assay between golgin-45 and rab2. It was possible, 
however, to map the rab2 binding site to the central, coiled-coil domain of golgin-45 
using the yeast two hybrid system (Figure 3.8). Deletion mutants of golgin-45 were
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cloned into pACT2 and screened against rab2. The region encompassing amino acids 
123-282 was necessary and sufficient for the interaction with activated rab2 (Figure 
3.8). Only mutants containing the C-terminus of golgin-45 were able to interact with 
GRASP55, agreeing with the finding that the last 7 amino acids of golgin-45 are 
essential for this interaction (Figure 3.1 A).
3,3.8 Depletion of rabs and golgins by RNA interference
The data presented above suggests that a network of interactions exists at the early 
Golgi between rabs and coiled-coil proteins. To investigate the function of these 
proteins in maintaining Golgi structure, rabl, rab2, p ll5 , GM130, and golgin-45 were 
specifically depleted in cells using the technique of RNA interference (Elbashir et al. 
2001). This technique uses 21 base RNA duplexes to target particular mRNAs for 
degradation, thereby reducing protein levels in the cell. Duplexes were therefore 
designed to target early Golgi proteins and the effects on Golgi structure were 
monitored.
3.3.8.1 Depletion of rabl disrupts the Golgi apparatus
Treatment of HeLa cells with rabl small interfering RNA (siRNA) duplexes resulted 
in the depletion of rabl and the disruption of Golgi structure (Figure 3.9). After 72 
hours, rabl was no longer detectable by immunofluorescence compared to control 
cells treated with siRNA targeting lamin-A (Figure 3.9 A-C). At this time point, 
GM130 was found in small, punctate structures diffuse throughout the cytosol while 
control cells displayed a normal, reticular, perinuclear, staining pattern (Figure 3.9 A), 
p i 15 staining was also diffused throughout the cell in the absence of detectable rabl 
(Figure 3.9 B). The medial Golgi-localised enzyme «-acetylglucosaminyltransferase-I 
(NAGT-I), on the other hand, redistributes to give a nuclear envelope and ER-like 
staining pattern when rabl is depleted (Figure 3.9 C). Thus, depletion of rabl gives 
rise to a phenotype similar to the treatment of cells with BFA or dominant negative 
mutants of Sarip, in which forward transport from the ER to Golgi is blocked. Golgi 
resident enzymes recycle back to the ER, while Golgi matrix proteins remain in small 
Golgi remnant structures.
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Depletion of rabl 
disrupts the Golgi 
apparatus
(A) HeLa cells 
were treated with 
siRNA duplexes 
targeting  either 
rabl or lamin-A 
for 72 hours prior 
to fixation with 
3% PFA and 
s ta in in g  w ith  
mouse an ti-rab l 
and sheep anti- 
GM130. In the 
m erged im ages, 
D N A  ( D A P I  
staining) is in blue, 
rabl is in red, and 
GM 130 is in 
green. (B) HeLa 
cells were treated 
w i t h  siRNA 
duplexes targeting 
e ither rabl  or 
lamin-A for 54 
hours and then 
transfected with a 
plasmid encoding 
GFP-tagged 
N A GT-I for a 
further 18 hours. 
Cells were then 
fixed with 3% 
PFA and stained 
with mouse anti- 
r ab l .  In the 
m erged im ages, 
D N A  ( D A P I  
staining) is in blue, 
rabl is in red, and 
GFP-NAGT-I is in 
green.
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Figure 3.10 Depletion of rab2 disrupts the Golgi and causes cell death
HeLa cells were treated with siRNA duplexes targeting either rab2 or lamin-A for 72 hours 
prior to fixation with 3% PFA and staining with rabbit anti-rab2 and either sheep anti- 
GM130 (A) or sheep anti-pl 15 (B). In the merged images, DNA (DAPI staining) is in blue, 
rab2 is in red, and GM130/pl 15 is in green.
3.3.S.2 Depletion of rab2 disrupts the Golgi apparatus and causes cell death
Treatment of HeLa cells with rab2 siRNA duplexes resulted in the depletion of rab2, 
the disruption of Golgi structure, and an adverse effect on cell viability (Figure 3.10). 
After 72 hours, rab2 was no longer detectable by immunofluorescence compared to 
control cells treated with lamin-A siRNA (Figure 3.10 A and B). This corresponded 
to an increase in cell death and a marked change in cellular morphology: rab2- 
depleted cells became very small and rounded with compact nuclei taking up almost 
the entire cell and little cytoplasm remaining. GM130 and pi 15 staining was still 
present but was disrupted into punctate structures compared to control cells (Figure 
3.10 A and B).
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Figure 3.11 Depletion of rab2 correlates with changes in cell morphology
HeLa cells treated with siRNA duplexes targeting rab2 for 24, 36, or 48 hours were fixed 
with cold methanol and stained with rabbit anti-rab2 and sheep anti-GM130. In the merged 
images, DNA (DAPI staining) is in blue, rab2 is in red, and GM130 is in green. Control 
cells treated with siRNA duplexes targeting lamin-A for 48 hours were fixed and stained 
identically.
In order to better follow the changes associated with depletion of rab2, siRNA-treated 
cells were fixed at earlier time points and stained for rab2 and GM130 (Figure 3.11). 
This analysis showed a decrease in rab2 staining between 24 and 48 hours of 
treatment concomitant with an increase in the number of dying cells displaying an 
rounded morphology and reduced cytoplasmic volume. After 24 hours, the cells still 
appear normal with rab2 staining still present and GM130 staining appearing regular. 
At 36 hours, an intermediate phenotype is seen, in which rab2 levels are partially, but 
not completely, depleted and GM130 staining shows that the Golgi has become 
disrupted into smaller punctate and reticular structures. Most cells however are still 
flat and normally shaped. By 48 hours, the majority of cells have lost rab2 staining, 
as well as normal GM130 staining, and have become condensed and rounded up 
(Figure 3.11). Lamin-A siRNA-treated cells at the same time point are unaltered in
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terms of Golgi structure and cell shape. The difference in size between rab2-depleted 
and control cells is readily apparent.
Depletion of rab2 therefore results in the loss of Golgi structure with a deleterious 
effect on the cell as a whole.
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Figure 3.12 Depletion of pl l5  disrupts the Golgi 
apparatus
(A) HeLa cells were treated with siRNA duplexes targeting 
either pi 15 or lamin-A for 120 hours prior to fixation with 
cold methanol. 1.6pg/ml aphidicolin was added to the cells 
after 48 hours in order to prevent cells from overgrowing, 
pi 15 siRNA-treated cells were stained with sheep anti- 
pl 15 and rabbit anti-GM130. Lamin-A siRNA-treated cells 
were stained with sheep anti-pl 15 and mouse anti-lamin. 
In the merged images, DNA (DAPI staining) is in blue, 
pi 15 is in red and GM130/lamin is in green. (B) HeLa 
cells treated as in (A) were extracted in TNTE buffer after 
120 hours. 25pg extract was western blotted and probed 
with sheep anti-pl 15 and, as a loading control, mouse anti­
tubulin.
3.3.S.3 Depletion of p i 15 disrupts the Golgi apparatus
Treatment of cells with siRNA duplexes targeting pi 15 resulted in the depletion of 
pi 15 and the disruption of the Golgi apparatus (Figure 3.12). Depletion of pi 15 
protein levels took a longer time than that required to deplete rab 1 or rab2 but, after 
120 hours, pi 15 levels were undetectable by either immunofluorescence (Figure 3.12
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A) or western blotting (Figure 3.12 B) compared to lamin-A siRNA-treated cells. At 
this time, normal Golgi structure was disrupted, as assessed by staining for GM130 
(Figure 3.12 A) which was redistributed into small, punctate structures diffuse 
throughout the cytoplasm reminiscent of the staining pattern seen following rabl- 
depletion (Figure 3.9 A). Control cells showed normal levels of p i 15 and a normal 
p i 15 staining pattern, p i 15 is therefore also essential for the maintenance of normal 
Golgi structure.
3.3.8.4 Depletion of GM130 disrupts the Golgi apparatus and changes cell 
morphology
Treatment of cells with siRNA duplexes targeting GM130 resulted in the depletion of 
GM130, disruption of the Golgi apparatus, and an alteration in cellular morphology 
(Figure 3.13). After 72 hours, GM130 was no longer detectable by 
immunofluorescence (Figure 3.13 A-C) or by western blotting (Figure 3.13 D) 
compared to control cells treated with lamin-A siRNA. p i 15 levels remained 
unaffected (Figure 3.13 D) but its staining pattern was altered such that smaller, 
punctate structures throughout the cytoplasm and, in some cells, a reduced perinuclear 
staining compared to the extended reticular network seen in control cells (Figure 3.13 
A). The staining patterns of other Golgi markers were also affected with golgin-97 
(^ran5-Golgi) staining becoming dispersed into smaller, punctate structures (Figure
3.13 B) and GRASP55 (medial Golgi) staining almost entirely disappearing (Figure
3.13 C).
Strikingly, cell morphology was also altered by treatment with GM130 siRNA 
duplexes. DAPI staining revealed the nuclei to be misshapen while long processes 
formed from the cytoplasm projecting outwards from the centre of the cell (Figure
3.13 A-C).
pi 15 is proposed to be recruited to cis-Golgi membranes by binding to the N-terminus 
of GM130 (Nakamura et a l  1997). Phosphorylation of GM130 serine25 by Cdkl at 
the onset of mitosis is thought to inhibit this interaction, thereby preventing p ll5 -  
GM130 mediated vesicle docking and initiating Golgi mitotic fragmentation (Lowe et 
al. 1998). We therefore reasoned that transfection of cells with a siRNA-resistant 
form of GM130 should be able to restore normal p i 15 staining to GM130-depleted 
cells. GM130 siRNA-treated cells were transiently transfected after 24 hours with a
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Figure 3.13 Depletion of GM130 disrupts the Golgi 
apparatus and alters cell shape
(A-C) HeLa cells were treated with siRNA duplexes 
targeting either GM130 or lamin-A for 72 hours prior to 
fixation with either 3% PFA (A) or cold methanol (B and 
C). Cells were then stained with either rabbit anti-GM 130 
(A and C) or sheep anti-GM 130 (B) as well as either sheep 
anti-pl 15 (A), mouse anti-golgin-97 (B), or sheep anti- 
GRASP55 (C). In the merged images, DNA (DAPI 
staining) is in blue, GM130 is in red, and p i 15/golgin- 
97/GRASP55 is in green. (D) HeLa cells treated as in (A- 
C) were extracted in TNTE and 25 pg extract was western 
blotted and probed with sheep anti-GM 130, sheep anti- 
pl 15, and, as a loading control, mouse anti-tubulin.
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Figure 3.14 Transient transfection of wild type, but not mutant, rat GMI30 restores 
pll5  localisation in GM130-depleted cells
(A) HeLa cells were treated with siRNA duplexes targeting GM130 for 24 hours before 
transfection with myc-tagged rat GM130 constructs for a further 48 hours prior to fixation 
with 3% PFA and staining with mouse anti-myc and sheep anti-pl 15. Note that p i 15 
localisation is restored in cells transfected with wild type GM130 or GM130S25D but not in 
neighbouring, non-transfected cells nor in cells transfected with GM130AN74. (B) Cells 
marked with an asterisk in (A) are shown enlarged. In the merged images in (A) and (B), 
DNA (DAPI staining) is in blue, myc-tagged GM130 is in red, and pi 15 is in green.
plasmid encoding myc-tagged rat GM130 and fixed with 3% PFA after a further 48 
hours (Figure 3.14). The nucleotide sequence of rat GM130 differs from human 
GM130 in the region targeted by the GM130 siRNA duplex and should therefore be 
resistant to siRNA-mediated degradation.
Staining of cells with anti-myc revealed that myc-tagged GM130 was expressed in 
siRNA-treated cells and localised to perinuclear structures reminiscent of the Golgi
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apparatus in untreated cells (Figure 3.14). p i 15 co-localised to these structures while 
it was absent in neighbouring, non-transfected cells, suggesting that rat GM130 was 
able to rescue pi 15 localisation in GM130-depleted cells. Transfection of cells with a 
mutant rat GM130 (GM130S25D) thought to mimic the Cdkl-phosphorylated form of 
GM130 was also able to restore p i 15 localisation (Figure 3.14). However, a deletion 
mutant of rat GM130 lacking the first 74 amino acids (GM130AN74) was unable to 
restore normal p i 15 localisation, even though the GM130 mutant itself appeared to 
localise to a Golgi-like structure (Figure 3.14). This suggests that the N-terminus of 
GM130 is required for the correct localisation of p i 15 to the cis-Goigi and that either 
binding is not regulated by phosphorylation or that the mutation of serine25 to 
aspartate does not accurately mimic the phosphorylation of serine25 by Cdkl since 
this mutant, along with wild type GM130, successfully rescues the siRNA phenotype 
of GM130-depleted cells.
3.3.8.5 Rabl is the major membrane receptor for p ll5
GM130 is not, however, the only proposed membrane-associated receptor for p i 15, 
since rabl is also able to recruit p i 15 (Allan et al. 2000). To assess the contributions 
of rabl and GM130 to the membrane-association of p i 15,1 compared the localisation 
of p i 15 in rabl- and GM130-depleted cells and in cells simultaneously treated with 
rabl and GM130 siRNAs (Figure 3.15). In control cells, treated only with lamin-A 
siRNA, p i 15 displays a normal, perinuclear, reticular staining pattern. When rabl 
alone is depleted from the cells, p i 15 is diffused throughout the cell with some small, 
punctate structures remaining (Figure 3.15). In GM130-depleted cells, p i 15 staining 
appears to become more concentrated in a compacted, perinuclear region, as seen 
previously in Figures 3.13 and 3.14. This structure also stains positive for rabl 
(Figure 3.15). Some cells treated with GM130 siRNA also show a diffuse, 
cytoplasmic staining pattern for p i 15, but these cells also no longer stain for rabl. 
This is also demonstrated in cells simultaneously depleted of both GM130 and rabl 
(Figure 3.15). All cells depleted of GM130 (as assessed by the change in cellular 
morphology described in section 3.3.8.4) show a change in p i 15 localisation and 
membrane-association. However, it is only in cells also depleted of rabl that p i 15 
staining is completely lost from membrane structures (compare the two cells indicated 
by white arrows in Figure 3.15 with the two neighbouring cells). This suggests that,
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Figure 3.15 Depletion of rabl and GM130 affects p ll5  localisation and membrane- 
association
HeLa cells were treated with siRNA duplexes targeting either lamin-A alone, rabl and 
lamin-A, GM130 and lamin-A, or rabl and GM130. Cells were fixed with 3% PFA after 72 
hours and stained with mouse anti-rabl and sheep anti-pl 15. The white arrows indicate two 
cells in the GM 130/rab 1 double RNAi that are completely depleted of rabl. Note, that in 
these two cells, p i 15 staining is completely lost when compared to the two neighboring 
cells, which still display some rabl staining. In the merged images, DNA (DAPI staining) is 
in blue, rabl is in red, and pi 15 is in green.
although both rabl and GM130 are important for pi 15 localisation, the major protein 
responsible for the membrane-association of pi 15 is rabl.
3.3.S.6 Depletion of golgin-45 disrupts the Golgi apparatus
Treatment of cells with siRNA duplexes targeting golgin-45 resulted in the depletion 
of golgin-45 and disruption of the Golgi apparatus (Figure 3.16). After 48 hours, 
golgin-45 was undetectable by immunofluorescence compared to lamin-A siRNA- 
treated cells (Figure 3.16 A-C). At this time point, normal Golgi structure was 
disrupted, as assessed by staining for GRASP55 (Figure 3.16 A) and GM130 (Figure
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3.16 B). These two matrix proteins, medial and cw-localised respectively, redistribute 
to small, punctate structures diffused throughout the cytoplasm. The medial Golgi 
enzyme, NAGT-I, on the other hand, redistributes to give a nuclear envelope and ER- 
like staining pattern in golgin-45-depleted cells compared to lamin-A-depIeted cells 
(Figure 3.16 C). Golgin-45 therefore appears to be essential for the maintenance of 
Golgi structure.
3.4 Discussion
3.4.1 Golgin-45 is a novel Golgi matrix protein localised to the medial Golgi
Golgin-45 was identified as an interactor of the medial Golgi matrix protein 
GRASP55 by a yeast two hybrid screen and purification of endogenous GRASP55 
complexes (Figure 3.1). It has several features in common with other components of 
the Golgi matrix, particularly with GM130. It contains a region predicted to form a 
coiled-coil structure and, like GM130, it interacts via its C-terminus with a GRASP 
protein (Figure 3.1 A; (Barr et al. 1998)). The protein behaves as expected for a 
Golgi matrix protein in vivo, in that it redistributes from the Golgi stack to smaller, 
punctate, Golgi remnants upon treatment with BFA or nocodazole (Figure 3.2 A and 
B) rather than to the ER as would be expected for a Golgi resident enzyme (Seemann 
et al. 2000).
Golgin-45 is clearly important for the maintenance of Golgi structure since both 
overexpression of the protein (Figure 3.2 C) and its depletion by siRNA (Figure 3.16) 
disrupts the Golgi. This is not as paradoxical as it may first appear. The Golgi 
apparatus faces a constant flux of material through its structure and, in order to 
maintain its normal structure and function this flux must be carefully controlled 
(Warren and Malhotra 1998). Overexpression or depletion of a component important 
for regulating transport through the Golgi might therefore be expected to disrupt 
normal traffic flow and hence Golgi structure.
3.4.2 Golgins are rab effectors
If Golgi-localised coiled-coil proteins such as golgin-45 are key regulators of 
membrane traffic through the Golgi apparatus, they may do this via interactions with 
the rab family of small GTPases known to be regulators of vesicle transport. Using
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the yeast two hybrid system, golgin-45 was found to specifically interact with the 
activated form of rab2, GM130 was able to interact with rabl, rab2 and rab33b, while 
p i 15 displayed interactions with rabl and rab33b (Figure 3.3 A). The interactions 
between rabl and p i 15, rabl and GM130, and rab33b and GM130 agree with 
published data (Allan et aL 2000; Moyer et al. 2001; Valsdottir et al. 2001; Weide et 
al. 2001). Binding assays were also used to confirm the interactions of rabs 1 and 2. 
Both pi 15 and GM130 are pulled down from Golgi membranes by rabl (Figure 3.3 
B) and the recombinant proteins are able to bind directly (Figures 3.4 and 3.6). 
Golgin-45 and GM130 are pulled down from Golgi membranes by rab2 (Figure 3.3 
B) and recombinant GM130 binds directly (Figure 3.6). p i 15 is also pulled down by 
rab2 (Figure 3.3 B) but full length pi 15 does not bind directly (Figure 3.4) nor does it 
interact by yeast two hybrid (Figure 3.3 A). It is most likely therefore that p i 15 is 
pulled down by rab2 as a result of its interaction with GM130.
Golgin-45 and GM130 are the first known effectors of rab2, a protein previously 
implicated in anterograde transport (Tisdale et al. 1992). This suggests that rab2- 
mediated vesicle transport occurs at the level of both the cis- and medial Golgi. The 
interaction of GM130 with rab33b, a protein implicated in retrograde transport 
(Valsdottir et al. 2001), suggests that GM130 is also involved in retrograde 
trafficking, fitting with its involvement in COPI vesicle docking (Sonnichsen et al.
1998).
The ability of GM130 and, potentially, p i 15 to bind multiple rab proteins would 
therefore fit with the multiple roles assigned to these proteins. Interestingly, mapping 
of the rab binding sites on these proteins revealed that these sites were distinct, raising 
the possibility that these golgins may be able to bind multiple rab proteins 
simultaneously. The globular head domain of pi 15 binds rabl (and rab2, although 
not in the context of the full length protein) while the neck domain binds rab33b 
(Figure 3.5). Amino acids 433-679 of GM130 bind rabl, rab2, and rab33b while 
amino acids 679-986 bind rab2 and rab33b (Figure 3.7). Both of these sites contain 
extensive regions of coiled-coil, a motif that appears to be a common feature of rab- 
binding proteins. Similarly, the rab2 binding site on golgin-45 maps to the central 
coiled-coil domain of the protein (Figure 3.8).
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3,4.3 Rabs and golgins are essential for maintaining Golgi structure
As discussed in section 3.4,1, golgin-45 is essential for maintaining Golgi structure 
since its depletion by siRNA disrupts the Golgi (Figure 3.16). siRNA analysis of 
other early Golgi proteins suggests they are also essential for normal Golgi structure 
and function.
Depletion of rabl causes Golgi matrix proteins to redistribute into punctate Golgi 
remnants while Golgi enzymes relocalise to the ER (Figure 3.9). This is similar to the 
effects seen upon BFA treatment or addition of dominant negative Sarlp mutants 
which block ER to Golgi transport (Seemann et al. 2000). Since rabl itself is 
implicated in ER to Golgi transport (Tisdale et al. 1992), depletion of the protein 
might be expected to block this transport step and produce such similar effects.
Rab2 is also important for ER to Golgi transport (Tisdale et al. 1992), but its 
depletion by siRNA produces a markedly different effect (Figure 3.10 and 3.11). 
Normal Golgi structure is disrupted, but the rest of the cell is also strongly affected as 
they shrink in size, round up, and eventually die. This corresponds in time with the 
loss of rab2 and disruption of the Golgi (Figure 3.11) but it is certainly possible that 
the siRNA duplex designed to target rab2 has additional effects on other mRNA(s) or 
is toxic in some other way. The design of a second oligonucleotide pair targeting rab2 
would help to determine the specificity of the rab2-siRNA phenotype but the ultimate 
test of specificity would come from the ability of an siRNA-resistant rab2 to rescue 
the phenotype. Unfortunately, technical difficulties with transiently transfecting rab2 
siRNA-treated cells mean that rescue experiments must await the generation of a 
stable cell line expressing a resistant form of rab2. If this phenotype is a direct result 
of rab2-depletion, it is possible to envisage several explanations depending upon 
subtle differences between rabl and rab2 function. Since golgin-45 depletion does 
not display a similar phenotype, the explanation is not likely to involve the disruption 
of rab2-golgin-45 funetion. Rab2 has been reported to be essential for the maturation 
of pre-Golgi intermediates (Tisdale and Balch 1996). Prevention of this step might 
cause an accumulation of proteins in the ER and subsequent activation of the unfolded 
protein response (Kaufman et al. 2002), leading to cell death. Alternatively, loss of 
rab2 might result in too much material exiting the ER due to an ER retention defect, 
transiting through the Golgi, and being secreted, resulting in a cell stress response.
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This possibility could be tested for by examining the localisation of various ER 
resident proteins.
Depletion of p i 15 results in a more expected phenotype -  similarly to rabl depletion, 
Golgi matrix proteins are redistributed into punctate remnant structures (Figure 3.12). 
Depletion of GM130, also results in the disruption of the Golgi apparatus (Figure 
3.13). GM130 function has been closely linked to Golgi structure, given that its 
phosphorylation by Cdkl has been proposed to cause Golgi fragmentation at the onset 
of mitosis (Nakamura et al. 1997; Lowe et al. 1998). This model was recently 
contradicted however by a study characterising the conditional lethal mutant cell line 
IdlG, which is deficient in expression of the low-density lipoprotein receptor at the 
plasma membrane (Vasile et al. 2003). Although IdlG cells contain no detectable 
GM130 at 34°C, the temperature permissive for growth, they nevertheless have an 
organised and functional Golgi apparatus (Vasile et al. 2003). This is not to say these 
cells are entirely normal, as they exhibit reduced levels of protein secretion at the non- 
permissive temperature of 39.5°C and eventually die. This temperature-sensitive 
phenotype corresponds to a reversible disassembly of the Golgi at 39.5°C. 
Importantly, the growth and secretion phenotypes of IdlG cells can be rescued by 
transfection to restore expression of GM130 (Vasile et al. 2003).
In contrast to these results, depletion of GM130 in HeLa cells by siRNA does result in 
disruption of the Golgi apparatus (Figure 3.13). This discrepancy may simply be due 
to cell-type differences in the way in which Golgi structure is maintained or may be 
due to the higher temperature (37°C) at which siRNA treated HeLa cells were 
incubated. The efficiency of siRNA-treatment was greatly reduced at lower 
temperatures so that this latter possibility could not be tested (data not shown). 
Alternatively, a low level of GM130 may still exist in IdlG cells at 34°C which, 
although undetectable by immunofluorescence, is still sufficient to maintain Golgi 
structure. This critical threshold may be crossed in siRNA-treated HeLa cells. In any 
case, the data in Figure 3.13 suggests that, like p i 15, GM130 is essential for 
maintaining Golgi structure in HeLa cells at 37°C.
Depletion of GM130 also results in general changes in cell morphology as the cell 
nuclei become more irregularly shaped and cytoplasmic projections are formed 
(Figure 3.13). Again, it is possible that these effects are not related to GM130 
depletion and are secondary effects of the GM130 siRNA duplex, although it is
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tempting to speculate that depletion of a factor important for anterograde and 
retrograde transport through the Golgi might have effects on the morphology of the 
nuclear envelope and the plasma membrane. Transfection with siRNA-resistant rat 
GM130 was not able to rescue the cell morphology phenotypes (Figure 3.14), 
although this may be because the expression levels of rat GM130 are not sufficient 
when transiently transfected, or that rat GM130 only partially rescues the lack of 
human GM130. Generation of stable cell lines expressing rat GM130 would better 
address this question. Transient transfection of rat GM130 was able to restore the 
localisation of pi 15 to the Golgi however (Figure 3.14). This rescue depended on the 
N-terminus of GM130 since a deletion mutant did not restore p i 15 localisation 
although a serine to aspartate mutant purported to mimic the mitotic phosphorylation 
of GM130 was still able to rescue pi 15 staining (Figure 3.14). Nevertheless, this 
suggests that GM130 is important for the correct localisation of p i 15 to the c/^-Golgi 
and proves the potential of rescue experiments in the further analysis of siRNA- 
induced phenotypes.
Further experiments, however, suggest that rabl, rather than GM130, is the principle 
determinant of p i 15 localisation (Figure 3.15). Direct comparison of the effects of 
depleting rabl and GM130, either individually or simultaneously, revealed that the 
loss of p i 15 staining on membranous structures correlated with the presence or 
absence of rabl in the cells. GM130 depletion also had an effect on pi 15 localisation 
but the effect was not as marked as seen for rabl. This broadly agrees with the 
findings of Nelson et al, (1998) who found that p i 15 constructs lacking the C- 
terminal GM 130-binding site were still able to localise to the Golgi. Constructs 
lacking the first 283 amino acids from the N-terminus, however, failed to localise to 
the Golgi (Nelson et a l  1998). This N-terminal domain, containing the two regions 
most homologous to Usolp, corresponds to the region found to interact with rabl in 
the yeast two hybrid system (Figure 3.5).
Taken together, these results suggest that the recruitment of p i 15 to Golgi membranes 
is primarily dependent upon rabl while GM130 binding is responsible for the correct 
organisation of these membranes. Since rabl binds GM130 and, in rabl-depleted 
cells, GM130 is mislocalised (Figure 3.9), p i 15 is presumably neither efficiently 
recruited nor organised.
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3.4.4 Summary
A number of rab proteins, golgins, and GRASP proteins exist at the early Golgi, 
which are essential for maintaining the normal structure and function of the Golgi. 
These proteins interact with one another -  golgins with GRASPs, golgins with other 
golgins, and, perhaps most importantly in terms of regulatory events, golgins with rab 
proteins. A network of protein-protein interactions therefore establishes and 
maintains the early compartments of the Golgi apparatus.
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4.1 Introduction
As discussed in Chapter 3, rab proteins of the early Golgi are able to bind effector 
proteins in a nucleotide-dependent manner. Rabl binds p ll5  and GM130 (Figure 3.3; 
(Allan et al. 2000; Moyer et al. 2001; Weide et al. 2001)); rab2 binds GM130 and 
golgin-45 (Figure 3.3); and rab33b binds p ll5  and GM130 (Figure 3.3; (Valsdottir et 
al. 2001)).
More recently, additional rabl effectors have been identified in the form of golgin-84 
and MICAL-1 (Diao et al. 2003; Satoh et al. 2003; Weide et al. 2003). The 
possibility exists that yet more effector proteins of rabl and other early Golgi rabs 
remain to be found. Support for this idea comes from the fact that several proteins in 
addition to p i 15 were retained on GST-rabl-GTP beads in a pulldown from rat liver 
cytosol (Allan et al. 2000), and that the endosomal rab protein, rab5, binds 22 
interacting proteins from bovine brain upon large-scale affinity chromatography 
(Christoforidis and Zerial 2000).
This latter approach involved the incubation of 1 g GST-rab5 with cytosol prepared 
from 14 bovine brains (Christoforidis and Zerial 2000). For logistical reasons, this 
approach was not considered desirable for the identification of new Golgi rab 
effectors. We therefore considered alternative methods for identifying interactors of 
small GTPases.
The ras-related small GTPase ran controls a variety of cellular processes, including 
nuclear transport and mitotic spindle assembly. It accomplishes these different 
functions through interactions with a variety of effector proteins (Dasso 2002). 
Affinity chromatography has also been used to identify some of these effectors (see,
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for example, (Kutay et at, 2000)). This experiment is performed on a much smaller 
scale than the rab5-binding experiments, using only a few mg of GTPase and less than 
1 ml of HeLa cell extract. The key difference between the two methods appeared to 
be that bovine brain cytosol was bound to rab5 over 2 hours (Christoforidis and Zerial 
2000), while HeLa extract was bound to ran overnight (Kutay et al. 2000). Overnight 
binding might therefore allow maximal binding to occur despite working with less 
starting material.
I therefore incorporated the approach of Kutay et al., into the rab binding protocol 
used in Chapter 3. The resulting method, detailed in section 2.4.7, was then used to 
tiy to identify additional rabl- and rab2- binding proteins from rat liver cytosol.
4.2 Experimental Methods
4.2.1 Rab binding assay from transfected HeLa cells
HeLa cells were transfected for 20 hours with plasmids encoding myc-tagged proteins 
using the standai’d protocol. One 6 cm dish was sufficient for each binding reaction to 
be performed. Each dish of cells was harvested in 300 p,l lysis/binding buffer (10 mM 
Tri-HCl, pH 7.4, 150 mM NaCl, 1 mM MgCl^, 1 mM CaCl^, 0.2% TX-lOO, 
COMPLETE™ Protease Inhibitor Tablets (Roche)) for 45 minutes on ice before 
centrifugation for 10 minutes at 20000 x g at 4°C. Cell lysates transfected with the 
same construct were pooled before being re-aliquoted into each binding reaction.
For each reaction, 10 jag GST-rab protein (either rabl wild type, rablQ70L, rab2 wild 
type, or rab2Q65L) was bound to 15 p,l glutathione-sepharose beads and then 
incubated for 3 hours at room temperature with 300 |xl ti’ansfected HeLa lysate in the 
presence of 1 mM GDP (wild type rabs) or GMP-PNP (GTP-restricted mutants). 
Beads were then washed in 3 x 1ml lysis/binding buffer and bound proteins eluted in 
SDS-PAGE sample buffer. Bound proteins were then analysed by SDS-PAGE, 
western blotted, and probed with rabbit anti-myc antibody.
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4.3 Experimental Results
4.3.1 Identification of MTMR6 and centaurinp2 as putative rabl effectors
Overnight incubation of the GTP-restricted point mutant of rabl, rablQ70L, 
immobilised on glutathione sepharose, with rat liver cytosol, resulted in the specific 
binding of a number of proteins compared to rabl-GDP and rab2 (Figure 4.1). Two 
protein bands of approximately 90KDa and 70KDa in size, clearly visualised by 
Coomassie staining, were excised from the gel, subjected to tryptic digest, and then 
analysed by MALDI-TOF (Table 4.1). This analysis identified the 90KDa band (band 
A in Figure 4.1) as being Centaurinp2, a member of the centaurin family of 
PtdIns(3,4,5)P3“binding proteins (Jackson et al. 2000). The 70KDa band (band B in 
Figure 4.1) was identified as MTMR6, a member of the myotubularin family of 
inositol lipid phosphatases (Laporte et al. 1998).
Mouse Centaurinp2 92 16 10
(RIKEN cDNA
9530039J15)
Mouse MTMR6 74 20 13
(RIKEN cDNA
4022440C11)
Table 4.1 Identification of putative rabl-interacting proteins from rat liver cytosol
Allowing for partial oxidation of methionine residues, complete modification of cysteine by 
iodoacetamide during sample preparation, and single missed trypsin cleavages, searches were 
performed of monoisotopic peptide masses in the NCBInr database using the search engine at 
http://www.matrixscience.com/cgi/index.pl?page=../home.html. (An explanation of the 
scoring system is provided at this site; a score >67 is considered significant). Tolerance was 
set to 70-100 parts per million to allow for errors in peptide mass determination.
Little is known of the cellular localisation or function of these two proteins. 
Phosphoinositides are known to play key roles in the regulation of membrane 
trafficking events (Odorizzi et al, 2000; De Matteis et al. 2002). The involvement of 
both proteins in phosphoinositide metabolism and signalling, together with the
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rabl rab2
GDP GTP GDP GTP
212  —  
158 —  
116 
97 —
66 —  
56  —  
4 3  —
37 —
27 —
Figure 4.1 Centaurinpi and MTMR6 are specifically bound from rat liver cytosol by 
rabl-GTP
12 mg rat liver cytosol was bound overnight to either rabl wild type, rablQ70L, rab2 wild 
type, or rab2Q65L protein immobilised on glutathione-sepharose. Bound proteins were 
specifically eluted, TCA precipitated, and analysed by SDS-PAGE and Coomassie 
brilliant blue staining. The bands denoted A, B, and C were excised from the gel due to 
their specific binding to rabl-GTP (bands A and B) or rab2-GTP (band C). They were 
then subjected to tryptic digest, and analysed by MALDI-TOF. Band A was identified as 
Centaurinp2, band B was found to be MTMR6, and band C was identified as arginino- 
succinate synthetase. The positions of molecular standards (KDa) are indicated on the left 
hand side.
presence of a domain homologous to the Arf GAP domain of ArfGAPl in centaurin 
proteins (Jackson et al. 2000), therefore suggested their possible involvement in 
vesicle transport and made them intriguing candidates for further investigation as 
potential rabl effectors.
A pulldown was also performed with rab2, in which a protein of approximately 
40KDa was strongly and specifically bound only to the GTP-restricted point mutant 
rab2Q65L (band C in Figure 4.1). This protein was identified by MALDI-TOF as 
•arginino-succinate synthetase, a metabolic enzyme of the urea cycle. This protein has 
not been reported to have any connection with membrane transport events and could 
not be localised to the Golgi apparatus by either antibody staining or overexpression
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of myc- and GFP-tagged constructs (data not shown). In addition, an interaction 
between rab2Q65L and arginino-succinate synthetase could not be seen in the yeast 
two hybrid system (data not shown) and so the potential interaction of this enzyme 
with rab2-GTP was not pursued any further.
4.3.2 Rabl binds MTMR6 and centaurinp2 from transfected HeLa cells
No interaction between rablQVOL and MTMR6 and centaurin^Z could be seen in the 
yeast two hybrid system (data not shown) and recombinant expression of sufficient 
protein to perform direct binding assays proved difficult. In order to provide some 
corroboration for an interaction between these proteins and rabl, plasmids encoding 
myc-tagged MTMR6 and centaurinp2 were transfected into HeLa cells and the 
extracts were bound to immobilised rab proteins prior to analysis by western blotting 
(Figure 4.2).
Although poorly expressed, a small amount of myc-MTMR6 was specifically bound 
to activated rabl but not to rabl-GDP or rab2. In contrast, the closely related protein 
myotubularin (MTMl) is not bound by either rab (Figure 4.2). Centaurinp2 was 
bound significantly more by rabl-GTP than rabl-GDP. Smaller amounts were bound 
by both the active and inactive forms of rab2, but the nucleotide-specificity of rabl 
binding, and the greater efficiency of binding to rabl-GTP, suggests that a specific 
interaction between rabl and centaurinp2 might also exist. Finally, as a positive 
control, both rabl and rab2 were able to bind myc-tagged GM130 in a GTP- 
dependent manner (Figure 4.2).
Bound
Myc-Centaurinp2
TO Q  | _  Q  Figure 4.2 Centaurinpi and5 0 0 0 0  MTMR6 are specifically bound
O  CNJ CNl from transfected HeLa cells by
2  2  S  2  S  rabl-GTP^  Lysates from HeLa cells transfected
Myc-GM130 with plasmids encoding myc-tagged
GM130, centaurinp2, MTMR6, and 
MTM1 were incubated for 3 hours at 
room temperature with 10 jxg rabl 
. . R .-T k jio c  wild type, rablQ70L, rab2 wild type,MyC-MTMR6 or rab2Q65L. Bound proteins were
eluted, western blotted, and probed MyC-MTM1 with rabbit anti-myc polyclonal
antibody.
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4.3.3 Overexpressed MTMR6 and centaurinp2 have a predominantly cytosolic 
localisation
In the absence of specific antibodies to either MTMR6 or centaurin|32,1 attempted to 
determine the localisation of the two proteins by transfecting HeLa cells with 
plasmids encoding GFP-tagged constructs.
Both MTMR6 and centaurinp2 contain putative pleckstrin homology (PH) domains 
and might, therefore, be expected to be partially membrane associated (Jackson et al. 
2000; Wishart and Dixon 2002).
Upon overexpression, however, both proteins predominantly localise to the cytosol 
(Figures 4.3 and 4.4). MTMR6, tagged at either the N- or C-terminus with GFP, is 
mainly cytosolic with a slight concentration in a perinuclear region corresponding to 
the position of the Golgi apparatus (Figure 4.3). Similarly, GFP-tagged centaurinp2 
can be seen in many cells to have a slight accumulation in the region of the Golgi 
(Figure 4.4) but whether this indicates an actual association with the Golgi remains to 
be seen.
□API MTMR6 GM130 Merge
GFP-MTMR6
MTMR6-GFP
Figure 4.3 Overexpressed MTMR6 localises to the cytosol of HeLa cells
HeLa cells were transfected for 18 hours with plasmids encoding MTMR6 tagged at either 
the N- or C- terminus with GFP. Cells were fixed with 3% PFA and co-stained with sheep 
anti-GM130. In the merged images, DMA (DAPI staining) is in blue, MTMR6 is in green, 
and GM 130 is in red.
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DAPI Centauhnp2 GM130 Merge 
GFP-CentaurinP2
Centaurinp2-GFP
Figure 4.4 Overexpressed centaurinp2 localises to the cytosol of HeLa cells
HeLa cells were transfected for 18 hours with plasmids encoding centaurinP2 tagged at 
either the N- or C- terminus with GFP. Cells were fixed with 3% PFA and co-stained with 
sheep anti-GM130. In the merged images, DNA (DAPI staining) is in blue, centaurinp2 is 
in green, and GM 130 is in red.
4.4 Discussion
4.4.1 Overnight binding of rat liver cytosol to immobilised rab proteins allows 
the identification of putative rab effectors
In order to identify potential new rab effector proteins without using large amounts of 
starting material, immobilised rabl and rab2 proteins were incubated overnight with 
rat liver cytosol. Bound proteins were analysed by SDS-PAGE and Coomassie 
staining, revealing a number of protein bands not corresponding to the known 
rabl/rab2 effectors pi 15, GM130, and golgin-45 (Figure 4.1).
The two proteins bound specifically to activated rabl were identified by MALDI-TOF 
as MTMR6 and centaurinp2, two proteins linked to phosphoinositide binding and 
metabolism (Table 4.1). Both proteins could also be bound by rabl-GTP when 
overexpressed in HeLa cells (Figure 4.2). Whether these represent genuine in vivo 
interactions is unclear. The interactions could not be confirmed in the yeast two 
hybrid system. This could be because the interactions are not direct or because both 
centaurinp2 and MTMR6 form a tripartite complex with rabl. It is interesting to note 
that the two proteins are pulled down in approximately equal amounts by rabl from 
rat liver cytosol (Figure 4.1, compare bands A and B).
Given that they were pulled down from rat liver cytosol rather than from Golgi 
extract, it will be important to determine whether either of these proteins co-localise
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with rabl at the Golgi. We were unable to raise antibodies capable of recognising 
endogenous MTMR6 by western blot or immunofluorescence. Since no good 
antibody exists for any myotubularin-related protein, this may reflect a general feature 
of this family. In the absence of specific antibodies, MTMR6 and centaurin(32 
localisation could only be determined by overexpression of tagged constructs. This 
showed that both proteins predominantly localise to the cytoplasm (Figures 4.3 and 
4,4). Some perinuclear staining can be seen but this is by no means proof of 
localisation to the Golgi apparatus.
4.4.2 Phosphoinositide signalling in the regulation of membrane trafficking
Although it is unclear whether rabl interacts with centaurinp2 and MTMR6, and 
whether they localise to the Golgi apparatus in vivo, it is worth considering the 
possibility that these two proteins represent novel rab-effectors, given the role of 
phosphoinositide signalling in membrane trafficking events.
Many phosphoinositide kinases and phosphatases have been identified and linked to 
membrane trafficking at particular organelles (Odorizzi et al. 2000; De Matteis et al. 
2002). For example, mutants of the yeast phosphoinositide 3-kinase, Vps34p, show 
defects in vacuolar protein sorting (Stack et at. 1995). The generation of particular 
phosphoinositides at specific membrane sub-domains may then help recruit specific 
protein factors via their phosphoinositide binding motifs. The rab5 effector EEAl 
requires the presence of 3 ' -phosphorylated phosphoinositides in order to localise to 
endosomal membranes, which it binds via its FYVE domain (Stenmark et al. 1996; 
Patki et al. 1997).
The generation of 3’-phosphorylated phosphoinositides is therefore important for 
transport from the TGN to the endosomes/yeast vacuole. Based on the localisation of 
proteins which metabolise or bind PtdIns3P, PtdIns(3,5)P2, and PtdIns(3,4,5)P3, these 
three phosphoinositides are thought to be enriched in late Golgi compartments (De 
Matteis et al. 2002). PtdIns(3,4,5)P3 is thought to play a key role in regulating Arf 
function at the TGN via its recruitment of various Arf-binding proteins, including the 
centaurin family (Jackson et al. 2000).
Earlier Golgi compartments are thought to be more enriched in 4 ’-phosphorylated 
phosphoinositides, which play a role in different trafficking events (De Matteis et al. 
2002). PtdIns4P is important in controlling Golgi to plasma membrane trafficking
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since this pathway is strongly inhibited in mutants of the yeast phosphoinositide 4- 
kinase, Piklp (Audhya et al. 2000) and mutants of the yeast phosphoinositide 4- 
phosphatase. Sac Ip, can rescue Secl4p mutants (a phosphoinositide transfer protein) 
deficient in protein transport to the cell membrane (Whitters et al. 1993). In 
mammalian cells, these phosphoinositide 4-kinases and phosphatases localise to the 
Golgi apparatus ((De Matteis et al. 2002), and references therein). Indeed, kinase- 
dead forms of mammalian PtdIns4K|3 affect Golgi organisation after BFA washout 
and effect Golgi to plasma membrane transport in MDCK cells (Godi et al. 1999; 
Bruns et al. 2002).
PtdIns(4,5)P2, on the other hand, has been proposed to play a role in ER to Golgi 
transport by recruiting spectrin (Godi et al. 1998), as well as in the formation of post- 
Golgi vesicles and maintenance of Golgi structure (Sweeney et al, 2002).
Thus, 4 ’-phosphorylated phosphoinositides appear to be important earlier in the 
secretory pathway than 3 ’-phosphorylated phosphoinositides. If MTMR6 and 
centaurinp2 are genuine rabl effectors they might therefore be expected to be 
involved in 4 ’-phosphorylated phosphoinositide metabolism and binding.
4.4.3 MTMR6 is a phosphoinositide 3-phosphatase
Although centaurin(32 itself has not been directly investigated, other centaurin family 
members aie PtdIns(3,4,5)P3 binding proteins able to act as Arf GAPs and/or effectors 
(Jackson et al. 2000). Centaurinp2 might therefore be expected to localise to later 
Golgi compartments.
The myotubularins are a family of phosphoinositide 3-phosphatases (Laporte et al.
1998). Members of the family have been linked to disease: MTMl to X-linked 
myotubular myopathy, and MTMR2 to Charcot-Marie-Tooth disease type 4B 
(Laporte et al. 1996; Bolino et al. 2000). Following on from the work presented here, 
we investigated MTMR6 and found that both it and MTMl preferentially used 
PtdIns3P and PtdIns(3,5)P2 as substrates (Schaletzky et al. 2003). MTMR6s 
involvement in 3 ’ -phosphorylated phosphoinositide metabolism makes it unlikely to 
be a factor in transport events at the early Golgi.
The interactions of rabl with MTMR6 and centaurinp2 may not therefore represent 
genuine in vivo interactions despite the importance of both rab GTPase and 
phosphoinositide signalling in membrane trafficking.
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4.4.4 Summary
Two proteins, MTMR6 and centaurin|32, were identified as specific interactors of the 
activated form of rabl. We were unable to characterise this potential interaction 
further and the localisation of these two proteins remains unclear. If MTMR6 and 
centaurin p 2 are involved in the regulation of membrane trafficking events however, 
they are likely to be involved in later steps than those controlled by rabl.
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5.1 Introduction
The trans-Golgj network (TGN) is a complex network of tubules and vesicles located 
at the trans face of the Golgi (Griffiths and Simons 1986). There is a corresponding 
complexity in the membrane trafficking events with which the TGN is involved, since 
it is the major site of sorting events in the secretory pathway and an important 
interface between the secretory and endocytic pathways (Rohn et al. 2000). Secretory 
proteins and lipids are sorted for delivery to the plasma membrane (and targeted to 
either the apical or basolateral membranes in polarised cells), secretory granules, or 
the endosomal/lysosomal system. Retrograde transport also occurs from the 
endosomes to the TGN as well as transport from the TGN to earlier Golgi 
compartments and the ER.
Many of these transport steps involve clathrin-coated vesicles and a variety of adaptor 
proteins, which recognise specific sorting signals within the cytoplasmic tails of 
integral membrane cargo proteins (Robinson and Bonifacino 2001). Some of these 
cargo proteins are themselves receptors for luminal cargo. The classical example of 
this is the mannose 6-phosphate receptors, which are involved in the transport of 
newly-synthesised acid hydrolases from the TGN to the endosomal-lysosomal system 
(Ghosh et al. 2003). The cytoplasmic tail of the mannose 6-phosphate receptor 
contains several sorting signals recognised by both GGA (Golgi-localised, y-ear- 
containing, ADP-ribosylation factor-binding) and AP-1 adaptor proteins for 
incorporation into clathrin-coated vesicles and transport to endosomes (Honing et al. 
1997; Puertollano et al. 2001; Zhu et al. 2001).
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The small GTPase rab6 has been implicated in several trafficking steps at the late 
Golgi and is localised to the medial and trans cisternae, as well as the TGN (Gond et 
al. 1990; Antony et al. 1992).
Analysis of mutants of the budding yeast rab6 homologue, Ypt6p, has suggested its 
involvement in endosome-to-Golgi transport and in retrograde intra-Golgi transport 
from the TGN to earlier Golgi compartments (Tsukada et at. 1999; Siniossoglou et al. 
2000; Bensen et al. 2001). Ypt6p has alternatively been proposed to play a role in 
anterograde transport at the early Golgi (Li and Warner 1996), but kinetic analysis of 
conditional YPT6 mutants suggests that the transport defects observed are more likely 
due to inhibition of recycling pathways at the non-permissive temperature (Luo and 
Gallwitz 2003).
In mammalian cells, there are two ubiquitously expressed isoforms of rab6, a and a \  
which differ by only three amino acids (Echard et al. 2000). Rab6a has been 
implicated in retrograde intra-Golgi and Golgi to ER transport by reports that 
overexpression of wild type or GTP-restricted rab6a induces the redistribution of a 
trans-Golgi galactosyltransferase to the ER (Martinez et al. 1994; Martinez et al. 
1997). The overexpression of GDP-restricted rab6a blocks the transport of Shiga 
toxin and glycosylation enzymes to the ER, but this transport is not affected by 
microinjection of anti-COPI antibodies, suggesting the pathway is COPI-independent 
(Girod et al. 1999). Rabôa’, on the other hand, has been shown to be required for 
endosome-to-TGN transport in permeabilised cells although GDP-restricted rab6a 
also partially inhibited the same transport step (Mallard et al. 2002).
A number of rab6-interacting proteins have been identified. The kinesin-like protein 
rabkinesin-6 was found in a yeast two hybrid screen using rab6aQ72L as a bait. It 
was localised to the Golgi apparatus in interphase cells and found to affect Golgi 
membrane dynamics (Echard et al. 1998). Since kinesins control plus-end directed 
microtubule-based movement, the interaction between rab6a and rabkinesin-6 was 
proposed to control the rab6a/microtubule dependent Golgi-to-ER retrograde transport 
pathway (Martinez et al, 1997; White et al. 1999). Correspondingly, rabôa’ was not 
found to interact with rabkinesin-6 (Echard et al. 2000). However, subsequent data 
showed that rabkinesin-6 is primarily expressed in mitotic cells and localises to the 
midbody of dividing cells. Microinjection of anti-rabkinesin-6 antibodies inhibited
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cell division, suggesting the main role of this protein is in cytokinesis rather than in 
interphase membrane trafficking (Hill et al, 2000).
Additional rab6 interactors include GAPCenA, a centrosomal protein proposed to act 
as an activating protein for rab6, thereby controlling Golgi dynamics (Cuif et al.
1999), and rab6 interacting protein 2 A and B which may be involved in endosome-to- 
TGN transport (Monier et al. 2002). In yeast, the VFT quatrefoil tethering complex, 
required for the fusion of endosome-derived vesicles with the Golgi, has been found 
to interact with Ypt6p, as well as the late Golgi SNARE protein Tig Ip (Siniossoglou 
and Pelham 2001), while Riclp and Rgplp form an effector complex catalysing 
nucleotide exchange on Ypt6p (Siniossoglou et al. 2000). The GRIP domain- 
containing protein Imhlp has also been implicated in Ypt6p function (Tsukada et al.
1999).
Given the array of transport events controlled by rab6 isoforms, it is highly likely that 
further rab6 effectors remain to be found. In order to identify additional rab6 
interacting proteins, I performed a series of binding experiments from rat liver 
cytosol, using the protocol developed in Chapter 4 and identified a number of putative 
rab6-effectors by MALDI-TOF.
5,2 Experimental Results
5.2.1 Components of the dynein/dynactin complex are bound from rat liver 
cytosol by rab6a-GTP
Overnight incubation of the GTP-restricted point mutant of rab6a, rab6aQ72L, 
immobilised on glutathione sepharose, with rat liver cytosol, resulted in the specific 
binding of a number of proteins (Figure 5.1). These proteins were bound to a lesser 
extent by rab6a-GDP and were not seen to bind rabs 1 and 2 (see, for example Figure 
4.1). These protein bands were excised from the gel, subjected to tryptic digest, and 
then analysed by MALDI-TOF (Table 5.1). This analysis identified the pl50 '^""  ^
subunit of dynactin and the TGN-localised dynactin interacting protein bicaudal D2 
(BicD2; (Hoogenraad et al. 2001)) as being preferentially bound by activated rab6a. 
We were unable to identify additional dynactin subunits such as p50/dynamitin in the 
50-60 KDa region of the gel, due to the presence of rab-guanine nucleotide 
dissociation inhibitor (rab-GDI) in this region (Figure 5.1). In addition, we were able
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to identify rab6IP2 (Monier et al. 2002) and rab escort protein (REP-1), a protein 
essential for the delivery of newly synthesised rab proteins to membranes 
(Alexandrov et al. 1994) in the rab6a-GTP bound fraction.
Rat pl50*'“^ 109 21 22
Mouse rab6IP2 80 19 20
Rat REP-1 79 22 10
Human BicD2 63 15 18
Mouse rab-GDI 126 37 17
Table 5.1 Identification of rab6-interacting proteins in rat liver cytosol
Allowing for partial oxidation of methionine residues, complete modification of cysteine by 
iodoacetamide during sample preparation, and single missed trypsin cleavages, searches were 
performed of monoisotopic peptide masses in the NCBInr database using the search engine at 
http://www.matrixscience.com/cgi/index.pl?page=../home.html. (An explanation of the 
scoring system is provided at this site; a score >67 is considered significant). Tolerance was 
set to 70-100 parts per million to allow for errors in peptide mass determination. REP-1 and 
BicD2 ran in the same doublet band on the gel and so were doubly identified in a single 
digest. This leads to a decreased identification score due to the increased amount of peptides 
disturbing and suppressing each other.
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Figure 5.1 pl50“'“*^ and
bicaudal D2 are bound from 
rat liver cytosol by rab6a-GTP
12 mg rat liver cytosol was 
bound overnight to either rab6a 
wild type or rab6aQ72L protein 
im m obilised on glutathione- 
sepharose. Bound proteins were 
sp e c if ic a lly  e lu ted , TCA 
precipitated, and analysed by 
SD S-PA G E and Coomassie 
brilliant blue staining. Bands 
were excised from the gel, 
subjected to tryptic digest, and 
analysed by MALDI-TOF. The 
position of bands identified as 
plSQgiucd, interacting protein 
2 (R6IP2), bicaudal D2 (BicD2), 
rab escort protein (REP-1), and 
r a b - g u a n i n e  n u c l e o t i d e  
dissociation inhibitor (rab-GDI), 
are indicated. The positions of 
molecular standards (KDa) are 
indicated on the left hand side.
94
Chapter 5: Late Golgi Rab-Effector Complexes
rab6a- rab6a- Figure 5.2 The dynactin complex is a specific
GDP GTP binding partner for rab6
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5.2.2 Dynactin is a specific binding partner for rab6
To confirm the interaction between dynactin and rab6a, samples from the rat liver 
cytosol binding assay were western blotted and probed with specific antibodies 
(Figure 5.2). pl50*’“*‘‘ was again found to bind rab6a-GTP more efficiently than 
rab6a-GDP while tubulin and the light intermediate chain of the dynactin-interacting 
motor protein dynein were not found in the bound fraction (Figure 5.2 A). A variety 
of rab proteins were tested and pl50®‘“®‘^ binding was found to be specific to rab6
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(Figure 5.2 B). In addition, a second subunit of dynactin, p50/dynamitin, was 
specifically bound to rab6, suggesting that the dynactin complex as a whole is a rab6 
binding partner. Under the same conditions, pi 15 was bound specifically by rabl but 
not by rab6 (Figure 5.2 B). We were unable to probe for BicD2, due to the lack of a 
specific antibody.
5.2.3 Rab6 interacts with plSO**"®** and BicD2 by yeast two hybrid
To further confirm the interaction between rab6 and components of the dynactin 
complex, pl5(F'“®‘* and BicD2 were cloned into the yeast two hybrid prey vector 
pACT2 and screened against rab6a cloned into the bait vector pGBT9 (Figure 5.3). 
Both p i50^ '"^  ^and BicD2 showed a weak interaction with rabba wild type and a much 
stronger interaction with the GTP-restricted mutant rab6aQ72L as assessed by growth 
on quadruple dropout medium. No interaction was seen with the GDP-restricted 
mutant rab6aT27N or with the GTP-bound form of rabl (Figure 5.3). BicDl, a 
BicD2-related protein, (Baens and Marynen 1997) also displayed a specific 
nucleotide-dependent interaction with rab6a. pi 15, on the other hand, only interacted 
with rablQ70L and not with rab6 (Figure 5.3).
pACT2
p115 p 150giued BicD1 BicD2
CDÜQ.
rab1Q70L 
rab6aT27N  
rab6a wt 
rab6aQ72L
mm
-LW QDO QDO QDO -LW QDO
Figure 5.3 Rab6 interacts with pl50*‘“*^ , BicDl, and BicD2 by yeast two hybrid
Full length p i 15, p i50*'“*^ , BicDl, and BicD2 were tested in the yeast two hybrid system 
for interactions with the activated rab mutants rablQTOL and rab6aQ72L, as well as wild 
type rab6a and the inactive mutant rab6aT27N. Interactions were assessed by growth on 
quadruple dropout media.
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Figure 5.4 Identification of rab6 binding sites on pl50*'“*^ , BicDl, and BicD2
Deletion mutants of either p i50*'“*^  (A) or BicDl and BicD2 (B) were cloned into the yeast 
two hybrid prey vector pACT2 and were screened against the GTP-restricted point mutant 
rab6aQ72L cloned into the bait vector pGBT9. Interactions were assessed by growth on 
quadruple dropout media.
5.2.4 Identification of rab6 binding sites on pl5(F‘**®^, BicDl, and BicD2
The yeast two hybrid system was then used to map the rab6 binding site on these 
putative rab6 effectors (Figure 5.4). p i50^ '"^  ^has a microtubule binding motif near its 
N-terminus and has two regions predicted to form coiled-coil. The second, C- 
terminal-most, of these two coiled-coil regions appears to be important for the 
interaction with rab6 since deletion mutants of pl50*‘“®‘* lacking this region show no 
interaction with rab6aQ72L (Figure 5.4 A). This region alone, however, is not 
sufficient for the rab6-interaction, since pl50*‘“®‘^ amino acids 905-1278 does not 
interact with rab6 either. The middle region of pl50®‘“®‘‘, not predicted to form coiled- 
coil, is also necessary but not sufficient for the interaction with rab6, since pl50*‘“^ ‘^ 
amino acids 540-1278 but not amino acids 540-904 interact with rab6aQ72L. Thus, 
p l50giued amino acids 540-1278 interact with rab6. p i50®'“®^ amino acids 828-1059 
showed no interaction with rab6 (data not shown) suggesting that the rab6 binding site 
doesn’t lie specifically at the junction between the central domain of pl50*‘“®^ and the 
second coiled-coil. It is possible that amino acids 540-1278 are necessary for the
97
Chapter 5: Late Golgi Rab-Effector Complexes
correct folding and presentation of the binding site. It is interesting to note that the 
second coiled-coil domain and the extreme C-terminus of p i50**“®^ also regulates the 
interaction of dynactin with membranous cargo (Kumar et al. 2001).
BicDl and BicD2 both contain five separate regions predicted to form coiled-coil. 
BicDl contains an extended C-terminal region compared to BicD2. It is the C- 
terminus of both proteins that contains the binding site for rab6 (Figure 5.4 B). BicD2 
amino acids 706-824, which consists extensively of coiled-coil, interacts with 
rab6aQ72L in the yeast two hybrid system while amino acids 1-705 show no 
interaction. Interestingly, this C-terminal region of BicD2 has previously been 
implicated in binding to p50/dynamitin and localising BicD2 to the Golgi apparatus 
(Hoogenraad et al. 2001). Similarly, BicDl amino acids 704-975, consisting of a 
coiled-coil domain and the extended C-terminal region, interacts with rab6 while 
BicDl amino acids 1-703 does not (Figure 5.4 B).
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Figure 5.5 BicDl binds directly to rab6a
4 pg recombinantly expressed GST-tagged rab proteins were incubated with 10 pg His- 
tagged BicDl or pi 15 in the presence of 15 pi glutathione-sepharose beads and 10 pM 
either GDP or GMP-PNP in a total volume of 400 pi HNTM for 1 hour at 4®C. Bound 
proteins were eluted in SDS-PAGE sample buffer and analysed by SDS-PAGE. BicDl was 
specifically bound by activated rab6a.
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5.2.5 BicD2 and pl50®‘“®‘* bind rab6 directly
To prove a direct interaction between rab6 and BicD2,1 performed a direct binding 
assay using recombinantly expressed proteins (Figure 5.5). BicD2 specifically and 
quantitatively bound to rab6a-GTP (rab6aQ72L in the presence of GMP-PNP) 
compared to rab6a-GDP (wild type rab6a in the presence of GDP) and rabl. This is 
in contrast to p ll5 , which bound rabl-GTP but not rab6a (Figure 5.5).
I was unable to express soluble, full-length recombinant pl50®*“®‘* and so was unable to 
test wild type p i50^ '"®'' for direct binding to rab6. I was, however, able to express 
recombinant pl50®’“®‘‘ amino acids 540-1278, the region identified as binding rab6 by 
yeast two hybrid (Figure 5.4 A). pl50®‘"®'‘ 540-1278 specifically and quantitatively 
bound rab6a-GTP compared to rab6a-GDP (here, the GDP-restricted point mutant 
rab6aT27N in the presence of GDP) (Figure 5.6 C),
To date, the only putative rab6 effector that has been shown to differentiate between 
rab6a and a’ is rabkinesin-6 (Echard et al. 1998; Echard et al. 2000). Full length 
BicD2 and p i50®'“®'^ 540-1278 were able to bind rab6a’ as well as rab6a in a 
nucleotide-dependent manner (Figure 5.6). Additionally, BicD2 amino acids 706- 
824, was also able to bind both isoforms of rab6, confirming this region as the rab6 
binding site (Figure 5.6 B).
5.2.6 BicDl and B!cD2 target to the Golgi apparatus by their C-termini
Full length BicDl localises to the Golgi apparatus when overexpressed in HeLa cells 
and shows a high degree of co-localisation with rab6 (Figure 5,7). The region of the 
protein responsible for this appears to be the C-terminal region capable of interacting 
with rab6, since GFP-tagged BicDl amino acids 704-975 also co-localises with rab6 
at the Golgi while BicDl 1-703 displays a diffuse nuclear and cytoplasmic staining 
pattern (Figure 5.7).
Similarly, full length GFP-tagged BicD2 targets to the Golgi apparatus and co- 
localises with rab6 (Figure 5.8 A). As reported previously (Hoogenraad et al. 2001), 
this localisation is also mediated by the C-terminus of the protein. BicD2 amino acids 
706-824 co-localises with rab6 while BicD2 1-705 is predominantly nuclear with a 
diffuse cytoplasmic staining pattern in higher expressing cells (Figure 5.8 A), BicD2 
1-705 also has a tendency to form aggregates in both the nucleus and cytosol.
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Figure 5.7 BicDl targets to the Golgi apparatus by its C-terminus
Full length BicDl and deletion mutants were cloned into the N-terminal GFP-tagging vector, 
pEGFP-C2 and transfected into HeLa cells for 18 hours. Cells were fixed in 3% PFA and co- 
stained with rabbit anti-rab6. In the merged images, DNA (DAPI staining) is in blue, GFP- 
BicDl is in green, and rab6 is in red. Areas of overlap between BicDl and rab6 are in yellow.
Full length BicD2 also forms aggregates in cells expressing high amounts of the 
protein. Interestingly, these aggregates are able to recruit rab6 (Figure 5.8 B, white 
arrows) while the aggregates of BicD2 1-705, which lack the rab6 binding site, do not 
recruit the rab protein (Figure 5.8 A, middle panels, white arrowheads).
5.2.7 Rabkinesin-6 does not bind directly to rab6
The interaction between rab6 and BicDl, BicD2, and p i50*'“®^ implicates rab6 in the 
regulation of motor-based, microtubule-dependent transport. Rab6 has previously 
been proposed to be involved in such events by interacting with the kinesin family 
member rabkinesin-6 (Echard et al. 1998) although this protein’s main role appears to 
be in cytokinesis (Hill et al. 2000). Using recombinantly expressed rabkinesin-6, I 
was unable to detect direct binding to either rab6a or rab6a’ (Figure 5.9). In addition 
to the data of Hill et al., this further suggests that rabkinesin-6 is not involved in 
interphase membrane trafficking events and that the interaction of rab6 with the BicD 
proteins and dynactin is key to the microtubule-dependent movement of rab6-positive 
structures.
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Figure 5.8 BicDl targets to the Golgi apparatus by its C-terminus
(A) Full length BicDl and deletion mutants were cloned into the N-terminal GFP-tagging 
vector, pEGFP-C2 and transfected into HeLa cells for 18 hours. Cells were fixed in 3% PFA 
and co-stained with rabbit anti-rab6. In the merged images, DNA (DAPI staining) is in blue, 
GFP-BicD2 is in green, and rab6 is in red. Areas of overlap between BicDl and rab6 are in 
yellow. White arrowheads indicate examples of GFP-BicDl 1-705 aggregates that do not 
recruit rab6. (B) High overexpression of GFP-BicDl full length results in numerous protein 
aggregates containing both BicDl and rab6. White arrows indicate examples of GFP-BicDl 
aggregates that recruit rab6. (Transfection and staining conditions as in A).
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Figure 5.9 Rabkinesin-6 does not 
bind directly to rab6
4 pg recombinantly expressed GST- 
tagged rab proteins were incubated 
with 1 pg  His-tagged full length 
rabkinesin-6 (rab6-KIFL) in the 
presence of 15 p i  g lu ta th ione- 
sepharose beads and 10 pM  either 
GDP or GMP-PNP in a total volume of 
400 p i HNTM for 1 hour at 4®C. 
Bound proteins were eluted in SDS- 
PAGE sample buffer and analysed by 
western blotting with mouse anti- 
H is-rab6-K IFL histidine tag.
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5.2.8 Identification of GOPC as a putative rab6 effector
A further overnight binding experiment from rat liver cytosol, this time comparing 
proteins bound by GTP-restricted rab6aQ72L with proteins bound by point mutants 
mimicking the nucleotide free state (rab6aD129N and rab6a’D129N). Although no 
specific bands of interest could be seen to bind either of the two nucleotide free rabs, 
two bands of approximately 60KDa were seen to be present only in the fraction bound 
to rab6aQ72L (Figure 5.10). These protein bands were excised from the gel, 
subjected to tryptic digest, and analysed by MALDI-TOF (Table 5.2). The upper of 
these two bands (band A in Figure 5.10) was identified as rab-GDI, seen previously to 
bind rab6 from rat liver cytosol (Figure 5.1). Rab-GDI tryptic peptides were also 
found in the corresponding gel region of the fractions bound by rab6aD129N and 
rab6a’D129N. The lower band (band B in Figure 5.10) was identified as the Golgi- 
localised PDZ-domain-containing protein GOPC (Yao et al. 2001). Tryptic peptides 
derived from this protein were not found in the corresponding gel region of the 
fractions bound to rab6aD129N and rab6a’D129N, suggesting that GOPC may be a 
specific effector of rab6.
Mouse PIST/GOPC 1.19 22 8
Table 5.2 Identification of GOPC as a rab6-interacting protein from rat liver cytosol
Allowing for partial oxidation of methionine residues, complete modification of cysteine by 
iodoacetamide during sample preparation, and single missed trypsin cleavages, searches were 
performed of monoisotopic peptide masses in the NCBInr database using the search engine at 
http://prowl.rockefeller.edu/cgi-bin/ProFound. (An explanation of the scoring system is 
provided at this site). Tolerance was set to 70-100 parts per million to allow for errors in 
peptide mass determination.
5.2,9 GOPC is a specific binding partner of rab6
GOPC (Golgi associated PDZ and coiled-coil motif containing protein) was identified 
in a yeast two hybrid screen as an interaction partner of Frizzled, an integral 
membrane protein thought to act as a receptor for Wnt-signalling pathways (Yao et al.
2001), It has also been identified as PIST (PDZ domain protein interacting 
specifically with TCIO), in a yeast two hybrid screen using the rho GTPase family 
member TCIO as bait (Neudauer et al. 2001) and FIG (Fused in glioblastoma), as a
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Figure 5.10 GOPC is bound from rat liver cytosol by rab6a-GTP
12 mg rat liver cytosol was bound overnight to either rab6aQ72L, rab6aD129N, or 
rab6a’D129N protein immobilised on glutathione-sepharose. Bound proteins were 
specifically eluted, TCA precipitated, and analysed by SDS-PAGE and Coomassie 
brilliant blue staining. The bands of approximately 70KDa are heat shock protein (HSP) 
derived from the original purification of rab6aD129N and rab6a’D129N. The bands 
denoted A and B were excised from the gel due to their specific binding to rab6a-GTP. 
They were then subjected to tryptic digest, and analysed by MALDI-TOF. Band A was 
identified as rab-GDI, and band B was found to be GOPC. The positions of molecular 
standards (KDa) are indicated on the left hand side.
Golgi-localised protein interacting with the SNARE protein syntaxin 6 (Charest et al.
2001). The protein contains a PDZ domain near its C-terminus and two regions 
predicted to form coiled-coil (see diagram in Figure 5.15). Two additional regions 
show a particularly high level of conservation between GOPC in mouse and the 
putative homologue in C. elegans, zk849.2 (Yao et al. 2001).
The interaction of GOPC with rab6 was confirmed using a binding assay from 
transfected HeLa and the yeast two hybrid system (Figure 5.11). Using the method 
described in section 4.2.1, lysates from HeLa cells transfected with plasmids encoding
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Figure 5.11 GOPC is a specific binding partner of rab6
(A) Lysates from HeLa cells transfected with plasmids encoding myc-tagged GOPC and 
GM130 were incubated for 3 hours at room temperature with 10 pg rabl wild type, rabIQ70L, 
rab2 wild type, rab2Q65L, rab6a wild type, or rab6aQ72L. Bound proteins were eluted, 
western blotted, and probed with rabbit anti-myc polyclonal antibody. (B) Full length GOPC 
was tested in the yeast two hybrid system against the activated rab point mutants rablQ70L, 
rab2Q65L, rab5Q75L, rab6aQ72L, rab6a’Q72L, and rab33bQ92L and against the GDP- 
restricted point mutants rab6aT27N and rab6a’T27N. Interactions were assessed by growth on 
quadruple dropout media.
either myc-tagged GOPC or myc-tagged GM130 were bound to immobilised rab 
proteins and analysed by western blotting. This analysis revealed that myc-GOPC 
was specifically bound by rab6a-GTP and not by rab6a-GDP or by rabl or rab2 
(Figure 5.11 A). Similarly, when GOPC was cloned into the yeast two hybrid prey 
vector pACT2 and screened against a number of activated rab mutants in the bait 
vector pGBT9, an interaction was only seen with the two isoforms of rab6, a and a’ 
(Figure 5.11 B). This interaction was not seen with the GDP-locked mutants of rab6.
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5.2.10 GOPC binds rab6 directly
To determine whether the interaction between GOPC and rab6 is direct, I performed a 
direct binding assay between recombinantly expressed His-tagged GOPC and point 
mutants of rabba and rabba’. Both isoforms of rabb were able to bind GOPC in a 
nucleotide-dependent manner (Figure 5.12). Therefore, as with plSO*'"®**, BicDl, and 
BicD2, GOPC appears to be a specific rabb effector which does not distinguish 
between the two ubiquitously expressed rabb isoforms.
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Figure 5.12 GOPC binds directly to both rabb isoforms
4 pg recombinantly expressed GST-tagged rab proteins were incubated with 10 pg His- 
tagged full length GOPC in the presence of 15 pi glutathione-sepharose beads and 10 pM 
either GDP or GMP-PNP in a total volume of 400 pi HNTM for 1 hour at 4®C. Either 
GDP-restricted or GTP-restricted point mutants of the rab proteins were used. Bound 
proteins were eluted in SDS-PAGB sample buffer and analysed by SDS-PAGE. The 
positions of molecular standards (KDa) are indicated on the left hand side.
5.2.11 GOPC and rabb co-localise
GOPC has previously been localised to the Golgi apparatus (Charest et at. 2001; Yao 
et al. 2001 ) and immunoelectron microscopy has found the protein predominantly on 
the rraMj-cisternae and TGN in spermatids (Yao et al. 2002). To examine the 
localisation of GOPC in HeLa cells, cells were transfected with plasmids encoding 
GFP-tagged GOPC and counterstained for various Golgi markers (Figure 5.13). GFP- 
GOPC shows extensive co-localisation with rabb (Figure 5.13 A), supporting an
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DAPl GFP-GOPC rab6 M erge
DAPl G FP-G O PC Golgin-97 M erge
B
DAPl G FP-G O PC Golgin-160 M erge
DAPl G FP-G O PC GM130 M erge
Figure 5.13 GFP-GOPC co-localises with rabb at the Golgi apparatus
HeLa cells were transfected for 18 hours with a plasmid encoding GOPC tagged at its N- 
terminus with GPP. Cells were fixed in 3% PFA and co-stained with either rabbit anti-rabb 
(A), sheep anti-golgin-97 (B), rabbit anti-golgin-lbO (C), or sheep anti-GM130 (D). In the 
merged images, DNA (DAPl staining) is in blue, GFP-GOPC is in green, and rabb/golgin- 
97/golgin-1 bO/GM 130 is in red. Areas of overlap between GOPC and the Golgi markers are 
in yellow.
interaction between the two proteins in vivo. The distribution of GFP-GOPC partially 
overlaps with, but is distinct from, that of two other Golgi proteins, golgin-97 and 
golgin-lbO (Figure 5.13 B and C). GFP-GOPC staining shows the least overlap with 
GM130, indicating that GOPC is not localised to the cw-Golgi (Figure 5.13 D). 
Similarly, myc-tagged GOPC shows a high degree of co-localisation with rabb at the 
Golgi apparatus (Figure 5.14 A) but only partial co-localisation with golgin-lbO and 
GM130 (Figure 5.14 B and C).
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DAPl Myc-GOPC rab6 Merge
DAPl Myc-GOPC Golgin-160 Merge
B
DAPl Myc-GOPC GM130 Merge
Figure 5.14 Myc-GOPC co-localises with rabb at the Golgi apparatus
HeLa cells were transfected for 18 hours with a plasmid encoding GOPC tagged at its N- 
terminus with myc. Cells were fixed in 3% PFA and co-stained with either rabbit anti-rabb 
(A), rabbit anti-golgin-lbO (B), or sheep anti-GM130 (C). In the merged images, DNA 
(DAPl staining) is in blue, myc-GOPC is in red, and rabb/golgin-1 bO/GM 130 is in green. 
Areas of overlap between GOPC and the Golgi markers are in yellow.
5.2.12 GOPC interacts with rabb via its N-terminal coiled-coil domain
In order to define the rabb binding site on GOPC, deletion mutants of GOPC were 
cloned into the yeast two hybrid bait vector pGBT9 and were screened against the 
activated point mutants of rabba and rabba’ cloned into the prey vector pACT2 
(Figure 5.15). One of these mutants, GOPC amino acids 25b-454, containing the 
PDZ domain and C-terminus of GOPC, was self-activating when fused to the GAL4 
binding domain in pGBT9 (data not shown). This fragment was therefore cloned into 
pACT2 and screened against pGBT9.rabbaQ72L. This analysis revealed that the N- 
terminus and first coiled-coil domain of GOPC (amino acids I -141) was sufficient to 
mediate an interaction with rabb and that deletion of this region abrogates the 
interaction (Figure 5.15).
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Figure 5.15 GOPC interacts with rabb via its N-terminal coiled-coil domain
Deletion mutants of GOPC were cloned into the yeast two hybrid bait vector pGBT9 and 
screened against rabbaQ72L and rabba'Q72L cloned into the prey vector pACT2 as well as 
empty pACT2 as a control. Due to problems with self-activation, GOPC 256-454 was 
cloned into pACT2 and screened against pGBT9.rabbaQ72L. Interactions were assessed by 
growth on quadruple dropout media.
5.2.13 GOPC targets to the Golgi apparatus via its second coiled-coild domain
The same deletion mutants used to map the rabb binding site on GOPC, were cloned 
into a N-terminal GFP-tagging vector and transfected into HeLa cells (Figure 5.1b). 
GOPC amino acids 1-141, while able to interact with rabb, was not able to target to 
the Golgi apparatus as seen for the full length protein, instead having a nuclear and 
cytoplasmic localisation. The C-terminus of GOPC (amino acids 256-454), 
containing the proteins PDZ domain, was also insufficient for correct Golgi 
localisation and was predominantly localised to the nucleus. GOPC 1-255 localised to 
the Golgi as well as the full length protein. While deletion of the first 141 amino 
acids of the protein resulted in a less efficient targeting to the Golgi, GOPC 142-255, 
containing the second coiled-coil domain and second conserved region, still displayed 
some Golgi localisation in addition to cytoplasmic staining (Figure 5.1b). This region 
therefore appears to be essential for the Golgi targeting of GOPC, in agreement with 
previously published observations (Charest et al. 2001; Yao et al. 2001). It should be 
noted that the distribution of rabb appears unaffected by the overexpression of any of 
the GOPC deletion mutants.
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Figure 5.16 GOPC targets to the Golgi apparatus via its second coiled-coil domain
Deletion mutants of GOPC were cloned into the N-terminal GFP-tagging vector pEGFP-C2 and 
transfected into HeLa cells for 18 hours. Cells were fixed in 3% PFA and co-stained with rabbit 
anti-rabb. In the merged images, DNA (DAPl staining) is in blue, GFP-GOPC is in green, and 
rabb is in red. Areas of overlap between GOPC and rabb are in yellow.
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Table 5.3 shows a summary of the rab6-binding and Golgi-targeting properties of the 
various GOPC deletion mutants.
1
Full length
1-255
142-454
1-141 [
142-255
256-454
rabS binding
GOPC Î
454
CCI I I CC2
++ +++
= region conserved betw een m am m als and C. elegans 
CC 1 = Coiled-coil 
= PDZ domain
Table 5.3 Rab6 binding and Golgi targeting properties of GOPC deletion mutants
5.3 Discussion
5.3.1 Rab6 regulates the recruitment of the dynactin complex to Golgi 
membranes
The dynactin subunit pl50*‘“®‘^ and the dynactin-interacting protein BicD2 were bound 
by activated rabb from rat liver cytosol and identified by MALDI-TOF (Figure 5.1 
and Table 5.1). Dynactin is a multisubunit protein complex essential for the activity 
of the microtubule-based motor protein dynein (Karki and Holzbaur 1999; King and 
Schroer 2000). Dynein is a minus-end directed motor that, together with dynactin, 
mediates a variety of intracellular motility processes including membrane trafficking 
events (Karki and Holzbaur 1999; Allan et al. 2002). The pl50*'“®‘^ subunit of 
dynactin is able to bind both microtubules and the intermediate chain of dynein 
(Vaughan and Vallee 1995; Waterman-Storer et al. 1995).
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BicD2 is one of two mammalian homologues of the Drosophila protein Bicaudal-D, 
which is involved in the development of polarity in Drosophila oocytes and has been 
linked genetically to a transport pathway involving dynein and dynactin (Suter et al. 
1989; Wharton and Struhl 1989; Swan et al. 1999). Mammalian BicD2 localises to 
the Golgi apparatus and directly binds to the p50/dynamitin subunit of dynactin. 
Overexpression of the N-terminal domain of BicD2 disrupts minus-end-directed 
organelle transport (Hoogenraad et al. 2001).
The interaction of dynactin with rabb was found to be specific for this rab protein 
(Figure 5.2), and the interaction of both pl50®'""‘‘ and BicD2 with rabb was confirmed 
using the yeast two hybrid system (Figure 5.3). This analysis revealed that BicDl 
also interacts with rabb. In vitro binding assays showed that the interactions between 
rabb and pl50®'“® /^BicD2 are direct and common to both ubiquitously expressed 
isoforms of rabb, a and a’ (Figures 5.5 and 5.6).
The yeast two hybrid system was also used to map the rabb binding sites on p i50^ "^^ '' 
and the BicD proteins (Figure 5.4). The binding site on p i50®'"®'* could not be defined 
very precisely, but was localised to the C-terminal two-thirds of the protein, while the 
binding site on BicD2 was mapped to the C-terminal coiled-coil domain known to 
target BicD2 to the Golgi ((Hoogenraad et at. 2001); Figure 5.8). Interestingly, a 
number of loss-of-function mutations in Drosophila BicD map to the C-terminal 
coiled-coil (Ran et al. 1994; Oh et al. 2000). The C-terminus of BicDl, which 
contains a homologous region of coiled-coil plus an extra domain of approximately 
150 amino acids, also contained the rabb binding site and targeted BicDl to the Golgi 
(Figures 5.4 and 5.7).
This suggests that rabb binding is crucial for the membrane targeting of dynactin. 
Further evidence for this was supplied by experiments that demonstrated the rabb- 
dependent recruitment of dynactin to Golgi membranes in vitro and in vivo (Figure 3 
in (Short et al. 2002)). The C-terminus of pl50®''*®‘‘ has been proposed to regulate the 
interaction of dynactin with membranous cargo (Kumar et al. 2001). Dynein/dynactin 
can be recruited to protein-free liposomes containing phosphatidic acid in the 
presence of an acidic phospholipid-binding spectrin, and mediate their motility 
(Muresan et al. 2001). Spectrin and acidic phospholipids are unlikely to be the only 
regulators of dynactin-membrane association in vivo however, as they would not 
provide sufficient levels of specificity (Karcher et al. 2002).
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The interactions of rabb-GTP with and the BicD proteins would therefore be
ideally placed to regulate the specific recruitment of dynactin to membrane 
compartments for transport. The C-terminus of pl50®’“"‘* (including the C-terminal 
coiled-coil domain) may inhibit dynactins association with membranes since in vitro 
addition of this fragment inhibits dynactin membrane binding while dynactin 
constitutively binds to membranes in the presence of a plSO®^ ”®*^ mutant lacking the C- 
terminus ((Kumar et al. 2001). It is possible that binding of activated rabb to the C- 
terminus of pl50®‘"®‘‘ relieves this inhibition and allows dynactin to bind to 
membranes.
Associations between rab proteins and motor proteins controlling organelle motility 
have been reported previously. Rab27a regulates the peripheral distribution of 
melanosomes in melanocytes by binding its effector protein melanophilin, which, in 
turn, binds the actin-based motor protein myosin-Va (Hume et al. 2001; Wu et al. 
2001; Wu et al. 2002). The late endosomal/lysosomal rab protein, rab7, binds RILP 
which then recruits dynein/dynactin to late endosomes and lysosomes, promoting their 
movement towards the minus-end of microtubules (Cantalupo et al. 2001; Jordens et 
al. 2001).
Rabb itself has previously been suggested to bind the plus-end directed kinesin 
protein, rabkinesin-b (Echard et al. 1998). I was unable to detect an interaction 
between these two proteins (Figure 5.9) which, together with the observations that 
rabkinesin-b is primarily expressed in mitotic cells and plays a role in cytokinesis 
(Hill et al. 2000), suggests that a rabb-rabkinesin-b interaction is not important for 
interphase membrane transport. Nevertheless, given the range of membrane 
trafficking events associated with rabb, one might predict rabb to be involved in bi­
directional transport and to be connected with plus-end-directed motors as well as the 
minus-end-directed dynein motor. Although dynactin has until now only been linked 
with dynein function, a recent report demonstrated that pl50^ "^^ ^^  was also able to bind 
kinesinll and was required for bi-directional organelle transport (Deacon et al. 2003). 
Interestingly, kinesinll may be involved in retrograde Golgi-to-ER transport (Le Bot 
et al. 1998), a micro tubule-dependent transport step previously suggested to be 
regulated by rabb (Martinez et al. 1997; White et al. 1999). The rabb-dependent 
membrane recruitment of dynactin might therefore result in the recruitment of either 
dynein or kinesinll, depending on the transport step concerned.
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The bicaudal-D proteins have been implicated specifically in dynein/dynactin 
transport pathways (Swan et al. 1999; Hoogenraad et al. 2001) and, in particular, with 
Golgi-to-ER retrograde transport (Matanis et al. 2002). It is unclear, however, how a 
role in Golgi-to-ER trafficking would fit with a role in minus-end-directed transport 
since, in theory, transport from the Golgi to the ER should be a plus-end-directed 
activity. It is also unclear what functional differences exist (if any) between BicDl 
and BicD2. Both proteins localise to the Golgi apparatus and both bind rabb. The 
function of the C-terminal extension in BicDl compared to BicD2 should be of 
interest in answering this question.
5.3.2 GOPC is a rabb effector
The Golgi-localised, PDZ domain-containing protein, GOPC/PIST/FIG was also 
bound from rat liver cytosol by activated rabb (Figure 5.10 and Table 5.2). This 
interaction was confirmed as being specific to rabb by binding assays from transfected 
HeLa extract and by the yeast two hybrid system (Figure 5.11). In vitro binding 
assays showed the interaction to be direct and common to both rabba and rabba’
(Figure 5.12). j
Rabb and GOPC completely co-localise in cultured HeLa cells (Figures 5.13 A and
5.14 A). There is a partial overlap between GOPC, golgin-160, and golgin-97 e
distribution (Figures 5.13 B-C and 5.14 B) but little between GOPC and GM130
(Figures 5.13 D and 5.14 C). The targeting of GOPC to the Golgi apparatus appears
to be mediated by the second coiled-coil motif and second highly conserved region
since amino acids 142-255 are necessai'y and sufficient for the proteins localisation
:
(Figure 5,1b). This is in agreement with previous findings (Charest et al. 2001; Yao 
et al. 2001). This targeting domain, however, is distinct from the rabb binding site,
■ ■which maps to amino acids 1-141, containing the first coiled-coil motif and first 
conserved region (Figure 5.15). Rabb would not, therefore, appear to be essential for 
localising GOPC to the Golgi although constructs lacking the rabb binding site seem 
to target less well than constructs able to bind rabb (compare, for example, the 
localisation of GFP-GOPC 1-255 with GFP-GOPC 142-454 in Figure 5.1b). Rabb 
binding is perhaps required for efficient Golgi localisation,
Charest et al., (2001) found that the second coiled-coil domain and conserved region 
of GOPC binds syntaxin b and suggested this to be the mechanism of Golgi targeting.
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Syntaxin 6 is a t-SNARE localised primarily to the TGN (Bock et al. 1996; Bock et 
al. 1997), which has been implicated in TGN-to-endosome and rabba’-controlled 
endosome-to-TGN transport (Bock et al. 1997; Mallard et al. 2002). The interaction 
of GOPC with both a rab protein and a t-SNARE clearly suggests it is involved in 
membrane trafficking. This situation is not without precedent, since syntaxin b has 
previously been shown to bind the rab5 effector protein EEAl (Simonsen et al. 1999). 
GOPC was originally identified as an interactor of Frizzled, a plasma membrane 
receptor for Wnt signalling proteins (Yao et al. 2001). It has since been shown to 
interact with two other cell surface receptors; the 62 glutamate receptor and the cystic 
fibrosis transmembrane conductance regulator (CFTR; (Cheng et al. 2002; Yue et al. 
2002)). All of these interactions depend on the PDZ domain of GOPC, a domain also 
responsible for an interaction with the Golgi-localised chloride channel C1C-3B 
(Gentzsch et al. 2003).
Interestingly, overexpression of GOPC reduces the cell surface expression levels of 
CFTR by reducing the rate of its transport to the plasma membrane and decreasing the 
half-life of its cell surface localisation (Cheng et al. 2002). This suggests that GOPC 
may play a general role in controlling the cell surface expression of a variety of 
plasma membrane receptors either by negatively regulating anterograde transport to 
post-Golgi compartments or by promoting retrograde transport to the Golgi or from 
the Golgi to ER. The interaction of GOPC with rabb indicates that a role in retrograde 
transport is more likely although it is possible that this interaction is simply required 
for the recycling of GOPC back to the trans-Goigi.
GOPC overexpression also results in a reduction in the overall levels of CFTR and 
C1C-3B (Gentzsch et al. 2003). GOPC has also been found to interact, via its second 
coiled-coil domain, with Beclinl, a protein known to promote the cellular degradative 
pathway of autophagy (Yue et al. 2002). GOPC might therefore also be involved in 
sorting processes at the TGN directing proteins for degradation at the lysosomes.
A final clue to the function of GOPC comes from an analysis of GOPC-deficient mice 
(Yao et al. 2002). Male mice lacking GOPC are infertile due to a failure in acrosome 
formation during spermatogenesis. The acrosome is formed by the fusion of vesicles 
derived from the trans-Golgi, again implicating GOPC in post-Golgi trafficking 
events. Although GOPC is ubiquitously expressed in all human and mice tissues
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tested (Charest et a l  2001; Cheng et a l 2002), infertility was the only defect reported 
in GOPC-knockout mice (Yao et a l  2002).
GOPC therefore appears to be a molecule which regulates the trafficking of integral 
membrane proteins between the ?ran.y-Golgi and post-Golgi compartments possibly 
via a rabb-mediated retrograde transport step.
5.3.3 Rabba and rabba’ show identical interactions
The two ubiquitously expressed rabb proteins, rabba and rabba’, differ by just three 
amino acids as a result of alternative splicing (Echard et a l  2000). Rabba’ has an 
isoleucine instead of valine at position b2 and two alanines instead of threonine and 
valine at positions 87 and 88. Nevertheless, despite this small difference in amino 
acid sequence, the two proteins have been reported to have different functions in vivo, 
with rabba proposed to regulate retrograde intra-Golgi and Golgi to ER transport and 
rabba’ implicated in endosome to Golgi traffic (Martinez et a l  1994; Martinez et a l  
1997; Echard et a l 2000; Mallard et a l 2002).
The most obvious explanation for the ability of these two rabs to control different 
transport steps would be an ability to bind different effector proteins. The double 
alanine/threonine-valine substitution at positions 87 and 88 lies at the end of the 
putative a  2 helix corresponding to the switchll region predicted to change 
conformation depending on the nucleotide state of the rab protein, thereby mediating 
interactions with effector proteins (Echard et a l  2000). Small differences in this 
region might therefore have a large effect on protein interactions. To date, however, 
the only protein shown to differentiate between rabba and rabba’ is rabkinesin-b 
(Echard et a l 2000) which, as discussed above, may not in fact be a rabb effector. All 
other rabb effectors, including GOPC, pl50^'"^\ and the BicD proteins, appear to 
interact with both isoforms of rabb (see, for example, Figures 5.6 and 5.12). One 
possibility is that rabba and rabba’ differ in the affinities and/or kinetics of their 
interactions resulting in differential effects when the proteins and their mutants are 
overexpressed in cells. Alternatively, small differences in the kinetics of nucleotide 
exchange and/or hydrolysis may result in slightly different functions.
Whatever the differences between the a and a’ splice variants, rabb appears to control 
retrograde transport steps from the endosomal system to the trans-Golgi /TGN and 
from the trans-Golgji to earlier compartments. It does this through the recruitment of
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a variety of effectors including, as shown here, components of the dynactin complex 
involved in microtubule-based motility and a PDZ domain-containing protein able to 
bind integral membrane proteins and regulate their appearance at the cell surface. 
Nizak et a l, have recently reported the generation of a recombinant antibody specific 
for the GTP-bound form of rabb in vivo (Nizak et a l  2003). Tools such as this will 
doubtless help the precise function and mechanism of rabb activity to be defined more 
fully in future.
5,3.4 Summary
Four proteins were identified as novel effectors of rabb, a trans-Golgi localised 
regulator of retrograde transport steps. pl50®'“‘''' is a component of the dynactin 
complex required for dynein-dependent, microtubule-based motility of membranous 
cargo. BicDl and BicD2 are dynein/dynactin-associated proteins also essential for a 
microtubule-based transport pathway. GOPC is a PDZ domain-containing protein 
which binds a variety of integral membrane proteins and influences their transport to 
the cell surface as well as potentially being involved in sorting to degradative 
pathways and in acrosome formation. Rabb therefore regulates retrograde transport 
through interactions with a variety of different proteins.
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Complex At The Golgi Apparatus
6.1 Introduction
Emerging evidence suggests that the Golgi apparatus may be the site of numerous 
signalling events important for such diverse cellular processes as growth, 
differentiation, motility, mitosis, and apoptosis (Ferri and Kroemer 2001; Bivona and 
Philips 2003; Rios and B omens 2003).
Fragmentation of the Golgi has been found to be necessary for entry into mitosis, 
suggesting that the Golgi acts as a sensor controlling mitotic entry (Sutterlin et al.
2002). The pro-apoptotic cysteine protease caspase-2 partially localises to the Golgi, 
where it specifically cleaves golgin-160 in response to pro-apoptotic signals (Mancini 
et al. 2000). Other Golgi matrix proteins are also cleaved during mitosis: GRASP65 
by caspase-3 (Lane et al. 2002) and pi 15 by caspases-3 and -8 (Chiu et al. 2002). In 
all cases, these cleavages result in a fragmentation of the Golgi apparatus during 
apoptosis, which can be slowed by expression of cleavage-resistant forms of the three 
Golgi proteins.
Many signalling molecules have been localised to the Golgi including members of the 
rho/rac/Cdc42 family of small GTPases (reviewed in Rios and Bomens 2003 and 
Bivona and Philips 2003). Ras has also recently been shown to localise to the Golgi 
from where it is able to signal to downstream targets with different kinetics from 
plasma membrane-associated ras (Chiu et al. 2002). Ras activation at the Golgi was 
shown to be dependent on the tyrosine kinase Src (Chiu et al. 2002). Another protein 
kinase associated with the Golgi apparatus is Protein Kinase A since one of its 
anchoring proteins, AKAP350, has been localised to the organelle (Shanks et al.
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2002). Thus, the Golgi apparatus may act as a signalling platform, sensing and 
integrating signals and regulating downstream events.
The Ste20 (sterile 20) family of serine/threonine protein kinases is implicated in a 
variety of signalling pathways (Kyriakis 1999; Dan et al, 2001; Bokoch 2003). The 
founding member of the family, budding yeast Ste20p, was originally identified as a 
signalling component of the yeast mating pathway (Leberer et ah 1992), but is also 
important for other events, including the regulation of actin organisation and cell 
polarity (Holly and Blumer 1999). Ste20p acts as an upstream activator of MAP 
kinase cascades in response to a variety of extracellular signals(Wu et ah 1995; 
Drogen et al. 2000) and is regulated by binding to Gp^  subunits of heterotrimeric G 
proteins and by the small GTPase Cdc42 (Leeuw et al. 1998; Lamson et al. 2002). 
Approximately 30 Ste20 kinases exist in mammals, which can be classified into two 
sub-groups: p21-activated kinase (PAK)-family kinases and germinal centre (GC)- 
kinases (Dan et al. 2001). The main difference between these two groups is the 
position of the kinase domain. PAK kinases have a C-terminal kinase domain while 
GC kinases possess a N-terminal kinase domain and a C-terminal regulatory domain 
(Kyriakis, 1999; Dan et al., 2001a).
The PAK kinases are regulated by rac and Cdc42 via a Cdc42 and Rac interactive 
binding (CRIB) motif in their N-terminal regulatory domains (Bokoch 2003). Like 
Ste20p, PAK-kinases affect a wide range of downstream processes. PAKl controls 
actin remodelling and affects cell motility (Sells et al. 1997; Sells et al. 1999). PAK- 
kinases have also been implicated in MAP kinase signalling pathways (Bokoch 2003), 
by, for example, the phosphorylation of Raf-1 by PAKl in response to integrin 
activation (Chaudhary et al. 2000). Apoptosis is also regulated by PAK-kinases 
(Bokoch 2003). PAK2 is cleaved by caspases, resulting in a constitutively active 
form of the kinase, which promotes cell death (Lee et al. 1997; Rudel and Bokoch 
1997). PAKl, on the other hand, promotes cell survival by phosphorylating and 
inhibiting the pro-apoptotic protein Bad (Schurmann et al. 2000).
Relatively little is known, however, about the activation, regulation, and physiological 
functions of GC kinases, although some members of the family are thought to be 
involved in stress-activated MAP kinase pathways (Kyriakis 1999).
The GC kinases can be further sub-divided into 8 groups based on sequence 
homologies (Dan et al. 2001). One of these sub-groups, group III, contains the
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kinases MST3 (Schinkmann and Blenis 1997), MST4 (Lin et al. 2001; Qian et al. 
2001; Dan et al. 2002), and YSKl (Pombo et al. 1996; Osada et al. 1997).
YSKl (for Yeast Spsl/Ste20-related kinase 1), also known as SOKl (Ste20/oxidant 
stress response kinase 1), was found to be activated by reactive oxygen intermediates 
but not by any other environmental stresses, nor by growth factors (Pombo et al. 
1996). The kinase was unable, however, to activate any of the known MAPK 
pathways (Pombo et al. 1996; Osada et al. 1997) and a physiological function for 
YSKl remains unknown.
Serendipitously, having isolated YSKl in a yeast two hybrid screen using rabkinesin- 
6 as a bait protein, we discovered that GFP-tagged YSKl localised to the Golgi 
apparatus. This was interesting, given the wide range of processes regulated by Ste20 
kinases, and the increasing importance of the Golgi apparatus as a signalling platform. 
Therefore, although the interaction with rabkinesin-6 was not investigated further, I 
performed a series of experiments designed to characterise the localisation of YSKl 
and determine the mechanism by which the protein targets to the Golgi.
6.2 Experimental Methods
6.2.1 Yeast two hybrid screen using YSKl as bait
Full length, wild type, YSKl was cloned into the modified yeast two hybrid bait 
vector pFBT9 which, in contrast to pGBT9, carries a kanamycin resistance cassette 
rather than ampicillin resistance. This plasmid was transformed into the yeast strain 
PJ69-4A using the standard frozen yeast cell transformation protocol described in 
section 2.5.2. This bait strain was then screened against a human testis Matchmaker 
cDNA library (Clontech), using the ‘TRAFO’ yeast transformation protocol available 
at http://www.umanitoba.ca/faculties/medicine/biochem/gietz/, and performed at the 
30X scale as follows:
50 ml SC-Trp was inoculated with the YSKl bait strain and grown overnight at 30°C 
with shaking. The following morning, this culture was diluted in 150 ml YPDA 
medium to an OD^ oo of 0.2-0.3 (equivalent to approximately 7.5 x 10^  cells). This 
culture was then grown at 30°C for 3-4 hours until an O D ^ of 0.4-0.6 (approximately 
2 X 10^  cells/ml) was reached. Cells were then harvested by centrifugation at room 
temperature at 3000 x g for 5 minutes. The cell pellet was washed in half the culture
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volume sterile water and centrifuged as before. The pellet was then resuspended in 3 
ml 100 mM LiOAc and incubated for 15 minutes at 30°C before being centrifuged 
once again. A tiansformation mix was prepared by mixing, in order, the following 
components: 7.2 ml 50% PEG, 1.08 ml 1 M LiOAc, 1.5 ml 2 mg/ml single-stranded 
herring sperm DNA, and 1.02 ml sterile water. This mixture was added to the cell 
pellet and the pellet resuspended by vortexing. 2 pg library cDNA was then added to 
the mix and vortexed. The transformation mix was incubated for 30 minutes at 30°C 
and then heat shocked for 40 minutes at 42°C with occasional mixing. The cells were 
centrifuged as before, resuspended in 40 ml sterile water and plated onto 15 cm dishes 
of SC-Leu/-Trp/~His/-Ade (QDO) agar. The plates were incubated for 4 days at 30°C 
after which, large colonies were re-streaked onto fresh QDO plates. Library plasmids 
were recovered by performing minipreps from yeast cells (Section 2.5.3), and 
electroporation of the plasmid DNA into XLlb E.coli (Section 2.2.4) followed by 
selection on LB-Ampicillin plates. Recovered plasmids were then re-transformed into 
PJ69-4A yeast by the frozen cell method along with either pFBT9.YSKl or empty 
vector. Plasmids allowing growth on QDO in the presence of YSKl but not in the 
presence of empty vector were selected for sequencing.
6.2.2 Direct binding of YSKl and MST4 to GM130
1 pg recombinant, His-tagged, YSKl or MST4, expressed in baculovirus-infected Sf9 
cells was incubated with 5 pg either GST-tagged GM130 amino acids 75-271, golgin- 
45 amino acids 1-122, or GST alone for 1 hour at 4°C in HNTM buffer in the 
presence of 15 pi glutathione-sepharose and 100 pM ATP in a total volume of 300 pi. 
Beads were then washed in 3 x 1ml HNTM and bound protein was eluted directly in 
SDS-PAGE sample buffer. Samples were then western blotted and probed with either 
goat anti-YSKl N19 (Santa Cruz Biotech, USA) or affinity purified rabbit anti- 
YSK1/MST4. Loading controls were analysed by SDS-PAGE and Coomassie 
brilliant blue staining.
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6.3 Experimental Results
6.3.1 YSKl is a Golgi-localised kinase
Rabbit polyclonal antisera were raised against his-tagged full length YSKl 
recombinantly expressed in E.coli .  When the antisera was tested by 
immunofluorescence on cultured HeLa cells, it gave a Golgi-like, perinuclear staining 
pattern (Figure 6.1 A). Co-staining with anti-GM130 antibodies showed a partial co­
localisation of YSKl with the cis-Golgi matrix protein. A similar staining pattern was 
seen in the human melanoma cell line MelJuso with anti-YSKl sera strongly staining 
the Golgi and co-localising with GM130 (Figure 6.1 B).
These results suggest that endogenous YSKl localises to the Golgi apparatus. This 
corresponded to previous observations that both GFP- and myc-tagged YSKl 
localised to the Golgi upon transfection into HeLa cells (Figure 6.1 C and D).
6.3.2 Characterisation of rabbit anti-YSKl
The polyclonal antiserum was affinity purified and, to further characterise the 
antibody, recombinant YSKl expressed in baculovirus-infected Sf9 cells was western 
blotted and probed. The affinity-purified antibody recognised a band of 
approximately 60 KDa but recognition was blocked by pre-incubation of the 
antiserum with the bacterially expressed antigen (Figure 6.2 A). Additionally, the 
rabbit antiserum recognised proteins of the correct size in HeLa extract, rat liver 
cytosol, and rat liver Golgi membranes (Figure 6.2 A). The slight difference in 
apparent molecular weight between recombinant YSKl and endogenous protein is 
due to the his-tag on the recombinant protein.
Next, I examined the specificity of the antibody with respect to the two kinases most 
closely related to YSKl, namely MST3 and MST4 (Dan et al. 2001). These kinases 
have, respectively, 72.3% and 68.1% identity with YSKl over the full length of the 
protein. HeLa cells were transfected for 18 hours with plasmids encoding GFP- 
tagged kinases before cell extracts were prepared in TNTE buffer. 20|irg of each 
extract was western blotted and probed with the affinity-purified rabbit antibody 
(Figure 6.2 B). The antibody strongly recognised GFP-YSKl but was also able to 
recognise GFP-MST4. The antibody did not recognise GFP-MST3, however, even 
though equal amounts of all three kinases were present, as revealed by probing the
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DAPl antiserum #4256 GM130 Merge
B
GFP-YSK1 GM130
MVC-YSK1 GM130
Figure 6.1 YSKl is a Golgi-localised kinase
(A and B) HeLa cells (A) and MelJuso cells (B) were fixed with 3% PFA and co-stained 
with rabbit polyclonal anti serum #4256, raised against recombinant YSKl, and sheep anti- 
GM130. (C and D) HeLa cells were transfected for 18 hours with plasmids encoding either 
GFP-tagged YSKl (C) or Myc-tagged YSKl (D) prior to fixation with 3% PFA. Cells were 
then stained with sheep anti-GM130 and, in (D) with mouse anti-myc. In the merged 
images, DNA (DAPl staining) is in blue, YSKl is in either green (A and C) or red (B and 
D), and GM130 is in either red (A and C) or green (B and D). Areas of overlap between 
YSKl and GM130 are in yellow.
extracts with sheep anti-GFP (Figure 6.2 B). Thus, the rabbit ‘anti-YSKl’ polyclonal 
antibody is not entirely specific for YSKl and also recognises MST4. This is not too 
surprising, given that full length YSKl was used as the antigen for immunisation and 
the high level of identity between the two proteins.
Two different anti-YSKl antibodies are available commercially from Santa Cruz 
Biotechnology, California, USA. These antibodies were raised in goats against 
peptides corresponding to either the N-terminal or C-terminal amino acids of YSKl
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(A) Affinity-purified rabbit anti-YSKl 
was pre-incubated in the absence (-) or 
presence (+) of bacterially expressed 
YSKl and then used to probe western 
blots of full length YSKl expressed 
from baculovirus-infected Sf9 cells. 
Additionally, the antibody was used to 
probe HeLa extract, rat liver cytosol 
(RLC), and rat liver Golgi membranes 
(RLG). (B-D) 20 ng TNTE extract 
from HeLa cells transfected for 18 
hours with plasmids encoding GFP- 
tagged YSKl, MST3, or MST4 were western blotted and probed with either rabbit anti-YSKl (B), goat anti-YSKl N- 
terminus (C), or goat anti-YSKl C-terminus (D). All three blots were probed with 
sheep anti-GFP as a loading control. (E) The three anti-YSKl antibodies were used to 
probe decreasing amounts of recombinant YSKl expressed in Sf9 cells. The positions 
of molecular standards (KDa) are indicated on the left hand side of each blot.
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and might therefore be expected to be completely specific for YSKl. The specificity 
of these two antibodies was tested as before. Both antibodies recognised GFP-tagged 
YSKl in HeLa cell extracts but not GFP-MST3 or GFP-MST4 (Figure 6.2 C and D). 
The antibody raised against the C-terminal 19 amino acids of YSKl appeared to 
recognise an unknown additional protein in HeLa extract too large to be the 
endogenous kinase.
Finally, the relative affinities of the three antibodies for YSKl was tested by western 
blotting serial dilutions of Sf9-expressed YSKl (Figure 6.2 E). This suggested that 
the two goat antibodies (at the concentrations used for both western blotting and 
immunofluorescence) have a higher affinity for YSKl than the rabbit antibody. This 
is not a direct quantitative test however, since different secondary antibodies are used 
for either the goat or rabbit antibodies.
6.3.3 Immunofluorescence on HeLa cells with goat anti-YSKl antibodies
Having shown both goat anti-YSKl antibodies to be specific for YSKl and to have an 
apparently higher affinity for YSKl than the rabbit antibody by western blotting 
(Figure 6.2 C-E), 1 tested the antibodies by immunofluorescence. Somewhat 
surprisingly, neither of the two goat antibodies showed any staining of untransfected 
HeLa cells. This was not because the antibodies were unable to recognise YSKl by
DAPl aYSK1 GFP-YSK1 Merge
GaYSKI N19
GaYSKI C l9
Figure 6.3 Goat anti-YSKl antibodies only recognise exogenous YSKl by 
immunofluorescence
HeLa cells were transfected for 18 hours with a plasmid encoding GFP-tagged YSKl and 
fixed with 3% PFA. Cells were then stained with either goat anti-YSKl N-terminus or goat 
anti-YSKl C-terminus. In the merged images, DNA (DAPl staining) is in blue, YSKl 
antibody is in red, and GFP-YSKl is in green.
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immunofluorescence, since, in HeLa cells transfected with GFP-YSKl, the antibodies 
stained YSKl both at the Golgi and in the cytosol (Figure 6.3).
The rabbit anti-YSKl was able to stain the Golgi of untransfected HeLa cells (Figure
6.1 A) even though its affinity for YSKl is seemingly lower (Figure 6.2 E). This 
apparent discrepancy could be explained if MST4, which is also recognised by the 
rabbit antibody (Figure 6.2 B), also localises to the Golgi apparatus. In this case, the 
Golgi-localised protein recognised in immunofluorescence by rabbit anti-YSKl could 
be MST4.
6.3.4 MST4, but not MST3, localises to the Golgi
MST3 and MST4 were cloned into a N-terminal myc-tagging vector 
(pcDN A3.1 Myc A) and were transfected into HeLa cells (Figure 6.4). Myc-MST3 is 
localised diffusely throughout the cytosol, in contrast to myc-MST4 which, like myc- 
YSKl, localises to the Golgi apparatus where its distribution partially overlaps with 
GM130. This suggests that MST4 is also a Golgi-localised kinase, and that the Golgi- 
staining detected by the rabbit anti-‘YSKl’ in HeLa cells by immunofluorescence 
may represent MST4 rather than YSKl.
DAPl Myc-Kinase GM130 Merge
YSK1
MST3
MST4
Figure 6.4 MST4 is a Golgi-localised kinase
HeLa cells were transfected for 18 hours with plasmids encoding either myc-YSKl, myc- 
MST3, or myc-MST4 prior to fixation with 3% PFA. Cells were co-stained with mouse anti- 
myc and sheep anti-GM130. In the merged images, DNA (DAPl staining) is in blue, myc- 
tagged kinases are in red, and GM130 is in green. Areas of overlap between the kinases and 
GM130 are in vellow.
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6.3.5 YSKl and MST4 bind to the cis-Golgi matrix protein GM130
Protein kinase A localises to the Golgi apparatus via an interaction with the adaptor 
protein AKAP350 (Shanks et al. 2002). To help identify the mechanism by which 
YSKl targets to the Golgi, we performed a yeast two hybrid screen using YSKl as 
bait in order to identify potential interacting proteins. A total of 2.2x10^ 
transformants from a human testis cDNA library were screened and two plasmids 
were found to specifically interact with YSKl upon re-transformation. The two 
plasmids were sequenced and found to encode variants of full length human GM130 
containing a 27 amino acid insertion at position 57. Despite this insertion in the pi 15 
binding domain of GM130, the two clones were able to interact with pi 15 as well as 
YSKl in the yeast two hybrid system (Figure 6.5). Full length rat GM130 also 
interacted with YSKl, suggesting that this interaction is not dependent upon the 27 
amino acid insertion present in the positive yeast two hybrid screen clones.
3
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Figure 6.5 GM130 is identified in a yeast two hybrid screen as an interactor of YSKl
A yeast two hybrid screen was performed using a human testis cDNA library and YSKl as 
bait. Two positive clones were identified corresponding to a variant of GM130 containing a 
27 amino acid insertion near the N-terminus. Full length rat GM130 was also able to 
interact with YSKl. To map the YSKl binding site for YSKl on GM 130, deletion mutants 
of GM130 were cloned into pACT2 and screened against YSKl and pi 15 cloned into 
pGBT9. Interactions were assessed by growth on quadruple dropout media.
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To map the binding site for YSKl on GM130, a series of rat GM130 deletion mutants 
were cloned into pACT2 and screened against YSKl in the yeast two hybrid system. 
A deletion mutant comprising the N-terminal 271 amino acids of GM130 
(GM130AC271) was able to interact with YSKl (and, as expected, with pi 15), while 
a construct containing the C-terminal half of the protein (GM130AN433) interacted 
with neither YSKl nor pi 15 (Figure 6.5). This suggested that the YSKl binding site 
lies close to the pi 15 binding site in the N-terminus of GM130. The two sites are 
distinct however, since GM130AN74, which lacks the first 74 amino acids of GM130, 
interacted with YSKl but not with pi 15. A further mutant, GM130 amino acids 75- 
271, showed that these amino acids are sufficient to mediate the interaction with 
YSKl (Figure 6.5).
We then tested whether MST3 or MST4 could interact with GM130. Like YSKl, 
MST4 could also interact with GM130 in the yeast two hybrid system, while MST3 
showed no interaction (Figure 6.6). This corresponds to the localisation of YSKl and 
MST4 at the Golgi while MST3 is apparently cytosolic (Figure 6.4). As with YSKl, 
MST4 interacts with the N-terminal 271 amino acids of GM130 (Figure 6.6). Neither 
of the three kinases interact with the medial-Golgi matrix protein golgin-45.
YSK1
Empty Vector 
GM130 wt
GM130AC271 
Golgin45 wt
pGBT9
MST3 MST4
Figure 6.6 GM130 interacts with YSKl and MST4, but not MST3
The related Ste20 kinases YSKl, MST3, and MST4 were cloned into the yeast two hybrid 
vector bait vector pGBT9 and screened against either full length GM130, GM130AC271, or 
golgin-45 cloned into the prey vector pACT2 or against empty vector. Interactions were 
assessed by growth on quadruple dropout media.
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Figure 6.7 YSKl and MST4 bind directly to GM130
(A and B) 1 pg recombinant YSKl was incubated with immobilised GST-GM130 amino 
acids 75-271, GST-golgin-45 amino acids 1-122, or GST alone for 1 hour at 4®C. Bound 
proteins were western blotted and probed with goat anti-YSKl N19 (A). 500 ng of each 
protein used in the experiment was also analysed by SDS-PAGE and Coomassie brilliant 
blue staining (B). (C and D) 1 pg recombinant MST4 was incubated with immobilised 
GST-GM130 amino acids 75-271, GST-golgin-45 amino acids 1-122, or GST alone for 1 
hour at 4°C. Bound proteins were western blotted and probed with rabbit anti-YSKl/MST4 
(C). 500 ng of each protein used in the experiment was also analysed by SDS-PAGE and 
Coomassie brilliant blue staining (D).
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6.3.6 YSKl and MST4 bind GM130 directly
Protein binding assays were performed to test whether the interactions between 
YSK1/MST4 and GM130 were direct (Figure 6.7). Recombinant YSKl expressed in 
baculovirus-infected Sf9 cells was able to bind to immobilised GST-tagged GM130 
amino acids 75-271 but not to GST alone or the N-terminus of golgin-45 (amino acids 
1-122) (Figure 6.7 A and B). Similarly, Sf9-expressed MST4 only bound to GST- 
GM130 75-271 (Figure 6.7 C and D), suggesting that both kinases are able to bind 
GM130 directly.
6.3.7 Mapping of the GM130 binding site on YSKl
YSKl and MST4, like other members of the GC-kinase family, possess a conserved 
N-terminal kinase domain and a C-terminal domain believed to be regulatory in 
function (Kyriakis 1999). In order to map the binding site for GM130 on YSKl, a 
number of YSKl deletion mutants were cloned into the yeast two hybrid bait vector 
pGBT9 and screened against GM130 cloned into the prey vector pACT2. A YSKl 
deletion mutant (YSKl 1-302) missing most of the C-terminus but containing the 
kinase domain was still able to interact with GM130 in the yeast two hybrid system 
(Figure 6.8). The minimal kinase domain encompasses amino acids 20-270 of YSKl. 
YSKl 20-302, containing the minimal kinase domain and an additional 32 amino 
acids at its C-terminus was also able to interact with GM130. Deletion of these 32 
amino acids (YSKl 1-270) abolished the interaction however, suggesting that amino
___________ pACT2___________
YSKl GM130 Empty
-LW QDO -LW QDO1 426
Full length I I 
1-302 d r
1-270 I T
20-302
303-426
I 1 = Kinase domain 
WÊÊ = GM130 binding domain
Figure 6.8 Mapping of the GM130 binding site on YSKl
Deletion mutants of YSKl were cloned into the yeast two hybrid bait vector pGBT9 and 
screened against GM130 cloned into the prey vector pACT2 and against pACT2 alone. 
Interactions were assessed by growth on quadruple dropout media.
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acids 271-302 of YSKl are necessary for GM130 binding. A final deletion mutant, 
YSKl 303-426, was unable to interact with GM130 (Figure 6.8).
The short region between the kinase domain and the C-terminus is well conserved in 
MST4 suggesting that this region of MST4 is probably also crucial for GM130 
binding. The region is also well conserved in MST3 however, suggesting that subtle 
differences in amino acid sequence may have a marked effect on the kinases ability to 
bindGMBO.
6.3.8 Targeting of YSKl to the Golgi apparatus
The same deletion mutants used to map the GM130 binding site on YSKl were 
cloned into a N-terminal myc-tagging vector (pcDNA3.1mycA) and transfected into 
HeLa cells along with an additional deletion mutant (YSKl 275-426) and a kinase 
dead point mutant (YSK1K49R) (Figure 6.9). None of the deletion mutants tested 
were able to target to the Golgi, instead displaying a diffuse nuclear and cytoplasmic 
staining pattern. Only YSKl amino acids 1-302 displayed a slight concentration in 
the vicinity of the Golgi but was not truly Golgi-localised as seen for myc-tagged full 
length kinase. YSKl amino acids 20-302, although capable of interacting with 
GM130 in the yeast two hybrid system, did not show any Golgi localisation (Figure
6.9).
Interestingly, kinase dead YSKl was also unable to target to the Golgi, suggesting 
that kinase activity may be required for Golgi localisation.
6.3.9 Depletion of GM130 disrupts YSK1/MST4 localisation
Treatment of cells with siRNA duplexes targeting GM130 results in the depletion of 
GM130, disruption of the Golgi apparatus, and an alteration in cellular morphology 
(section 3.3.8.4). It also results in the loss of YSKl and MST4 staining (Figure 6.10). 
After 72 hours, YSK1/MST4 staining is dispersed throughout the cytosol and in a few 
Golgi remnant stinctures similar to the effect seen on pi 15 localisation when GM130 
is depleted (Figure 3.13 A).
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DAPl Myc GM130 Merge
Full length
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1-270
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303-426
Figure 6.9 YSKl mutants do not localise to the Golgi
Deletion mutants of YSKl and a kinase dead point mutant (YSK1K49R) were cloned into the 
N-terminal myc-tagging vector pcDNAS.lmycA and transfected into HeLa cells for 18 hours. 
Cells were fixed in 3% PFA and co-stained with mouse anti-myc and sheep anti-GM130. In the 
merged images, DNA (DAPI staining) is in blue, myc-YSKl is in red, and CM 130 is in green. 
Areas of overlap between YSKl and GM130 are in yellow.
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Figure 6.10 Depletion of GM130 disturbs YSK1/MST4 localisation
HeLa cells were treated with siRNA duplexes targeting either GM130 or lamin-A for 72 
hours prior to fixation with 3% PFA. Cells were then stained with sheep anti-GM 130 and 
rabbit anti-YSKl/MST4. In the merged images, DNA (DAPI staining) is in blue, GM130 is 
in red, and YSK1/MST4 is in green.
6.4 Discussion
6.4.1 YSKl and MST4 are Golgi-localised Ste20 kinases
Having serendipitously identified YSKl, a member of the GC-kinase subfamily of 
Ste20 kinases, as localising to the Golgi (Figure 6.1) we were able to show that the 
closely related protein MST4 is also located at the Golgi (Figure 6.4). A third closely 
related protein, MST3, did not localise to the Golgi, at least in HeLa cells (Figure 
6.4).
A rabbit polyclonal antibody was raised against bacterially expressed YSKl which 
stained the Golgi in HeLa and MelJuso cells by immunofluorescence (Figure 6.1 A 
and B), and recognised a protein of the correct size in HeLa and rat liver extracts by 
western blotting (Figure 6.2 A). Testing of the antibody on transfected HeLa extracts 
revealed that the antibody recognised both YSKl and MST4 but not MST3 (Figure
6.2 B). Thus, the antibody recognises both of the kinases, which localise to the Golgi. 
Since two commercially available antibodies specific for YSKl do not stain the Golgi 
in untransfected HeLa cells, but are capable of staining overexpressed YSKl (Figure 
6.3), the rabbit antibody most likely recognises MST4 in HeLa cells by 
immunofluorescence. mRNA for YSKl, MST3, and MST4 could all be detected by 
RT-PCR in HeLa cells (data not shown), but, taken together, these findings suggest 
that MST4 is the major Golgi-localised Ste20 kinase in HeLa cells.
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6,4,2 YSKl and MST4 bind the cw-Golgi matrix protein GM130
A yeast two hybrid screen was performed using YSKl as bait to screen a human testis 
cDNA library. Two positive clones were isolated, both of which were found to 
encode a novel variant of full length human GM130 containing a 27 amino acid 
insertion at position 57 (Figure 6.5). This insertion was not necessary for the 
interaction with YSKl since rat GM130 was also able to interact. The yeast two 
hybrid system was also used to show that MST4, but not MST3, is able to bind 
GM130 (Figure 6,6). The interactions of YSKl and MST4 with GM130 were shown 
to be direct in a binding assay using recombinantly expressed proteins (Figure 6.7). 
Thus, the two GC-kinases which localise to the Golgi are able to bind GM130 while 
MST3, which appears to be cytosolic, does not. This suggests that GMl30-binding 
may be the mechanism by which YSKl and MST4 localise to the Golgi.
The binding site for YSKl on G M l30 was mapped to amino acids 75-271 and is thus 
distinct from the p i 15 binding site which lies in the N-terminal 74 amino acids 
(Figure 6.5). MST4 also interacts with the first 271 amino acids of G M l30 (Figure 
6.6). Although the pi 15 and YSKl binding sites are distinct, it will be important to 
determine whether p i 15 and YSKl can bind GM l30 simultaneously, or whether two 
separate pools of GM l30 exist in vivo.
A 32 amino acid region lying C-terminal to the minimal kinase domain of YSKl was 
found to be required for the interaction with GM l30 (Figure 6.8). In vivo, kinase 
activity appears to be required for Golgi localisation, since two kinase dead point 
mutants, YSK1K49R and YSK1D158A, are distributed throughout the cytosol 
(Figure 6.9 and data not shown). The K49R mutant is still able to interact with 
G M l30 in the yeast two hybrid system however (data not shown). None of the 
deletion mutants tested targeted properly to the Golgi (Figure 6.9), possibly because 
YSKl folding is perturbed by these mutations and fails to adopt a native 
conformation, and thus lacks activity. The mutants do not aggregate, however, 
suggesting that the proteins are not completely misfolded.
Depletion of GM l30 by siRNA perturbs YSK1/MST4 localisation in a very similar 
manner to the effect seen on the distribution of p i 15 (compare Figures 3.13 A and
6.10). Although G M l30 depletion disrupts the overall structure of the Golgi 
apparatus, the similarity between pi 15 and YSK1/MST4 localisation upon siRNA
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treatment supports the idea that YSKl is at least partially localised to the Golgi by its 
interaction with GM l30.
6.4.3 Function of the GM130-YSK1/MST4 interaction
To date, no substrates have been identified for either YSKl or MST4. Having 
identified GM l30 as a YSKl/MST4-interacting protein, we tested in in vitro kinase 
assays whether it was also a target for phosphorylation by these kinases. GM l30 was 
not phosphorylated by YSKl or MST4 and neither were a number of other Golgi- 
localised proteins, including pi 15, golgin-45, GRASP55, and GRASP65 (Christian 
Preisinger, unpublished observations). YSKl is able to phosphorylate the model 
substrate myelin basic protein (MBP) in vitro however. We observed that this activity 
is greatly stimulated in the presence of the kinase-binding fragment of GM l30 in a 
dose-dependent manner (Figure 6.11). Similar results are obtained with MST4. This 
indicates that GM l30 is able to regulate the kinase activity of YSKl and MST4. The 
increase in kinase activity upon addition of G M l30 corresponds to the 
autophosphorylation of a threonine residue in the T-loop of the two kinases (Christian 
Preisinger, unpublished data). The 32 amino acids important for the interaction with 
G M l30 are between the kinase domain and C-terminal domain (believed to be 
regulatory in GC-kinases). This would place GM l30 binding in an excellent position 
to regulate kinase function.
It remains to be seen whether all Golgi-localised YSKl and MST4 in the cell is bound 
to G M l30 and whether all kinase bound to G M l30 is constitutively active. The 
kinases may cycle on and off from GMl 30/the Golgi, thereby undergoing a rapid 
cycle of activation/deactivation. The activity of phosphatases on the T-loop 
phosphorylation could regulate such a cycle. A further question is whether active 
YSK1/MST4 remains at the Golgi (and functions there), or whether, once activated, 
the kinase translocates to a different site to fulfil its function. The development of 
phospho-specific antibodies, specific for the active forms of YSKl and MST4, should 
help answer such questions.
Full activity of YSKl and MST4 may therefore require extra signals in addition to 
GM l30 binding, particularly if the physiological role of these kinases is in a specific 
signalling pathway rather than in a constitutive aspect of cellular function.
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Figure 6.11 GM130 stimulates the kinase activity of YSKl
(A) Increasing amounts of GST-GM130 amino acids 75-271 were added to an in vitro 
kinase assay containing recombinant YSKl and myelin basic protein (MBP). 
Phosphorylation of MBP was monitored by ^^P-labelling while YSKl and G M l30 levels 
were assessed by western blotting. Note that the amount of MBP-phosphorylation increases 
in proportion to the amount of G M l30 75-271 added to the assay. (B) Same as in (A) but 
using GST-golgin-45 amino acids 1-122 in place of GST-GM130 75-271. The 
phosphorylation of MBP by YSKl is not stimulated by the presence of golgin-45 1-122.
The data in this figure was kindly provided by Christian Preisinger.
6.4.4 Physiological function of YSKl and MST4
No physiological function has so far been shown for YSKl, although it has been 
suggested to be stimulated by oxidative stress (Pombo et al. 1996). MST4 has been 
implicated in cell growth and transformation via the ERK pathway (Lin et al. 2001),
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and has recently been found to be stimulated by EGF treatment of cells and to control 
anchorage-independent growth and proliferation (Sung et al. 2003).
The closely related kinase MST3 has been shown to activate p42/44 MAPK (Zhou et 
al. 2000) and has been proposed to have a pro-apoptotic function following caspase- 
mediated cleavage and nuclear translocation of the kinase domain (Huang et al. 
2002). A Drosophila homologue of the related kinases MSTl and MST2 has recently 
also been shown to promote apoptosis as well as restricting cell growth and 
proliferation (Harvey et al. 2003; Wu et al. 2003).
A role for MST-related kinases in apoptosis is potentially intriguing since, in addition 
to YSKl and MST4, GM l30 also binds p ll5  and GRASP65, two proteins known to 
be cleaved by caspases resulting, in the case of p i 15, in a pro-apoptotic cleavage 
fragment (Chiu et al. 2002; Lane et al. 2002).
Alternatively, the localisation of YSKl and MST4 to the Golgi could indicate a role in 
the regulation of cell polarity, as proposed for other Ste20 kinases (Holly and Blumer 
1999; Sells et al. 1999; Dan et al. 2001). Changes in cell polarity must be 
accompanied by cy to skeletal rearrangements and the secretion of proteins and lipids 
to specific subdomains of the plasma membrane. Golgi-localised kinases would be in 
an ideal location to regulate these processes.
Other signalling events are also now known to occur at the Golgi apparatus. Ras has 
recently been shown to be activated at the Golgi apparatus following the Src-and 
PLCy- dependent activation of the exchange factor RasGRPl (Chiu et al. 2002; 
Bivona et al. 2003). Why should signalling events such as this, which often result in 
alterations in transcription activity, be localised to the Golgi? One possibility is that 
the Golgi matrix offers an ideal structure for the organisation and regulation of 
signalling events, either downregulating pathways by sequestration of molecules or 
promoting signalling by organising proteins in close proximity to one another as seen 
for signalling events at the plasma membrane. Another possibility is that kinases such 
as YSKl and MST4 play a duel role. Firstly taking part in signal transduction 
pathways resulting in changes in transcriptional activity, but also then directly 
affecting certain aspects of Golgi structure and function. This could be important 
since any changes in cellular activity such as growth and proliferation rates or 
differentiation must be accompanied by changes in the rate and direction of 
membrane trafficking as well as cytoskeletal rearrangements. Co-ordination of the
137
Chapter 6: A Golgin-Kinase Complex
nuclear and Golgi localised events required to effect these changes would therefore be 
desirable. Identification of the physiological roles of YSKl and MST4, and their 
relationship to GM l30, must await identification of in vivo substrates however.
6.4.5 Summary
Two related Ste20 kinases, YSKl and MST4, were found to localise to the Golgi 
apparatus. A yeast two hybrid screen enabled the identification of the cw-Golgi 
matrix protein G M l30 as an interacting protein of both kinases and the reciprocal 
binding sites on YSKl and G M l30 were mapped. Although the physiological 
function of YSKl and MST4 is unclear, G M l30 binding appears to regulate their 
kinase activity.
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The integrity of the secretory and endocytic pathways depends upon the efficient 
packaging of cargo molecules into vesicles and their specific delivery to target 
membranes. In this thesis, I have focussed on the roles of the rab family of small 
GTPases and their effector proteins in vesicular transport, in particular on rab proteins 
localised to the Golgi apparatus.
Through their cycle of GTP binding and hydrolysis, rab proteins cycle through active 
and inactive, membrane-bound and cytosolic, states, thereby regulating membrane 
trafficking events. They have been shown to be involved in almost all stages of 
vesicle transport, from vesicle budding and motility to tethering and fusion (Zerial and 
McBride 2001).
Rab proteins accomplish all of this through the nucleotide-dependent recruitment of a 
variety of effector proteins. It has become clear, both through work presented here 
and through the published work of numerous other groups, that many of these 
effectors are coiled-coil proteins important for tethering membranes together and 
docking vesicles to their target membrane. Those coiled-coil tethering factors that are 
localised to the Golgi are collectively referred to as golgins.
Other rab effector proteins have different functions however. In this thesis I have 
presented data showing that rab effector proteins include microtubule-motor accessory 
proteins (BicD and pl50®’"''‘’), putative membrane protein-sorting proteins (GOPC), 
and kinase regulatory proteins (GM l30). Rab effectors may also include proteins 
involved in phosphoinositide metabolism (MTMR6 and Centaurin|32).
One interesting consideration is whether different rab proteins have similar 
complements of effector proteins. To date, rabl effectors (e.g. p i 15, GM130, golgin- 
84) have tended to be of the coiled-coil, membrane tethering type, while known rab6 
effectors (e.g. BicD, GOPC) ai*e more diverse in function and do not include
any conventional membrane docking proteins. Of course, more effector proteins of 
each rab probably remain to be identified and known effectors may prove to have
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additional functions, such as GM l30 activating the Ste20 kinases YSKl and MST4, 
but it is likely that the overall complement of effector-types differs between rabs. 
This would represent specialisations of rab proteins for specific transport steps and 
reflect the role of rabs as organisers of protein complexes at membrane surfaces to 
accomplish particular tasks.
Nevertheless, it is likely that membrane tethering is important for all vesicle 
trafficking steps. It is possible, however, that many of the coiled-coil proteins 
labelled simply as ‘tethering factors’ are, in fact, much more active in their function 
than previously thought. Golgin-84, for example, has been proposed to have a 
specific role in the lateral organisation of Golgi stacks (Diao et al. 2003), while p i 15 
may actively promote SNARE complex assembly for membrane fusion (Shorter et al. 
2002). One can imagine other possible functions for coiled-coil ‘tethering proteins’ 
such as negative regulation of membrane fusion by keeping membranes apart and 
providing transient binding sites for vesicles in order to limit their diffusion. The 
stacking of Golgi cisternae, for example, would represent a case in which membranes 
are tethered together but do not undergo fusion.
If there are such functional differences between golgins, structural differences 
between the proteins may be significant. Is the length of a golgin important? Why is 
G M l30 approximately three times the size of golgin-45 but three times smaller than 
giantin? Why are some golgins peripheral membrane proteins while others are 
integral membrane proteins? In some cases, the transmembrane domain of a golgin 
may be important for the proteins specific function. The transmembrane domain of 
Coy Ip (the yeast homologue of GASP, a golgin related to golgin-84 and giantin) is 
clearly important for some aspect of Coy Ip function, since mutation of conserved 
residues in the transmembrane domain abolishes a genetic interaction with the 
SNARE protein Goslp (Gillingham et al. 2002). This suggests that integral 
membrane golgins may link membrane tethering events to SNARE-mediated fusion 
events.
Further functional differences are likely to exist between golgin-type tethering 
proteins and multimeric tethering complexes such as the COG and VFT complexes. 
In yeast, Ypt6p has been shown to interact with the VFT complex (Siniossoglou and 
Pelham 2001), suggesting that rab proteins also regulate this type of tethering 
complex.
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Whatever the precise function of tethering factors such as p i 15 and G M l30, the 
question remains of how this function is regulated by rab proteins. The rab activity 
could simply be to recruit tethering factors to a specific part of the membrane, thereby 
facilitating their assembly into a docking complex. Alternatively, rab proteins might 
induce small conformational changes in their effectors, thereby activating or 
inhibiting their function. For example, the rab9 effector, TIP47, undergoes a 
conformational change upon rab9 binding, resulting in an increased affinity for the 
cytoplasmic domain of the mannose-6-phosphate receptor, which it helps to recycle 
back to the Golgi (Carroll et al. 2001). Rab binding might similarly alter the affinity 
of a tethering factor for its binding partner. On the other hand, larger rab-induced 
conformational changes in a golgin might directly assist vesicle docking and fusion by 
‘collapsing’ a tethered vesicle onto its target membrane. Breaks in the coiled-coil 
sequence of a golgin might act as hinges to facilitate such a process.
Another outstanding question is over the valency of rab-effector interactions. As 
demonstrated in chapter 3 of this thesis, G M l30 is an effector of rabl, rab2, and 
rab33b, while pi 15 is possibly an effector of rab33b as well as rabl. This is similar to 
the situation with endosome-associated tethering proteins where the effectors 
rabenosyn and rabaptin-5 bind both rab4 and rab5 (Vitale et al. 1998; de Renzis et al. 
2002). Does this reflect a function for GM130/pll5 in multiple processes, each one 
of which is regulated by a different rab? This would imply the existence of sub-pools 
of effector bound to different rabs, possibly with distinct localisations and binding 
partners. Or do multiple rabs bind to a single golgin as part of the same process and 
act co-operatively to ensure specificity? It remains to be seen whether multiple rabs 
can actually bind to a single effector simultaneously but one possibility is that 
multiple rab-binding occurs to order sequential events so that, for example, a rabl- 
GM 130-dependent process is followed by a rab2-GM 130-directed event.
The binding of effector proteins by multiple rabs lends an extra layer of complexity to 
the organisation of membrane domains by rab proteins. Different members of the rab 
family are able to target to specific compartments within the cell. Precisely how this 
targeting is achieved is unclear but, once a rab protein is localised and activated, it is 
able to recruit its effectors either from the cytosol or from within the two-dimensional 
plane of the membrane. These effectors can then be organised and a series of protein- 
protein and protein-lipid interactions set up to establish a specific membrane sub­
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domain. The participation of rab proteins at all stages of vesicle transport, from cargo 
selection to docking and fusion, suggests that vesicles may be looked on as rab- 
organised membrane sub-domains, which, during their lifetime, are able to physically 
separate from one membrane and join with another.
Essential to these events is the regulation of rab activity. An understanding of the 
function of specific nucleotide-exchange factors and GTPase activating proteins will 
be key to understanding how membrane trafficking events are regulated.
Thus, future work should focus on the regulation of rab activity as well as the 
regulation by rabs of their effector proteins and the specific functions of these 
effectors. A general view of the function of rab proteins is already in place; what 
remains is to develop a greater understanding of the specific ways in which individual 
transport steps are carried out.
142
Acknowledgments
First and foremost, I would like to thank Francis -  not because I have to thank my 
supervisor first but because Fm genuinely grateful for all his help and friendship over 
the past few years. I couldn’t have hoped to have a better grounding in cell biology, 
and the conversations have always been stimulating -  whether about science, politics, 
or football.
Thanks also to my colleagues in the lab -  Christian, Robert, Rudiger, and Evelyn -  for 
their help and for the enjoyable working environment. No thanks for the bad jokes 
though Christian. Fd also like to thank all previous members of the lab in Munich 
and Glasgow -  particularly Alex for his help with mapping the rab binding sites, Julia 
for her monastic silence and Mairi for all her technical help at the very beginning.
Fd also like to thank Professor Erich Nigg and his laboratory for support and 
discussions and especially the technical support staff for all their help.
Back in Glasgow, my thanks go to Olwyn (sorry things didn’t work out as originally 
envisioned but thanks for sticking with me), as well as Dave Barry and Bill Cushley 
for their encouragement and for accepting me on to the Wellcome PhD Programme in 
the first place. Thanks also to the Wellcome Trust and the Max Planck Society for 
their funding.
Many thanks to my family: To Mum, Dad, Reb, Beth, Jake, and Granny for all their 
support from the very, very beginning!
And thanks to all my friends including (pre-Glasgow) Pete, Pei, and Tom; (Glasgow) 
Emma, Pam, Gilles, Catherine, Lesley, Maria, and Daniel; (Munich) Olaf, Thibault,
Silvia, Bjorn, Ingvar, and my fellow Gooners at Gunther Murphys. And finally........
A Giulia, Martina e Guido: se avessi scritto tutte le cose meravigliose di voi su questa 
tesi sarebbe stata due volte piu lunga. Grazie per la vostra amicizia e il vostro 
supporto -  e'stato tutto piu facile e divertente con voi tre che mi facevate compagnia.
143
Bibliography
Alexandrov, K., H. Horiuchi, O. Steele-Mortimer, M. C. Seabra and M. Zerial (1994). 
"Rab escort protein-1 is a multifunctional protein that accompanies newly 
prenylated rab proteins to their target membranes." Embo J 13(22): 5262-73.
Allan, B. B., B. D. Moyer and W. E. Balch (2000). "Rabl recruitment of p ll5  into a 
cis-SNARE complex: programming budding COPII vesicles for fusion." 
Science 289154781: 444-8.
Allan, V. J., H. M. Thompson and M. A. McNiven (2002). "Motoring around the 
Golgi." Nat Cell Biol 4(10): E236-42.
Aivai'ez, C., R. Garcia-Mata, H. P. Hauri and E. Sztul (2001). "The pi 15-interactive 
proteins G M l30 and giantin participate in endoplasmic reticulum-Golgi 
ti’affic." JBioLChem 276(4): 2693-700.
Andag, U., T. Neumann and H. D. Schmitt (2001). "The coatomer-interacting protein 
Dsllp is required for Golgi-to-endoplasmic reticulum retrieval in yeast." J Biol 
Chem 276(42): 39150-60.
Antony, C., C. Cibert, G. Geraud, A. Santa Maria, B. Mai’o, V. Mayau and B. Goud 
(1992). "The small GTP-binding protein rab6p is distributed from medial 
Golgi to the trans-Golgi network as determined by a confocal microscopic 
approach." J Cell Sci 103 ( Ft 3): 785-96.
Audhya, A., M. Foti and S. D. Emr (2000). "Distinct roles for the yeast 
phosphatidylinositol 4-kinases, Stt4p and Piklp, in secretion, cell growth, and 
organelle membrane dynamics." Mol Biol Cell 11(8): 2673-89.
144
Bibliography
Baens, M. and P. Marynen (1997). "A human homologue (BICDl) of the Drosophila 
bicaudal-D gene." Genomics 45(3): 601-6.
Baker, D., L. Hicke, M. Rexach, M. Schleyer and R. Schekman (1988). 
"Reconstitution of SEC gene product-dependent intercompartmental protein 
transport." Cell 54(3): 335-44.
Barlowe, C. and R. Schekman (1993). "SEC12 encodes a guanine-nucleotide- 
exchange factor essential for transport vesicle budding from the ER." Nature 
365(6444): 347-9.
Barlowe, C., L. Orel, T. Yeung, M. Hosobuchi, S. Hamamoto, N. Salama, M. F. 
Rexach, M. Ravazzola, M. Amherdt and R. Schekman (1994). "COPII: a 
membrane coat formed by Sec proteins that drive vesicle budding from the 
endoplasmic reticulum." Cell 77(6): 895-907.
Barlowe, C. (1997). "Coupled ER to Golgi transport reconstituted with purified 
cytosolic proteins." J Cell Biol 139(5): 1097-108.
Barr, F. A. and G. Warren (1996). "Disassembly and reassembly of the Golgi 
apparatus." Semin Cell Biol 7: 505-510.
Barr, F. A., M. Puype, J. Vandekerckhove and G. Warren (1997). "GRASP65, a 
protein involved in the stacking of Golgi cisternae." Cell 91(2): 253-62.
Barr, F. A., N. Nakamura and G. Warren (1998). "Mapping the interaction between 
GRASP65 and G M l30, components of a protein complex involved in the 
stacking of Golgi cisternae." Embo J 17(12): 3258-68.
Barr, F. A. (1999). "A novel Rab6-interacting domain defines a family of Golgi- 
targeted coiled-coil proteins." Curr Biol 9(7): 381-4.
Bascom, R. A., S. Srinivasan and R. L. Nussbaum (1999). "Identification and 
characterization of golgin-84, a novel Golgi integral membrane protein with a 
cytoplasmic coiled-coil domain." J Biol Chem 274(5): 2953-62.
145
Bibliography
Bennett, M. K., N. Calakos and R. H. Scheller (1992). "Syntaxin: a synaptic protein 
implicated in docking of synaptic vesicles at presynaptic active zones." 
Science 257(5067): 255-9.
Bensen, E. S., B. G. Yeung and G. S. Payne (2001). "Riclp and the Ypt6p GTPase 
function in a common pathway required for localization of trans-Golgi 
network membrane proteins." Mol Biol Cell 12(1): 13-26.
Bivona, T. G., I. Perez De Castro, I. M. Ahearn, T. M. Grana, V. K. Chiu, P. J. 
Lockyer, P. J. Cullen, A. Pellicer, A. D. Cox and M. R. Philips (2003). 
"Phospholipase Cgamma activates Ras on the Golgi apparatus by means of 
RasGRPl." Nature 424(6949): 694-8.
Bivona, T. G. and M. R. Philips (2003). "Ras pathway signaling on endomembranes." 
Curr Qpin Cell Biol 15121: 136-42.
Block, M. R., B. S. Glick, C. A. Wilcox, F. T. Wieland and J. E. Rothman (1988). 
"Purification of an N-ethylmaleimide-sensitive protein catalyzing vesicular 
transport." Proc Natl Acad Sci U S A  85(21): 7852-6.
Bock, J. B., R. C. Lin and R. H. Scheller (1996). "A new syntaxin family member 
implicated in targeting of intracellular transport vesicles." J Biol Chem 
271(30): 17961-5.
Bock, J. B., J. Klumperman, S. Davanger and R. H. Scheller (1997). "Syntaxin 6 
functions in trans-Golgi network vesicle trafficking." Mol Biol Cell 8(7): 
1261-71.
Bock, J. B., H. T. Matern, A. A. Peden and R. H. Scheller (2001). "A genomic 
perspective on membrane compartment organization." Nature 409(6822): 839- 
41.
Bokoch, G. M. (2003). "Biology of the p21-Activated Kinases." Annu Rev Biochem.
Bolino, A., M. Muglia, F. L. Conforti, E. LeGuern, M. A. Salih, D. M. Georgiou, K. 
Christodoulou, I. Hausmanowa-Petrusewicz, P. Mandich, A. Schenone, A. 
Gambardella, F. Bono, A. Quattrone, M. Devoto and A. P. Monaco (2000).
146
Bibliography
"Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding 
myotubularin-related protein-2." Nat Genet 25(1): 17-9.
Brennwald, P., B. Kearns, K. Champion, S. Keranen, V. Bankaitis and P. Novick 
(1994). "Sec9 is a SNAP-25-like component of a yeast SNARE complex that 
may be the effector of Sec4 function in exocytosis." Cell 79(2): 245-58.
Bretscher, M. S. and S. Munro (1993). "Cholesterol and the Golgi apparatus." Science 
261(5126): 1280-1.
Bruns, J. R., M. A. Ellis, A. Jeromin and O. A. Weisz (2002). "Multiple roles for 
phosphatidylinositol 4-kinase in biosynthetic transport in polarized Madin- 
Darby canine kidney cells." J Biol Chem 277(3): 2012-8.
Burkhard, P., J. Stetefeld and S. V. Strelkov (2001). "Coiled coils: a highly versatile 
protein folding motif." Trends Cell Biol 11(2): 82-8.
Calero, M., C. Z. Chen, W. Zhu, N. Winand, K. A. Havas, P. M. Gilbert, C. G. Burd 
and R. N. Collins (2003). "Dual prénylation is required for rab protein 
localization and function." Mol Biol Cell 14(5): 1852-67.
Cantalupo, G., P. Alifano, V. Roberti, C. B. Bruni and C. Bucci (2001). "Rab- 
interacting lysosomal protein (RILP): the Rab7 effector required for transport 
to lysosomes." Embo J 20(4): 683-93.
Cao, X., N. Ballew and C. Barlowe (1998). "Initial docking of ER-derived vesicles 
requires Usolp and Yptlp but is independent of SNARE proteins." Embo J 
17(8): 2156-65.
Cao, X. and C. Barlowe (2000). "Asymmetric requirements for a Rab GTPase and 
SNARE proteins in fusion of COPII vesicles with acceptor membranes." J Cell 
Biol 149(1): 55-66.
Carroll, K. S., J. Hanna, I. Simon, J. Krise, P. Barbero and S. R. Pfeffer (2001). "Role 
of Rab9 GTPase in facilitating receptor recruitment by TIP47." Science 
292(5520): 1373-6.
147
Bibliography
Chan, E. K. L. and M. J. Fritzler (1998). "Golgins: coiled-coil proteins associated with 
the Golgi complex." Electron J Biotechnol 1: 1-10.
Charest, A., K. Lane, K. McMahon and D. E. Housman (2001). "Association of a 
novel PDZ domain-containing peripheral Golgi protein with the Q-SNARE 
(Q-soluble N-ethylmaleimide-sensitive fusion protein (NSF) attachment 
protein receptor) protein syntaxin 6." J Biol Chem 276(31): 29456-65.
Chaudhary, A., W. G. King, M. D. Mattaliano, J. A. Frost, B. Diaz, D. K. Morrison, 
M. H. Cobb, M. S. Marshall and J. S. Brugge (2000). "Phosphatidylinositol 3- 
kinase regulates Rafl through Pak phosphorylation of serine 338." Curr Biol 
10(9): 551-4.
Chavrier, P., R. G, Parton, H. P. Hauri, K. Simons and M. Zerial (1990). "Localization 
of low molecular weight GTP binding proteins to exocytic and endocytic 
compartments." Cell 62(2): 317-29.
Chavrier, P., J. P. Gorvel, E. Stelzer, K. Simons, J. Gruenberg and M. Zerial (1991). 
"Hypervariable C-terminal domain of rab proteins acts as a targeting signal. " 
Nature 353(6346): 769-72.
Cheng, J., B. D. Moyer, M. Milewski, J. Loffing, M. Ikeda, J. E. Mickle, G. R. 
Cutting, M. Li, B. A. Stanton and W. B. Guggino (2002). "A Golgi-associated 
PDZ domain protein modulates cystic fibrosis transmembrane regulator 
plasma membrane expression." J Biol Chem 277(5): 3520-9.
Chiu, R., L. Novikov, S. Mukherjee and D. Shields (2002). "A caspase cleavage 
fragment of p i 15 induces fragmentation of the Golgi apparatus and 
apoptosis." J Cell Biol 159(4): 637-48.
Chiu, V. K., T. Bivona, A. Hach, J. B. Sajous, J. Silletti, H. Wiener, R. L. Johnson, 
2nd, A. D. Cox and M. R. Philips (2002). "Ras signalling on the endoplasmic 
reticulum and the Golgi." Nat Cell Biol 4(5): 343-50.
Christoforidis, S., H. M. McBride, R. D. Burgoyne and M. Zerial (1999). "The Rab5 
effector EEAl is a core component of endosome docking." Nature 397(6720): 
621-5.
148
Bibliography
Christoforidis, S. and M. Zerial (2000). "Purification and identification of novel Rab 
effectors using affinity chromatography." Methods 20(4): 403-10.
Clary, D. O., I. C. Griff and J. E. Rothman (1990). "SNAPs, a family of NSF 
attachment proteins involved in intracellular membrane fusion in animals and 
yeast." Cell 61(4): 709-21.
Cluett, E. B. and W. J. Brown (1992). "Adhesion of Golgi cisternae by proteinaceous 
interactions: intercisternal bridges as putative adhesive structures." J Cell Sci 
103 ( Ft 3): 773-84.
Conibear, E. and T. H. Stevens (2000). "Vps52p, Vps53p, and Vps54p form a novel 
multisubunit complex required for protein sorting at the yeast late Golgi." Mol 
Biol Cell 11(11:305-23.
Cuif, M. H., F. Possmayer, H. Zander, N. Bordes, F. Jollivet, A. Couedel-Courteille, I. 
Janoueix-Lerosey, G. Langsley, M. Bornens and B. Goud (1999). 
"Characterization of GAPCenA, a GTPase activating protein for Rab6, part of 
which associates with the centrosome." Embo J 18(7): 1772-82.
Dalton, A. J. and M. D. Felix (1954). "Cytologic and cytochemical characteristics of 
the Golgi substance of epithelial cells of the epididymus in situ, in 
homogenates and after isolation." Am J Anat 94: 171-187.
Dan, I., N. M. Watanabe and A. Kusumi (2001). "The Ste20 group kinases as 
regulators of MAP kinase cascades." Trends Cell Biol 11(5): 220-30.
Dan, I., S. E. Ong, N. M. Watanabe, B. Blagoev, M. M. Nielsen, E. Kajikawa, T. Z. 
Kristiansen, M. Mann and A. Pandey (2002). "Cloning of MASK, a novel 
member of the mammalian germinal center kinase III subfamily, with 
apoptosis-inducing properties." J Biol Chem 277(8): 5929-39.
Dascher, C., R. Ossig, D. Gallwitz and H. D. Schmitt (1991). "Identification and 
structure of four yeast genes (SLY) that are able to suppress the functional loss 
of YPTl, a member of the RAS superfamily." Mol Cell Biol 11(2): 872-85.
149
Bibliography
Dasso, M. (2002). "The Ran GTPase: theme and variations." Curr Biol 12(14): R502- 
8 .
De Matteis, M., A. Godi and D. Corda (2002). "Phosphoinositides and the golgi 
complex." Curr Qpin Cell Biol 14(4): 434-47.
de Renzis, S., B. Sonnichsen and M. Zerial (2002). "Divalent Rab effectors regulate 
the sub-compartmental organization and sorting of early endosomes." Nat Cell 
Biol 4(2): 124-33.
Deacon, S. W., A. S. Serpinskaya, P. S. Vaughan, M. Lopez Fanarraga, I. Vernos, K. 
T. Vaughan and V. I. Gelfand (2003). "Dynactin is required for bidirectional 
organelle transport." J Cell Biol 160(3): 297-301.
Diao, A., D. Rahman, D. J. Pappin, J. Lucocq and M. Lowe (2003). "The coiled-coil 
membrane protein golgin-84 is a novel rab effector required for Golgi ribbon 
formation." J Cell Biol 160(2): 201-12.
Dirac-Svejstrup, A. B., T. Sumizawa and S. R. Pfeffer (1997). "Identification of a 
GDI displacement factor that releases endosomal Rab GTPases from Rab- 
GDI." EmboJ 16(3): 465-72.
Dominguez, M., K. Dejgaard, J. Fullekrug, S. Dahan, A. Fazel, J. P. Paccaud, D. Y. 
Thomas, J. J. Bergeron and T. Nilsson (1998). "gp25L/emp24/p24 protein 
family members of the cis-Golgi network bind both COP I and II coatomer." J 
Cell Biol 140141: 751-65.
Drogen, F., S. M. O’Rourke, V. M. Stucke, M. Jaquenoud, A. M. Neiman and M. 
Peter (2000). "Phosphorylation of the MEKK S tellp  by the PAK-like kinase 
Ste20p is required for MAP kinase signaling in vivo." Curr Biol 10(11): 630-9.
Duprez, E., J. H. Tong, J. Derre, S. J. Chen, R. Berger, Z. Chen and M. Lanotte
(1997). "JEM-1, a novel gene encoding a leucine-zipper nuclear factor 
upregulated during retinoid-induced maturation of NB4 promyelocytic 
leukaemia." Oncogene 14(13): 1563-70.
150
Bibliography
Echard, A., F. Jollivet, O. Martinez, J. J. Lacapere, A. Rousselet, I. Janoueix-Lerosey 
and B. Goud (1998). "Interaction of a Golgi-associated kinesin-like protein 
with Rab6." Science 279(5350): 580-5,
Echard, A., F. J. Opdam, H. J. de Leeuw, F. Jollivet, P. Savelkoul, W. Hendriks, J. 
Voorberg, B. Goud and J. A. Fransen (2000). "Alternative splicing of the 
human Rab6A gene generates two close but functionally different isoforms." 
Mol Biol Cell 11(11): 3819-33.
Elbashir, S. M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber and T. Tuschl
(2001). "Duplexes of 21-nucleotide RNAs mediate RNA interference in 
cultured mammalian cells." Nature 411(6836): 494-8.
Ellgaard, L. and A. Helenius (2001). "ER quality control: towards an understanding at 
the molecular level." Curr Qpin Cell Biol 13(4): 431-7.
Ellgaai'd, L. and A. Helenius (2003). "Quality control in the endoplasmic reticulum." 
Nat Rev Mol Cell Biol 4131: 181-91.
Farquhar, M. G. and G. E. Palade (1981). "The Golgi apparatus (complex)-(1954- 
1981)-from artifact to center stage." J Cell Biol 91(3 Pt 2): 77s-103s.
Fasshauer, D., W. K. Eliason, A. T. Brunger and R. Jahn (1998). "Identification of a 
minimal core of the synaptic SNARE complex sufficient for reversible 
assembly and disassembly." Biochemistry 37(29): 10354-62.
Fasshauer, D., W. Antonin, V. Subramaniam and R. Jahn (2002). "SNARE assembly 
and disassembly exhibit a pronounced hysteresis." Nat Struct Biol 9(2): 144- 
51.
Ferri, K. F. and G. Kroemer (2001). "Organelle-specific initiation of cell death 
pathways." Nat Cell Biol 3(11): E255-63.
Fleischer, B., S. Fleischer and H. Ozawa (1969). "Isolation and characterization of 
Golgi membranes from bovine liver." J Cell Biol 43(1): 59-79.
Franco, M., J. Boretto, S. Robineau, S. Monier, B. Goud, P. Chardin and P. Chavrier 
(1998). "ARN03, a Sec7-domain guanine nucleotide exchange factor for ADP
151
Bibliography
ribosylation factor 1, is involved in the control of Golgi structure and 
function." Proc Natl Acad Sci U S A  95(17): 9926-31.
Fries, E. and J. E. Rothman (1980). "Transport of vesicular stomatitis virus 
glycoprotein in a cell-free extract." Proc Natl Acad Sci U S A  77(7): 3870-4.
Fritzler, M. J., J. C. Hamel, R. L. Ochs and E. K. Chan (1993). "Molecular 
characterization of two human autoantigens: unique cDNAs encoding 95- and 
160-kD proteins of a putative family in the Golgi complex." J Exp Med 
178(1): 49-62.
Fritzler, M. J., C. C. Lung, J. C. Hamel, K. J. Griffith and E. K. Chan (1995). 
"Molecular characterization of Golgin-245, a novel Golgi complex protein 
containing a granin signature." J Biol Chem 270(52): 31262-8.
Gallwitz, D., C. Donath and C. Sander (1983). "A yeast gene encoding a protein 
homologous to the human c-has/bas proto-oncogene product." Nature 
306(5944): 704-7.
Gallwitz, D. and R. Jahn (2003). "The riddle of the Secl/Munc-18 proteins - new 
twists added to their interactions with SNAREs." Trends Biochem Sci 28(3): 
113-6.
Gentzsch, M., L. Cui, A. Mengos, X. B. Chang, J. H. Chen and J. R. Riordan (2003). 
"The PDZ-binding chloride channel C1C-3B localizes to the Golgi and 
associates with cystic fibrosis transmembrane conductance regulator- 
interacting PDZ proteins." J Biol Chem 278(8): 6440-9.
Ghosh, P., N. M. Dahms and S. Kornfeld (2003). "Mannose 6-phosphate receptors: 
new twists in the tale." Nat Rev Mol Cell Biol 4(3): 202-12.
Gillingham, A. K., A. C. Pfeifer and S. Munro (2002). "CASP, the alternatively 
spliced product of the gene encoding the CCA AT-displacement protein 
transcription factor, is a Golgi membrane protein related to giantin." Mol Biol 
Cell 13(11): 3761-74.
152
Bibliography
Gillingham, A. K. and S. Munro (2003). "Long coiled-coil proteins and membrane 
traffic." Biochim Biophys Acta 1641(2-3): 71-85.
Girod, A., B. Stome, J. C. Simpson, L. Johannes, B. Goud, L. M. Roberts, J. M. Lord, 
T. Nilsson and R. Pepperkok (1999). "Evidence for a COP-I-independent 
transport route from the Golgi complex to the endoplasmic reticulum." Nat 
Cell Biol 1(7): 423-30.
Goder, V. and M. Spiess (2001). "Topogenesis of membrane proteins: determinants 
and dynamics." FEBS Lett 504(3): 87-93.
Godi, A., I. Santone, P. Pertile, P. Devarajan, P. R. Stabach, J. S. Morrow, G. Di 
Tullio, R. Polishchuk, T. C. Petrucci, A. Luini and M. A. De Matteis (1998). 
"ADP ribosylation factor regulates spectrin binding to the Golgi complex." 
Proc Natl Acad Sci U S A 95( 151: 8607-12.
Godi, A., P. Pertile, R. Meyers, P. Marra, G. Di Tullio, C. lurisci, A. Luini, D. Corda 
and M. A. De Matteis (1999). "ARE mediates recruitment of PtdIns-4-OH 
kinase-beta and stimulates synthesis of PtdIns(4,5)P2 on the Golgi complex," 
Nat Cell Biol 1(5): 280-7.
Godman, G. C. and N. Lane (1964). J Cell Biol 21: 353-366.
Goldberg, J. (2000). "Decoding of sorting signals by coatomer through a GTPase 
switch in the COPI coat complex." Cell 100(6): 671-9.
Golgi, C. (1898). "Sur la structure des cellules nerveuses." Arch Ital Biol 30: 60-71.
Goud, B., A. Salminen, N. C. Walworth and P. J. Novick (1988). "A GTP-binding 
protein required for secretion rapidly associates with secretory vesicles and the 
plasma membrane in yeast." Cell 53(5): 753-68.
Goud, B., A. Zahraoui, A. Tavitian and J. Saraste (1990). "Small GTP-binding protein 
associated with Golgi cisternae." Nature 345(6275): 553-6.
Grasse, P. P. (1957). Acad Sci (Paris) 245: 1278-1281.
153
Bibliography
Griffith, K. J., E. K. Chan, C. C. Lung, J. C. Hamel, X. Guo, K. Miyachi and M. J. 
Fritzler (1997). "Molecular cloning of a novel 97-kd Golgi complex 
autoantigen associated with Sjogren's syndrome." Arthritis Rheum 40(9): 
1693-702.
Griffiths, G. and K. Simons (1986). "The trans Golgi network: sorting at the exit site 
of the Golgi complex." Science 234(4775): 438-43.
Hammond, A. T. and B. S. Glick (2000). "Dynamics of transitional endoplasmic 
reticulum sites in vertebrate cells." Mol Biol Cell 11(9): 3013-30.
Harter, C., J. Pavel, F. Coccia, E. Draken, S. Wegehingel, H. Tschochner and F. 
Wieland (1996). "Nonclathrin coat protein gamma, a subunit of coatomer, 
binds to the cytoplasmic dilysine motif of membrane proteins of the early 
secretory pathway." Proc Natl Acad Sci U S A 93(5): 1902-6.
Harvey, K. F., C. M. Pfleger and I. K. Hariharan (2003). "The Drosophila MST 
Ortholog, hippo. Restricts Growth and Cell Proliferation and Promotes 
Apoptosis." Cell 114: 457-467.
Hauri, H. P. and A. Schweizer (1992). "The endoplasmic reticulum-Golgi 
intermediate compartment." Curr Qpin Cell Biol 4(4): 600-8.
Hill, E., M. Clarke and F. A. Barr (2000). "The Rab6-binding kinesin, Rab6-KIFL, is 
required for cytokinesis." Embo J 19(21): 5711-9.
Holly, S. P. and K. J. Blumer (1999). "PAK-family kinases regulate cell and actin 
polarization throughout the cell cycle of Saccharomyces cerevisiae." J Cell 
Biol 147(4): 845-56.
Honing, S., M. Sosa, A. Hille-Rehfeld and K. von Figura (1997). "The 46-kDa 
mannose 6-phosphate receptor contains multiple binding sites for clathrin 
adaptors." J Biol Chem 212(32): 19884-90.
Hoogenraad, C. C., A. Akhmanova, S. A. Howell, B. R. Dortland, C. I. De Zeeuw, R. 
Willemsen, P. Visser, F. Grosveld and N. Galjart (2001). "Mammalian Golgi-
154
Bibliography
associated Bicaudal-D2 functions in the dynein-dynactin pathway by 
interacting with these complexes." Embo J 20(15): 4041-54.
Huang, C. Y., Y. M. Wu, C. Y. Hsu, W. S. Lee, M. D. Lai, T, J. Lu, C. L, Huang, T. 
H. Leu, H. M. Shih, H. I. Fang, D. R. Robinson, H. J. Kung and C. J. Yuan 
(2002). "Caspase activation of mammalian sterile 20-like kinase 3 (MstS). 
Nuclear translocation and induction of apoptosis." J Biol Chem 277(37): 
34367-74.
Hume, A. N., L. M. Collinson, A. Rapak, A. Q. Gomes, C. R. Hopkins and M. C. 
Seabra (2001). "Rab27a regulates the peripheral distribution of melanosomes 
in melanocytes." J Cell Biol 152(4): 795-808.
Hunt, J. M., K. Bommert, M. P. Charlton, A. Kistner, E. Habermann, G. J. Augustine 
and H. Betz (1994). "A post-docking role for synaptobrevin in synaptic vesicle 
fusion." Neuron 12(6): 1269-79.
Jackson, M. R., T. Nilsson and P. A. Peterson (1993). "Retrieval of transmembrane 
proteins to the endoplasmic reticulum." J Cell Biol 121(2): 317-33.
Jackson, T. R., B. G. Kearns and A. B. Theibert (2000). "Cytohesins and centaurins: 
mediators of PI 3-kinase-regulated Arf signaling." Trends Biochem Sci 
25(10): 489-95.
James, P., J. Halladay and E. A. Craig (1996). "Genomic libraries and a host strain 
designed for highly efficient two-hybrid selection in yeast." Genetics 144(4): 
1425-36.
Jordens, I., M, Fernandez-Borja, M. Marsman, S. Dusseljee, L. Janssen, J. Calafat, H. 
Janssen, R. Wubbolts and J. Neefjes (2001). "The Rab7 effector protein RILP 
controls lysosomal transport by inducing the recruitment of dynein-dynactin 
motors." Curr Biol 11(21): 1680-5.
Karcher, R. L., S. W. Deacon and V. I. Gelfand (2002). "Motor-cargo interactions: the 
key to transport specificity." Trends Cell Biol 12(1): 21-7.
155
Bibliography
Karki, S. and E. L. Holzbaur (1999). "Cytoplasmic dynein and dynactin in cell 
division and intracellular transport." Curr Qpin Cell Biol 11(1): 45-53.
Kaufman, R. J., D. Scheuner, M. Schroder, X. Shen, K. Lee, C. Y, Liu and S. M. 
Arnold (2002). "The unfolded protein response in nutrient sensing and 
differentiation." Nat Rev Mol Cell Biol 3(6): 411-21.
King, S. J. and T. A. Schroer (2000). "Dynactin increases the processivity of the 
cytoplasmic dynein motor." Nat Cell Biol 2(1): 20-4.
Kirchhausen, T. (2000). "Three ways to make a vesicle." Nat Rev Mol Cell Biol 1(3): 
187-98.
Kjer-Nielsen, L., R. D. Teasdale, C. van Vliet and P. A. Gleeson (1999). "A novel 
Golgi-localisation domain shared by a class of coiled-coil peripheral 
membrane proteins." Curr Biol 9(7): 385-8.
Klumperman, J., A. Schweizer, H. Clausen, B. L. Tang, W. Hong, V. Oorschot and H. 
P. Kauri (1998). "The recycling pathway of protein ERGIC-53 and dynamics 
of the ER-Golgi intermediate compartment." J Cell Sci 111 ( Ft 22): 3411-25.
Kooy, J., B. H. Toh, J. M. Pettitt, R. Erlich and P. A. Gleeson (1992). "Human 
autoantibodies as reagents to conserved Golgi components. Characterization of 
a peripheral, 230-kDa compartment-specific Golgi protein." J Biol Chem 
267(28): 20255-63.
Kornfeld, R. and S. Kornfeld (1985). "Assembly of asparagine-linked 
oligosaccharides." Annu Rev Biochem 54: 631-64.
Kumar, S., Y. Zhou and M. Plamann (2001). "Dynactin-membrane interaction is 
regulated by the C-terminal domains of pl50(Glued)." EMBO Rep 2(10): 939- 
44.
Kutay, U., E. Hartmann, N. Treichel, A. Calado, M. Carmo-Fonseca, S. Prehn, R. 
Kraft, D. Gorlich and P. R. Bischoff (2000). "Identification of two novel 
RanGTP-binding proteins belonging to the importin beta superfamily." J Biol 
Chem 275(51): 40163-8.
156
Bibliography
Kyriakis, J. M. (1999). "Signaling by the germinal center kinase family of protein 
kinases." J Biol Chem 274(9): 5259-62.
Lamson, R. E., M. J. Winters and P. M. Pryciak (2002). "Cdc42 regulation of kinase 
activity and signaling by the yeast p21-activated kinase Ste20." Mol Cell Biol 
22(9): 2939-51.
Lane, J. D., J. Lucocq, J. Pryde, F. A, Barr, P. G. Woodman, V. J. Allan and M. Lowe
(2002). "Caspase-mediated cleavage of the stacking protein GRASP65 is 
required for Golgi fragmentation during apoptosis." J Cell Biol 156(3): 495- 
509.
Laporte, J., L. J. Hu, C. Kretz, J. L. Mandel, P. Kioschis, J. F. Coy, S. M. Klauck, A. 
Poustka and N. Dahl (1996). "A gene mutated in X-linked myotubular 
myopathy defines a new putative tyrosine phosphatase family conserved in 
yeast." Nat Genet 13(2): 175-82.
Laporte, J., F. Blondeau, A. Buj-Bello, D. Tentler, C. Kretz, N. Dahl and J. L. Mandel
(1998). "Characterization of the myotubularin dual specificity phosphatase 
gene family from yeast to human." Hum Mol Genet 7(11): 1703-12.
Le Bot, N., C. Antony, J. White, E. Karsenti and I, Vernos (1998). "Role of xklp3, a 
subunit of the Xenopus kinesin II heterotrimeric complex, in membrane 
transport between the endoplasmic reticulum and the Golgi apparatus." J Cell 
BM  143(6): 1559-73.
Leberer, E., D. Dignard, D. Harcus, D. Y. Thomas and M. Whiteway (1992). "The 
protein kinase homologue Ste20p is required to link the yeast pheromone 
response G-protein beta gamma subunits to downstream signalling 
components." Embo J 11(13): 4815-24.
Lee, N., H. MacDonald, C. Reinhaid, R. Halenbeck, A. Roulston, T. Shi and L. T. 
Williams (1997). "Activation of hPAK65 by caspase cleavage induces some of 
the morphological and biochemical changes of apoptosis." Proc Natl Acad Sci 
U S A  94r25k 13642-7.
157
Bibliography
Leeuw, T., C. Wu, J. D. Schrag, M. Whiteway, D. Y. Thomas and E. Leberer (1998). 
"Interaction of a G-protein beta-subunit with a conserved sequence in 
Ste20/PAK family protein kinases." Nature 391(6663): 191-5.
Levine, T. P., C. Rabouille, R. H. Kieckbusch and G. Warren (1996). "Binding of the 
vesicle docking protein pi 15 to Golgi membranes is inhibited under mitotic 
conditions." J Biol Chem 2711291: 17304-11.
Lewis, M. J. and H. R. Pelham (1992). "Ligand-induced redistribution of a human 
KDEL receptor from the Golgi complex to the endoplasmic reticulum," Cell 
68(2): 353-64,
Li, B. and J. R. Warner (1996). "Mutation of the Rab6 homologue of Saccharomyces 
cerevisiae, YPT6, inhibits both early Golgi function and ribosome 
biosynthesis." J Biol Chem 2711281: 16813-9.
Lian, J. P., S. Stone, Y. Jiang, P. Lyons and S. Ferro-Novick (1994). "Yptlp 
implicated in v-SNARE activation." Nature 372(6507): 698-701.
Lin, J. L., H. C. Chen, H. I. Fang, D. Robinson, H. J. Kung and H. M, Shih (2001), 
"MST4, a new Ste20-related kinase that mediates cell growth and 
transformation via modulating ERK pathway," Oncogene 20(45): 6559-69.
Lin, R. C. and R. H. Scheller (1997). "Structural organization of the synaptic 
exocytosis core complex." Neuron 19(5): 1087-94.
Linstedt, A. D. and H. P. Hauri (1993). "Giantin, a novel conserved Golgi membrane 
protein containing a cytoplasmic domain of at least 350 kDa." Mol Biol Cell 
4(7): 679-93.
Linstedt, A. D., S. A. Jesch, A. Mehta, T. H. Lee, R. Garcia-Mata, D, S. Nelson and 
E. Sztul (2000). "Binding relationships of membrane tethering components. 
The giantin N terminus and the GM130 N terminus compete for binding to the 
pi 15 C terminus." J Biol Chem 275(14): 10196-201.
Lotti, L. V., M. R. Torrisi, M. C. Pascale and S. Bonatti (1992). 
"Immunocytochemical analysis of the transfer of vesicular stomatitis virus G
158
Bibliography
glycoprotein from the intermediate compartment to the Golgi complex." J Cell 
Biol 118(1): 43-50.
Lowe, M., C. Rabouille, N. Nakamura, R. Watson, M. Jackman, E. Jamsa, D. 
Rahman, D. J. Pappin and G. Warren (1998). "Cdc2 kinase directly 
phosphorylates the cis-Golgi matrix protein GM130 and is required for Golgi 
fragmentation in mitosis." Cell 94(6): 783-93.
Luo, Z. and D. Gallwitz (2003). "Biochemical and genetic evidence for the 
involvement of yeast Ypt6-GTPase in protein retrieval to different Golgi 
compartments." J Biol Chem 278(2): 791-9.
Lupashin, V. V. and M. G. Waters (1997). "t-SNARE activation through transient 
interaction with a rab-like guanosine triphosphatase." Science 276(5316): 
1255-8.
Mallard, P., B. L. Tang, T. Galli, D. Tenza, A. Saint-Pol, X. Yue, C. Antony, W. 
Hong, B. Goud and L. Johannes (2002). "Early/recycling endosomes-to-TGN 
transport involves two SNARE complexes and a Rab6 isoform." J Cell Biol 
156(4): 653-64.
Mancini, M., C. E. Machamer, S. Roy, D. W. Nicholson, N. A. Thornberry, L. A. 
Casciola-Rosen and A. Rosen (2000). "Caspase-2 is localized at the Golgi 
complex and cleaves golgin-160 during apoptosis." J Cell Biol 149(3): 603-12.
Martinez, O., A. Schmidt, J. Salamero, B. Hoflack, M. Roa and B. Goud (1994). "The 
small GTP-binding protein rab6 functions in intra-Golgi transport." J Cell Biol 
127(6 Pt 1): 1575-88.
Martinez, O., C. Antony, G. Pehau-Arnaudet, E. G. Berger, J. Salamero and B. Goud
(1997). "GTP-bound forms of rab6 induce the redistribution of Golgi proteins 
into the endoplasmic reticulum." Proc Natl Acad Sci U S A  94(5): 1828-33.
Matanis, T., A. Akhmanova, P. Wulf, E. Del Nery, T. Weide, T. Stepanova, N. 
Galjart, F. Grosveld, B. Goud, C. I. De Zeeuw, A. Barnekow and C. C. 
Hoogenraad (2002). "Bicaudal-D regulates COPI-independent Golgi-ER
159
Bibliography
transport by recruiting the dynein-dynactin motor complex." Nat Cell Biol 
4(12): 986-92.
Mayer, A. and W. Wickner (1997). "Docking of yeast vacuoles is catalyzed by the 
Ras-like GTPase Ypt7p after symmetric priming by Secl8p (NSF)." J Cell 
Biol 136(2): 307-17.
McBride, H. M., V. Rybin, C. Murphy, A. Giner, R. Teasdale and M. Zerial (1999). 
"Oligomeric complexes link Rab5 effectors with NSF and drive membrane 
fusion via interactions between EEAl and syntaxin 13." Cell 98(3): 377-86.
McConville, M. J., S. C. Ilgoutz, R. D. Teasdale, B. J. Foth, A. Matthews, K. A. 
Mullin and P. A. Gleeson (2002). "Targeting of the GRIP domain to the trans- 
Golgi network is conserved from protists to animals." Eur J Cell Biol 8119): 
485-95.
McNew, J. A., F. Parlati, R. Fukuda, R. J. Johnston, K. Paz, F. Paumet, T, H. Sollner 
and J. E. Rothman (2000). "Compartmental specificity of cellular membrane 
fusion encoded in SNARE proteins." Nature 407(6801): 153-9.
Mellman, I. and G. Warren (2000). "The road taken: past and future foundations of 
membrane traffic." Cell 100(1): 99-112.
Miller, E. A., T. H. Beilharz, P. N. Malkus, M. C. S. Lee, S. Hamamoto, L. Orel and 
R. Schekman (2003). "Multiple Cargo Binding Sites on the COPII Subunit 
Sec24p Ensure Capture of Diverse Membrane Proteins into Transport 
Vesicles." Cell 114: 497-509.
Monier, S., F. Jollivet, I. Janoueix-Lerosey, L. Johannes and B. Goud (2002). 
"Characterization of novel Rab6-interacting proteins involved in endosome-to- 
TGN transport." Traffic 3(4): 289-97.
Montecucco, C. and G. Schiavo (1995). "Structure and function of tetanus and 
botulinum neurotoxins." Q Rev Biophvs 28(4): 423-72.
160
Bibliography
Morre, J., L. M. Merlin and T. W. Keenan (1969). "Localization of glycosyl 
transferase activities in a Golgi apparatus-rich fraction isolated from rat liver." 
Biochem Biophvs Res Commun 37(51: 813-9.
Mossessova, E., L. C. Bickford and J. Goldberg (2003). "SNARE Selectivity of the 
COPII Coat." Cell 114: 483-495.
Moyer, B. D., B. B. Allan and W. E. Balch (2001). "Rabl interaction with a GM130 
effector complex regulates COPII vesicle cis-Golgi tethering." Traffic 2(4): 
268-76.
Munro, S. and H. R. Pelham (1987). "A C-terminal signal prevents secretion of 
luminal ER proteins." Cell 48(5): 899-907.
Munro, S. and B. J. Nichols (1999). "The GRIP domain - a novel Golgi-targeting 
domain found in several coiled-coil proteins." Curr Biol 9(7): 377-80.
Muresan, V., M. C. Stankewich, W. Steffen, J. S. Morrow, E. L. Holzbaur and B. J. 
Schnapp (2001). "Dynactin-dependent, dynein-driven vesicle transport in the 
absence of membrane proteins: a role for spectrin and acidic phospholipids." 
Mol Cell 7(11: 173-83.
Nakamura, N., C. Rabouille, R. Watson, T. Nilsson, N. Hui, P. Slusarewicz, T. E. 
Ki'eis and G. Warren (1995). "Characterization of a cis-Golgi matrix protein, 
GM130." J Cell Biol 131(6 Pt 2): 1715-26.
Nakamura, N., M. Lowe, T. P. Levine, C. Rabouille and G. Warren (1997). "The 
vesicle docking protein p i 15 binds GM130, a cis-Golgi matrix protein, in a 
mitotically regulated manner." Cell 89(3): 445-55.
Nelson, D. S., C. Alvarez, Y. S. Gao, R. Garcia-Mata, E. Fialkowski and E. Sztul
(1998). "The membrane transport factor TAP/pll5 cycles between the Golgi 
and earlier secretory compartments and contains distinct domains required for 
its localization and function," J Cell Biol 143(2): 319-31.
161
Bibliography
Neudauer, C. L., G. Joberty and I. G. Macara (2001). "PIST: a novel PDZ/coiled-coil 
domain binding partner for the rho-family GTPase TCIO." Biochem Biophvs 
Res Commun 280121: 541-7.
Neutra, M. and C. P. Leblond (1966). "Radioautographic comparison of the uptake of 
galactose-H and glucose-H3 in the golgi region of various cells secreting 
glycoproteins or mucopolysaccharides." J Cell Biol 3011): 137-50.
Nickel, W., T. Weber, J. A. McNew, F. Parlati, T. H. Sollner and J. E. Rothman
(1999), "Content mixing and membrane integrity during membrane fusion 
driven by pairing of isolated v-SNAREs and t-SNAREs." Proc Natl Acad Sci 
U S A  96(22): 12571-6.
Nielsen, E., S. Christoforidis, S. Uttenweiler-Joseph, M. Miaczynska, F. Dewitte, M. 
Wilm, B. Hoflack and M, Zerial (2000). "Rabenosyn-5, a novel Rab5 effector, 
is complexed with hVPS45 and recruited to endosomes through a FYVE 
finger domain." J Cell Biol 151(3): 601-12.
Nizak, C., S. Monier, E. del Nery, S. Moutel, B. Goud and F. Perez (2003). 
"Recombinant antibodies to the small GTPase Rab6 as conformation sensors." 
Science 300(5621): 984-7.
Novick, P., C. Field and R, Schekman (1980). "Identification of 23 complementation 
groups required for post-translational events in the yeast secretory pathway." 
Cell 21(1): 205-15.
Novick, P. and M. Zerial (1997). "The diversity of Rab proteins in vesicle transport." 
Curr Qpin Cell Biol 9(4): 496-504.
Nuoffer, C., H. W. Davidson, J. Matteson, J. Meinkoth and W. E. Balch (1994). "A 
GDP-bound of rabl inhibits protein export from the endoplasmic reticulum 
and transport between Golgi compartments." J Cell Biol 125(2): 225-37.
162
Nilsson, T. and G. Warren (1994). "Retention and retrieval in the endoplasmic 
reticulum and the Golgi apparatus." Curr Qpin Cell Biol 6(4): 517-21.
Bibliography
Odorizzi, G., M. Babst and S. D. Emr (2000). "Phosphoinositide signaling and the 
regulation of membrane trafficking in yeast." Trends Biochem Sci 25(5): 229- 
35.
Oh, J., K. Baksa and R. Steward (2000). "Functional domains of the Drosophila 
bicaudal-D protein." Genetics 154(2): 713-24.
Opdam, F. J., A. Echard, H. J. Croes, J. A. van den Hurk, R. A. van de Vorstenbosch, 
L. A. Ginsel, B. Goud and J. A. Fransen (2000). "The small GTPase Rab6B, a 
novel Rab6 subfamily member, is cell-type specifically expressed and 
localised to the Golgi apparatus." J Cell Sci 113 ( Pt 15): 2725-35.
Orci, L., M. Stamnes, M. Ravazzola, M. Amherdt, A. Perrelet, T. H. Sollner and J. E. 
Rothman (1997). "Bidirectional transport by distinct populations of COPI- 
coated vesicles." Cell 90(2): 335-49.
Orci, L., A. Perrelet and J. E. Rothman (1998). "Vesicles on strings: morphological 
evidence for processive transport within the Golgi stack. " Proc Natl Acad Sci 
U S A  95(5): 2279-83.
Osada, S., M. Izawa, R, Saito, K. Mizuno, A. Suzuki, S. Hirai and S. Ohno (1997). 
"YSKl, a novel mammalian protein kinase structurally related to Ste20 and 
SPSl, but is not involved in the known MAPK pathways." Oncogene 14(17): 
2047-57.
Palade, G. (1975). "Intracellular aspects of the process of protein synthesis." Science 
189(4200): 347-58.
Parlati, F., J. A. McNew, R. Fukuda, R. Miller, T. H. Sollner and J. E. Rothman
(2000). "Topological restriction of SNARE-dependent membrane fusion." 
Nature 407(6801): 194-8.
Patki, V., J. Virbasius, W. S. Lane, B. H. Toh, H. S. Shpetner and S. Corvera (1997). 
"Identification of an early endosomal protein regulated by phosphatidylinositol 
3-kinase." Proc Natl Acad Sci U S A  94(14): 7326-30.
163
Bibliography
Pelham, H. R. (1998). "Getting through the Golgi complex." Trends Cell Biol 8(1): 
45-9.
Peng, R., R. Grabowski, A. De Antoni and D. Gallwitz (1999). "Specific interaction 
of the yeast cis-Golgi syntaxin Sed5p and the coat protein complex II 
component Sec24p of endoplasmic reticulum-derived transport vesicles." Proc 
Natl Acad Sci U S A 96(71: 3751-6.
Plutner, H., A. D. Cox, S. Pind, R. Khosravi-Far, J. R. Bourne, R. Schwaninger, C. J. 
Der and W. E. Balch (1991). "Rablb regulates vesicular transport between the 
endoplasmic reticulum and successive Golgi compartments." J Cell Biol 
115(1): 31-43.
Pombo, C. M., J. V. Bon ventre, A. Molnar, J. Kyriakis and T. Force (1996). 
"Activation of a human Ste20-like kinase by oxidant stress defines a novel 
stress response pathway." Embo J 15(17): 4537-46.
Presley, J. F., N. B. Cole, T. A. Schroer, K. Hirschberg, K. J. Zaal and J. Lippincott- 
Schwartz (1997). "ER-to-Golgi transport visualized in living cells." Nature 
389(6646): 81-5.
Puertollano, R., R. C. Aguilar, I. Gorshkova, R. J. Crouch and J. S. Bonifacino 
(2001). "Sorting of mannose 6-phosphate receptors mediated by the GGAs." 
Science 292(5522): 1712-6.
Qian, Z., C. Lin, R. Espinosa, M. LeBeau and M. R. Rosner (2001). "Cloning and 
characterization of MST4, a novel Ste20-like kinase." J Biol Chem 276(25): 
22439-45.
Ran, B., R. Bopp and B. Suter (1994). "Null alleles reveal novel requirements for Bic- 
D during Drosophila oogenesis and zygotic development." Development 
120(5): 1233-42.
Rapoport, T. A., M. M. Rolls and B. Jungnickel (1996). "Approaching the mechanism 
of protein transport across the ER membrane." Curr Qpin Cell Biol 8(4): 499- 
504.
164
Bibliography
Reilly, B. A., B. A. Kraynack, S. M. VanRheenen and M. G. Waters (2001). "Golgi- 
to-endoplasmic reticulum (ER) retrograde traffic in yeast requires Dsllp, a 
component of the ER target site that interacts with a COPI coat subunit." Mol 
Biol Cell 12G2): 3783-96.
Rieder, S. E. and S. D, Emr (1997). "A novel RING finger protein complex essential 
for a late step in protein transport to the yeast vacuole." Mol Biol Cell 8(11): 
2307-27.
Rios, R. M. and M. Bornens (2003). "The Golgi apparatus at the cell centre," Curr 
Qpin Cell Biol 15(1): 60-6.
Robinson, M. S. and J. S. Bonifacino (2001). "Adaptor-related proteins." Curr Qpin 
Cell Biol 13(4): 444-53.
Rogalski, A. A., J. E. Bergmann and S. J. Singer (1984). "Effect of microtubule 
assembly status on the intracellular processing and surface expression of an 
integral protein of the plasma membrane." J Cell Biol 99(3): 1101-9.
Rohn, W. M., Y, Rouille, S. Waguri and B. Hoflack (2000). "Bi-directional 
trafficking between the trans-Golgi network and the endosomal/lysosomal 
system." J Cell Sci 113 ( Pt 12): 2093-101.
Rothman, J. E. (1994). "Mechanisms of intracellular protein transport." Nature 
372(6501): 55-63.
Rudel, T. and G. M. Bokoch (1997). "Membrane and morphological changes in 
apoptotic cells regulated by caspase-mediated activation of PAK2." Science 
276(5318): 1571-4.
Rybin, V., O. Ullrich, M. Rubino, K. Alexandrov, I. Simon, M. C, Seabra, R. Goody 
and M. Zerial (1996). "GTPase activity of Rab5 acts as a timer for endocytic 
membrane fusion." Nature 383(6597): 266-9.
Sacher, M., J. Barrowman, W. Wang, J. Horecka, Y. Zhang, M. Pypaert and S. Ferro- 
Novick (2001). "TRAPP I implicated in the specificity of tethering in ER-to- 
Golgi transport." Mol Cell 7(2): 433-42.
165
Bibliography
Salminen, A. and P. J. Novick (1987). "A ras-like protein is required for a post-Golgi 
event in yeast secretion." Cell 49(4): 527-38.
Sambrook, J., E. F. Fritsch and T. Maniatis (1989). Molecular Cloning: A Laboratorv 
Manual (Second Edition! Cold Spring Harbor Laboratory Press.
Sapperstein, S. K., D. M. Walter, A. R. Grosvenor, J. E. Heuser and M. G. Waters 
(1995). "pi 15 is a general vesicular transport factor related to the yeast 
endoplasmic reticulum to Golgi transport factor Usolp." Proc Natl Acad Sci U 
S A 92(21: 522-6.
Sapperstein, S. K., V. V. Lupashin, H. D. Schmitt and M. G. Waters (1996). 
"Assembly of the ER to Golgi SNARE complex requires Usolp." J Cell Biol 
132(5): 755-67.
Satoh, A., Y. Wang, J. Malsam, M. B. Beard and G. Warren (2003). "Golgin-84 is a 
rabl Binding Partner Involved in Golgi Structure." Traffic 4(3): 153-61.
Schaletzky, J., S. K. Dove, B. Short, O. Lorenzo, M. J. Clague and F. A. Barr (2003). 
"Phosphatidylinositol-5-phosphate activation and conserved substrate 
specificity of the myotubularin phosphatidylinositol 3-phosphatases." Curr 
Biol 13(6): 504-9.
Schinkmann, K. and J. Blenis (1997). "Cloning and characterization of a human 
STE20-like protein kinase with unusual cofactor requirements." J Biol Chem 
272(45): 28695-703.
Schurmann, A., A. F. Mooney, L. C. Sanders, M. A. Sells, H. G. Wang, J. C. Reed 
and G. M. Bokoch (2000). "p21-activated kinase 1 phosphorylates the death 
agonist bad and protects cells from apoptosis." Mol Cell Biol 20(2): 453-61.
Schweizer, A,, J. A. Fransen, T. Bachi, L. Ginsel and H. P. Hauri (1988). 
"Identification, by a monoclonal antibody, of a 53-kD protein associated with 
a tubulo-vesicular compartment at the cis-side of the Golgi apparatus." J Cell 
Biol 107(5): 1643-53.
166
Bibliography
Seemann, J., E. Jokitalo, M. Pypaert and G. Warren (2000). "Matrix proteins can 
generate the higher order architecture of the Golgi apparatus." Nature 
407(6807): 1022-6.
Segev, N., J. Mulholland and D. Botstein (1988). "The yeast GTP-binding YPTi 
protein and a mammalian counterpart are associated with the secretion 
machinery." Cell 52(6): 915-24.
Sells, M. A., U. G. Knaus, S. Bagrodia, D. M. Ambrose, G. M. Bokoch and J. 
Chernoff (1997). "Human p21-activated kinase (Pakl) regulates actin 
organization in mammalian cells." Curr Biol 7(3): 202-10.
Sells, M. A., J. T. Boyd and J. Chernoff (1999). "p21-activated kinase 1 (Pakl) 
regulates cell motility in mammalian fibroblasts." J Cell Biol 145(4): 837-49.
Serafini, T., G. Stenbeck, A. Brecht, F. Lottspeich, L. Orci, J. E. Rothman and F. T. 
Wieland (1991). "A coat subunit of Golgi-derived non-clathrin-coated vesicles 
with homology to the clathrin-coated vesicle coat protein beta-adaptin." 
Nature 349(6306): 215-20.
Shanks, R. A., B. T. Steadman, P. H. Schmidt and J. R. Goldenring (2002). 
"AKAP350 at the Golgi apparatus. I. Identification of a distinct Golgi 
apparatus targeting motif in AKAP350." J Biol Chem 277(43): 40967-72.
Shevchenko, A., M. Wilm, O. Vorm and M. Mann (1996). "Mass spectrometric 
sequencing of proteins silver-stained polyacrylamide gels." Anal Chem 68(5): 
850-8.
Short, B., C. Preisinger, J. Schaletzky, R. Kopajtich and F. A. Barr (2002). "The Rab6 
GTPase regulates recruitment of the dynactin complex to Golgi membranes." 
CuiT Biol 12(20): 1792-5.
Shorter, J. and G. Warren (1999). "A role for the vesicle tethering protein, p i 15, in 
the post-mitotic stacking of reassembling Golgi cisternae in a cell-free 
system." J Cell Biol 146(1): 57-70.
167
Bibliography
Shorter, J., R. Watson, M. E. Giannakou, M. Clarke, G. Warren and F. A. Barr (1999). 
’'GRASP55, a second mammalian GRASP protein involved in the stacking of 
Golgi cisternae in a cell-free system." Embo J 18(18): 4949-60.
Shorter, J., M. B. Beard, J. Seemann, A. B, Dirac-Svejstrup and G. Warren (2002). 
"Sequential tethering of Golgins and catalysis of SNAREpin assembly by the 
vesicle-tethering protein pi 15." J Cell Biol 157(1): 45-62.
Simonsen, A., R. Lippe, S. Christoforidis, J. M. Gaullier, A. Brech, J. Callaghan, B, 
H. Toh, C. Murphy, M. Zerial and H. Stenmark (1998). "EEAl links PI(3)K 
function to Rab5 regulation of endosome fusion." Nature 394(6692): 494-8.
Simonsen, A., J. M. Gaullier, A. D'Arrigo and H. Stenmark (1999). "The Rab5 
effector EEAl interacts directly with syntaxin-6." J Biol Chem 274(411: 
28857-60.
Siniossoglou, S., S. Y. Peak-Chew and H. R. Pelham (2000). "Riclp and Rgplp form 
a complex that catalyses nucleotide exchange on Ypt6p." Embo J 19(18): 
4885-94.
Siniossoglou, S. and H. R. Pelham (2001). "An effector of Ypt6p binds the SNARE 
Tig Ip and mediates selective fusion of vesicles with late Golgi membranes." 
Embo J 20(211: 5991-8.
Slusarewicz, P., T. Nilsson, N. Hui, R. Watson and G. Warren (1994). "Isolation of a 
matrix that binds medial Golgi enzymes." J Cell Biol 124(4): 405-13.
Sollner, T., S. W. Whiteheart, M. Brunner, H. Erdjument-Bromage, S. Geromanos, P. 
Tempst and J. E. Rothman (1993). "SNAP receptors implicated in vesicle 
targeting and fusion." Nature 362(6418): 318-24.
Sonnichsen, B., M. Lowe, T. Levine, E. Jamsa, B. Dirac-Svejstrup and G. Warren 
(1998). "A role for giantin in docking COPI vesicles to Golgi membranes." J 
Cell Biol 140(51: 1013-21.
Stack, J. H., D. B. DeWald, K. Takegawa and S. D. Emr (1995). "Vesicle-mediated 
protein transport: regulatory interactions between the Vpsl5 protein kinase
168
Bibliography
and the Vps34 Ptdlns 3-kinase essential for protein sorting to the vacuole in 
yeast." J Cell Biol 129(2): 321-34.
Stamnes, M. A. and J. E. Rothman (1993). "The binding of AP-1 clathrin adaptor 
particles to Golgi membranes requires ADP-ribosylation factor, a small GTP- 
binding protein." Cell 73(5): 999-1005,
Stenmark, H., R. Aasland, B. H. Toh and A. D'Arrigo (1996). "Endosomal 
localization of the autoantigen EEAl is mediated by a zinc-binding FYVE 
finger." J Biol Chem 271(39): 24048-54.
Stephens, D. J., N. Lin-Marq, A. Pagano, R. Pepperkok and J. P. Paccaud (2000). 
"COPI-coated ER-to-Golgi transport complexes segregate from COPII in close 
proximity to ER exit sites." J Cell Sci 113 ( Pt 12): 2177-85.
Sung, V., W. Luo, D. Qian, I. Lee, B. Jallal and M. Gishizky (2003). "The Ste20 
kinase MST4 plays a role in prostate cancer progression." Cancer Res 63(12): 
3356-63.
Suter, B., L. M. Romberg and R. Steward (1989). "Bicaudal-D, a Drosophila gene 
involved in developmental asymmetry: localized transcript accumulation in 
ovaries and sequence similarity to myosin heavy chain tail domains." Genes 
Dev3(12A): 1957-68.
Sutteiiin, C., P. Hsu, A. Mallabiabarrena and V. Malhotra (2002). "Fragmentation and 
dispersal of the pericentriolar Golgi complex is required for entry into mitosis 
in mammalian cells." Cell 109(3): 359-69.
Sutton, R. B., D. Fasshauer, R. Jahn and A. T. Brunger (1998), "Crystal structure of a 
SNARE complex involved in synaptic exocytosis at 2.4 A resolution." Nature 
395(6700): 347-53.
Swan, A., T. Nguyen and B. Suter (1999). "Drosophila Lissencephaly-1 functions 
with Bic-D and dynein in oocyte determination and nuclear positioning." Nat 
Cell Biol 1(7): 444-9.
169
Bibliography
Sweeney, D. A., A, Siddhanta and D. Shields (2002). "Fragmentation and re-assembly 
of the Golgi apparatus in vitro. A requirement for phosphatidic acid and 
phosphatidylinositol 4,5-bisphosphate synthesis." J Biol Chem 277(4): 3030-9.
Tang, B. L., S. H. Low, H. P. Hauri and W. Hong (1995). "Segregation of ERGIC53 
and the mammalian KDEL receptor upon exit from the 15 degrees C 
compartment." Eur J Cell Biol 68(4): 398-410.
Taylor, R. S., C. C. Wu, L. G. Hays, J. K, Eng, J. R. Yates, 3rd and K. E. Howell
(2000). "Proteomics of rat liver Golgi complex: minor proteins are identified 
through sequential fractionation." Electrophoresis 21(16): 3441-59.
TerBush, D. R., T. Maurice, D. Roth and P. Novick (1996). "The Exocyst is a 
multiprotein complex required for exocytosis in Saccharomyces cerevisiae." 
Embo J 15(23): 6483-94.
Thurmond, D. C., B. P. Ceresa, S. Okada, J. S. Elmendorf, K. Coker and J. E. Pessin 
(1998). "Regulation of insulin-stimulated GLUT4 translocation by Muncl8c 
in 3T3L1 adipocvtes." J Biol Chem 273(501: 33876-83.
Tisdale, E. J., J. R. Bourne, R. Khosravi-Far, C. J. Der and W. E. Balch (1992). "GTP- 
binding mutants of rabl and rab2 are potent inhibitors of vesicular transport 
from the endoplasmic reticulum to the Golgi complex." J Cell Biol 119(41: 
749-61.
Tisdale, E. J. and W. E. Balch (1996). "Rab2 is essential for the maturation of pre- 
Golgi intermediates." J Biol Chem 271(46): 29372-9.
Toonen, R. F. and M. Verhage (2003). "Vesicle trafficking: pleasure and pain from 
SM genes." Trends Cell Biol 13(4): 177-86.
Trimble, W. S., D. M. Cowan and R. H. Scheller (1988). "VAMP-1: a synaptic 
vesicle-associated integral membrane protein." Proc Natl Acad Sci U S A  
85(12): 4538-42.
170
Bibliography
Trombetta, E. S. and A. Helenius (2000). "Conformational requirements for 
glycoprotein reglucosylation in the endoplasmic reticulum." J Cell Biol 
148(6): 1123-29.
Tsukada, M., E. Will and D. Gallwitz (1999). "Structural and functional analysis of a 
novel coiled-coil protein involved in Ypt6 GTPase-regulated protein transport 
in yeast." Mol Biol Cell 10(1): 63-75.
Valsdottir, R., H. Hashimoto, K. Ashman, T. Koda, B. Storrie and T. Nilsson (2001). 
"Identification of rabaptin-5, rabex-5, and GM130 as putative effectors of 
rab33b, a regulator of retrograde traffic between the Golgi apparatus and ER." 
FEBS Lett 508(21: 201-9.
Van Valkenburgh, H., J. F. Shern, J. D. Sharer, X. Zhu and R. A. Kahn (2001). "ADP- 
ribosylation factors (ARFs) and ARF-like 1 (ARLl) have both specific and 
shared effectors: characterizing ARLl-binding proteins." J Biol Chem 
276(25): 22826-37.
Vasile, E., T. Perez, N. Nakamura and M. Krieger (2003). "Structural Integrity of the 
Golgi is Temperature Sensitive in Conditional-Lethal Mutants with No 
Detectable GM130." Traffic 4(4): 254-72.
Vaughan, K. T. and R. B. Vallee (1995). "Cytoplasmic dynein binds dynactin through 
a direct interaction between the intermediate chains and pl50Glued." J Cell 
Biol 131(6 Pt 1): 1507-16.
Vitale, G., V. Rybin, S. Christoforidis, P. Thornqvist, M. McCaffrey, H. Stenmark 
and M. Zerial (1998). "Distinct Rab-binding domains mediate the interaction 
of Rabaptin-5 with GTP-bound Rab4 and Rab5." Embo J 17(7): 1941-51.
von Mollard, G. F., S. F. Nothwehr and T. H. Stevens (1997). "The yeast v-SNARE 
Vtilp mediates two vesicle transport pathways through interactions with the t- 
SNAREs Sed5p and Pepl2p." J Cell Biol 137(7): 1511-24,
Wang, W., M. Sacher and S. Ferro-Novick (2000). "TRAPP stimulates guanine 
nucleotide exchange on Yptlp." J Cell Biol 151(2): 289-96.
171
Bibliography
Ward, T. H., R. S. Polishchuk, S. Caplan, K. Hirschberg and J. Lippincott-Schwartz
(2001). "Maintenance of Golgi structure and function depends on the integrity 
of ER export." J Cell Biol 155(4): 557-70.
Warren, G, and V. Malhotra (1998). "The organisation of the Golgi apparatus." Curr 
Qpin Cell Biol 10(4): 493-8.
Waterman-Storer, C. M., S. Karki and E. L. Holzbaur (1995). "The pl50Glued 
component of the dynactin complex binds to both microtubules and the actin- 
related protein centractin (Arp-1)." Proc Natl Acad Sci U S A  92(5): 1634-8.
Waters, M. G., T. Serafini and J. E. Rothman (1991). "'Coatomer': a cytosolic protein 
complex containing subunits of non-clathrin-coated Golgi transport vesicles." 
Nature 349(6306): 248-51.
Waters, M. G., D. O. Clary and J. E. Rothman (1992). "A novel 115-kD peripheral 
membrane protein is required for intercisternal transport in the Golgi stack." J 
Cell Biol 118(5): 1015-26.
Weber, T., B. V. Zemelman, J. A. McNew, B. Westermann, M. Gmachl, F. Parlati, T. 
H. Sollner and J. E. Rothman (1998). "SNAREpins: minimal machinery for 
membrane fusion." Cell 92(6): 759-72.
Weide, T., M. Bayer, M. Koster, J. P. Siebrasse, R, Peters and A. Barnekow (2001). 
"The Golgi matrix protein GM130: a specific interacting partner of the small 
GTPase rablb." EMBO Rep 2(4): 336-41.
Weide, T., J. Teuber, M. Bayer and A. Barnekow (2003), "MICAL-1 isoforms, novel 
rabl interacting proteins," Biochem Biophvs Res Commun 306(1): 79-86.
Wharton, R. P. and G. Struhl (1989). "Structure of the Drosophila BicaudalD protein 
and its role in localizing the the posterior determinant nanos." Cell 59(5): 881- 
92.
White, J., L. Johannes, F. Mallard, A. Girod, S. Grill, S. Reinsch, P. Keller, B. 
Tzschaschel, A. Echard, B. Goud and E. H. Stelzer (1999). "Rab6 coordinates
172
Bibliography
a novel Golgi to ER retrograde transport pathway in live cells," J Cell Biol 
147(4); 743-60.
Whitters, E. A., A. E. Cleves, T. P. McGee, H. B. Skinner and V. A. Bankaitis (1993). 
"SACIp is an integral membrane protein that influences the cellular 
requirement for phospholipid transfer protein function and inositol in yeast." J 
Cell Biol 122(11: 79-94.
Whyte, J. R. and S. Munro (2001). "The Sec34/35 Golgi transport complex is related 
to the exocyst, defining a family of complexes involved in multiple steps of 
membrane traffic." Dev Cell 1(4): 527-37.
Whyte, J. R. and S. Munro (2002). "Vesicle tethering complexes in membrane 
traffic." J Cell Sci 115(Pt 13): 2627-37.
Wilson, D. W., C. A. Wilcox, G. C. Flynn, E. Chen, W. J. Kuang, W. J. Henzel, M. R. 
Block, A. Ullrich and J. E. Rothman (1989). "A fusion protein required for 
vesicle-mediated transport in both mammalian cells and yeast." Nature 
339(6223): 355-9.
Wishart, M. J. and J. E. Dixon (2002). "PTEN and myotubularin phosphatases: from 
3-phosphoinositide dephosphorylation to disease. Phosphatase and tensin 
homolog deleted on chromosome ten." Trends Cell Biol 12(12): 579-85.
Wu, C., M. White way, D. Y. Thomas and E, Leberer (1995). "Molecular 
characterization of Ste20p, a potential mitogen-activated protein or 
extracellular signal-regulated kinase kinase (MEK) kinase kinase from 
Saccharomyces cerevisiae." J Biol Chem 270(271: 15984-92.
Wu, S., J. Huang, J. Dong and D. Pan (2003). "hippo Encodes a Ste-20 Family Protein 
Kinase that Restricts Cell Proliferation and Promotes Apoptosis in 
Conjunction with Salvador and warts" Cell 114: 445-456.
173
Bibliography
Wu, X., K. Rao, M. B. Bowers, N. G. Copeland, N. A. Jenkins and J. A. Hammer, 3rd
(2001). "Rab27a enables myosin Va-dependent melanosome capture by 
recruiting the myosin to the organelle." J Cell Sci 114(Pt 6): 1091-100,
Wu, X. S., K. Rao, H. Zhang, F. Wang, J. R. Sellers, L. E. Matesic, N. G. Copeland, 
N. A. Jenkins and J. A. Hammer, 3rd (2002). "Identification of an organelle 
receptor for myosin-Va." Nat Cell Biol 4(4): 271-8.
Yamakawa, H., D. H. Seog, K. Yoda, M. Yamasaki and T. Wakabayashi (1996). 
"Usol protein is a dimer with two globular heads and a long coiled-coil tail." J 
Sti'uct Biol 116(3): 356-65.
Yao, R., T. Maeda, S. Takada and T. Noda (2001). "Identification of a PDZ domain 
containing Golgi protein, GOPC, as an interaction partner of frizzled." 
Biochem Biophvs Res Commun 286(4): 771-8.
Yao, R., C. Ito, Y. Natsume, Y. Sugitani, H. Yamanaka, S. Kuretake, K. Yanagida, A. 
Sato, K. Toshimori and T. Noda (2002). "Lack of acrosome formation in mice 
lacking a Golgi protein, GOPC." Proc Natl Acad Sci U S A 99(17): 11211-6.
Yoshihisa, T., C. Barlowe and R. Schekman (1993). "Requirement for a GTPase- 
activating protein in vesicle budding from the endoplasmic reticulum." 
Science 259(5100): 1466-8.
Yue, Z., A. Horton, M. Bravin, P. L. DeJager, F. Selimi and N. Heintz (2002). "A 
novel protein complex linking the delta 2 glutamate receptor and autophagy: 
implications for neurodegeneration in lurcher mice." Neuron 35(5): 921-33.
Zerangue, N., B. Schwappach, Y. N. Jan and L. Y. Jan (1999). "A new ER trafficking 
signal regulates the subunit stoichiometry of plasma membrane K(ATP) 
channels." Neuron 22(3): 537-48.
Zerial, M. and H. McBride (2001). "Rab proteins as membrane organizers." Nat Rev 
Mol Cell Biol 2(2\. 107-17.
174
Bibliography
Zheng, J. Y., T. Koda, T. Fujiwara, M. Kishi, Y. Ikehara and M. Kakinuma (1998). 
"A novel Rab GTPase, Rab33B, is ubiquitously expressed and localized to the 
medial Golgi cisternae." J Cell Sci 111 ( Pt 8): 1061-9.
Zhou, T. H., K. Ling, J. Guo, H. Zhou, Y. L. Wu, Q. Jing, L. Ma and G. Pei (2000). 
"Identification of a human brain-specific isoform of mammalian STE20-like 
kinase 3 that is regulated by cAMP-dependent protein kinase." J Biol Chem 
275(4): 2513-9.
Zhu, Y., B. Doray, A. Poussu, V. P. Lehto and S. Kornfeld (2001). "Binding of GGA2 
to the lysosomal enzyme sorting motif of the mannose 6-phosphate receptor." 
Science 292(55221: 1716-8.
175
